Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3019473	li-prot	mg/l (mg/l)	9912	13585	0.12%
3019473	li-prot	— (—)	620	706	100.00%	Distribution not available
3019473	li-prot	g/l (mg/l)	206	233	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Viral encephalitis, not elsewhere classified/unspecified

248

139

25.89

322.46

1.6

1.4

705.58

454.70

mg/l

6.72

238

132

Anxiety disorders, excluding more controls

2000

4985

2.67

314.66

1.4

1.3

521.89

546.38

mg/l

0.38

1894

4786

Other and unspecified polyneuropathies, also in other diseases

704

1497

5.04

311.61

1.3

619.96

545.14

mg/l

1.00

681

1407

Psychiatric diseases

2309

4620

2.56

308.24

1.4

500.17

554.06

mg/l

2.53

2180

4438

Other demyelinating diseases of the central nervous system

419

300

18.90

307.65

1.2

1.4

412.89

501.08

mg/l

2.21

408

284

Other neurological diseases

2900

4879

4.95

307.65

1.6

1.2

516.19

564.71

mg/l

1.32

2782

4624

Migraine

1545

3630

3.58

307.65

1.4

421.96

502.12

mg/l

3.69

1484

3460

Malaise and fatigue

1524

2832

4.51

307.65

1.3

1.2

539.47

519.12

mg/l

0.26

1455

2688

Abnormalities of gait and mobility

561

816

7.61

307.65

1.4

524.45

540.94

mg/l

0.16

540

767

Alzheimer’s disease (Late onset), excluding more controls

447

152

20.42

307.65

1.2

1.1

484.62

596.77

mg/l

1.59

394

143

Any dementia

1111

1843

4.38

307.65

1.2

1.3

506.16

570.27

mg/l

1.47

1014

1759

Hydrocephalus

956

466

29.09

307.65

2.1

1.4

470.30

552.41

mg/l

1.88

941

434

Meningitis

394

402

11.95

307.65

1.9

1.2

1069.91

493.47

mg/l

15.92

382

379

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

801

686

6.00

307.65

1.5

1.2

495.68

527.38

mg/l

0.65

755

655

Dementia, including avohilmo

1351

2201

4.43

307.65

1.2

1.3

504.69

578.16

mg/l

2.12

1246

2108

Headache

2944

3929

6.36

307.65

1.5

1.2

467.78

513.09

mg/l

2.05

2813

3734

Organic, including symptomatic, mental disorders

1785

2593

5.19

307.65

1.2

1.3

514.38

577.44

mg/l

2.22

1664

2477

Disturbances of skin sensation

1118

2731

4.36

307.65

1.2

1.3

432.76

511.43

mg/l

6.33

1068

2599

STROKE

1639

3626

3.19

307.65

1.5

1.3

637.31

526.02

mg/l

2.16

1570

3450

Degenerative diseases of the nervous system

1033

1712

4.65

307.65

1.2

1.3

479.03

585.07

mg/l

4.86

946

1634

Symptoms and signs involving the nervous and musculoskeletal systems

2499

5275

5.06

307.65

1.4

496.41

546.96

mg/l

1.61

2379

5037

Implicit Sepsis

2694

5538

3.70

307.65

1.3

499.46

547.41

mg/l

2.12

2562

5294

Cerebrovascular diseases

2040

4682

3.17

307.65

1.5

1.3

638.16

545.24

mg/l

1.97

1947

4456

Polyneuropathies and other disorders of the peripheral nervous system

851

1742

5.26

307.65

1.6

1.3

633.53

542.46

mg/l

1.68

824

1641

Other symptoms and signs involving the nervous and musculoskeletal systems

1776

3679

5.16

307.65

1.3

1.4

487.32

525.30

mg/l

1.05

1687

3510

MS-disease / Multiple Sclerosis

682

600

14.23

307.65

1.1

1.3

421.95

475.50

mg/l

1.91

656

569

Inflammatory diseases of the central nervous system

758

696

13.60

307.65

1.8

1.3

882.08

497.92

mg/l

20.17

738

658

Implicit Sepsis

2349

5288

3.48

307.65

1.4

1.3

507.90

544.47

mg/l

1.30

2235

5047

Focal epilepsy, mode (most common among epilepsy diagnosis)

764

1654

4.96

307.65

1.5

1.6

552.02

506.65

mg/l

1.27

733

1570

Other encephalitis

361

202

26.40

307.65

1.7

1.3

695.95

459.55

mg/l

8.43

354

190

Neurological diseases, wide definition

1127

420

14.13

307.65

1.6

1.4

461.10

411.25

mg/l

1.88

1070

397

Focal epilepsy

861

1890

4.88

307.65

1.5

1.6

543.54

507.56

mg/l

1.01

826

1795

Intracranial trauma

1413

1404

7.31

307.65

1.4

549.58

465.14

mg/l

1.04

1340

Abnormal findings on diagnostic imaging of central nervous system

437

404

13.64

307.65

1.4

1.6

475.59

507.91

mg/l

0.56

419

382

Any dementia, excluding more controls

1086

1502

5.24

307.65

1.2

1.3

508.09

595.73

mg/l

1.90

991

1443

Demyelinating diseases of the central nervous system

820

752

13.68

307.65

1.2

1.3

423.55

505.68

mg/l

3.84

792

710

Other mental disorders due to brain damage and dysfunction and to physical disease

489

693

7.73

307.65

1.3

490.72

572.02

mg/l

2.77

465

665

Visual disturbances and blindness

1612

5119

3.28

307.65

1.3

1.4

510.95

522.79

mg/l

0.24

1535

4880

Other headache syndromes

1270

3497

3.78

307.65

1.4

1.3

479.37

535.24

mg/l

1.43

1219

3324

Viral infections of the central nervous system

554

624

10.62

307.65

1.5

1.3

674.48

512.09

mg/l

7.46

530

590

Unspecific neurodegenerative disorder

1120

1957

4.08

307.65

1.2

1.3

480.77

603.08

mg/l

5.93

1030

1866

Other degenerative diseases of the nervous system

1767

561

26.44

307.65

1.2

1.1

448.17

513.96

mg/l

2.78

1660

532

Episodal and paroxysmal disorders

2887

5418

2.78

307.65

1.4

470.14

541.84

mg/l

4.77

2749

5161

Encephalitis

375

218

25.02

307.65

1.7

1.3

691.95

448.80

mg/l

9.62

368

206

Condition for Implicit Sepsis (Organ dysfunction codes)

2974

5745

3.71

307.65

1.3

493.01

538.96

mg/l

2.15

2830

5500

Fever of other and unknown origin

1540

3538

4.01

307.65

1.7

1.2

582.40

525.58

mg/l

1.32

1484

3365

Symptoms and signs involving cognition, perception, emotional state and behaviour

3623

5950

4.35

307.65

1.3

1.4

493.33

553.13

mg/l

3.46

3444

5692

Viral infections of the central nervous system

575

667

10.23

307.65

1.5

1.3

666.61

513.14

mg/l

7.14

550

632

Other symptoms and signs involving cognitive functions and awareness

2284

2812

8.06

307.65

1.3

1.4

507.23

574.28

mg/l

2.30

2148

2686

Dementia

1265

1933

4.72

307.65

1.2

1.3

506.41

582.31

mg/l

1.96

1166

1851

Dizziness and giddiness

1930

4945

3.19

307.65

1.3

1.4

491.75

564.17

mg/l

3.59

1845

4735

General symptoms and signs

3329

4322

3.99

307.65

1.4

1.2

540.49

534.83

mg/l

0.08

3185

4114

Epilepsy

1207

2391

5.34

307.65

1.5

561.37

573.77

mg/l

0.15

1155

2275

Any mental disorder

2691

5382

2.56

307.65

1.4

502.57

548.40

mg/l

1.82

2538

5171

Condition for Implicit Sepsis (Organ dysfunction codes)

2870

5534

3.82

307.65

1.3

493.92

548.74

mg/l

2.74

2724

5297

Visual disturbances

1529

4757

3.36

307.65

1.3

1.4

503.01

510.09

mg/l

0.15

1457

4528

Cerebrovascular diseases (FINNGEN)

1251

1975

4.75

307.65

1.6

1.2

673.57

508.26

mg/l

2.71

1196

1881

Implicit viral Sepsis

948

2213

4.51

307.65

1.5

1.3

530.11

537.65

mg/l

0.10

897

2098

Normal-pressure hydrocephalus

639

276

35.05

307.65

1.8

1.2

379.80

602.17

mg/l

7.55

631

254

Neurological diseases

2811

1906

7.72

307.65

1.5

1.4

474.47

504.68

mg/l

0.65

2680

1814

Convulsions, not elsewhere classified

907

1470

6.47

307.65

1.7

1.3

492.96

505.22

mg/l

0.25

868

1401

Mood disorders, excluding more controls

2339

5253

2.72

307.65

1.3

504.64

550.34

mg/l

1.24

2225

5046

Focal epilepsy, strict definition

812

1737

5.03

307.65

1.5

1.6

538.74

510.78

mg/l

0.75

781

1648

Concussion

1182

1379

7.22

307.65

1.4

533.41

466.48

mg/l

0.66

1121

1315

Disorders of optic nerve and visual pathways

569

849

7.62

307.65

1.3

1.5

478.11

492.20

mg/l

0.14

540

805

Postprocedural disorders of nervous system

610

551

13.45

307.65

1.3

1.2

382.94

488.29

mg/l

4.68

580

522

Cerebral cysts

387

406

11.14

307.65

1.5

1.3

437.83

502.84

mg/l

0.81

376

380

Alzheimer disease, excluding more controls

732

189

27.68

307.65

1.2

1.1

469.79

571.68

mg/l

1.90

660

178

Implicit bacterial Sepsis

1166

3005

3.47

307.57

1.5

1.3

554.23

559.03

mg/l

0.06

1104

2861

Stroke, including SAH

1570

3980

2.95

303.24

1.5

1.3

650.92

557.56

mg/l

1.49

1493

3772

N06DA Anticholinesterases

898

1766

4.18

298.48

1.2

1.3

477.77

598.76

mg/l

4.88

822

1680

Use of anticholinesterases

898

1766

4.18

298.48

1.2

1.3

477.77

598.76

mg/l

4.88

822

1680

Viral Sepsis

691

1496

4.90

298.15

1.5

1.3

537.55

544.32

mg/l

0.08

655

1414

Implicit viral Sepsis

687

1495

4.87

294.56

1.5

1.3

538.61

544.15

mg/l

0.07

651

1413

Infections, IBD-co-morbidities

363

226

11.90

291.97

1.7

1.3

601.41

430.92

mg/l

1.47

345

209

Delirium, not induced by alcohol and other psychoactive substances

435

637

7.34

284.55

1.3

591.16

576.73

mg/l

0.08

410

612

Implicit bacterial Sepsis

1054

2769

3.50

283.05

1.5

1.3

554.46

549.86

mg/l

0.06

996

2631

Other antidepressants

2437

5383

2.37

279.77

1.3

489.85

548.23

mg/l

3.20

2309

5148

Mood [affective] disorders

2523

7415

2.25

276.00

1.3

496.80

547.95

mg/l

1.55

2400

7077

Mood disorders

2526

7422

2.25

275.31

1.3

496.63

547.85

mg/l

1.56

2403

7084

Traumatic subdural haemorrhage

295

256

11.54

274.97

1.5

1.1

672.62

523.22

mg/l

0.77

278

241

Alzheimer disease, including avohilmo

915

1695

3.95

272.42

1.2

1.3

509.67

574.66

mg/l

1.16

835

1614

Depression

2376

7209

2.28

271.03

1.3

496.63

546.85

mg/l

1.41

2255

6879

Bacterial Sepsis

1154

3181

3.20

267.58

1.5

1.3

582.74

555.23

mg/l

0.48

1094

3027

Pain, not elsewhere classified

723

1771

4.24

264.51

1.3

1.2

513.87

496.24

mg/l

0.17

684

1688

Other and unspecified hydrocephalus

212

129

23.17

264.35

2.5

1.3

506.48

511.48

mg/l

0.03

207

122

Alzheimer’s disease, strict definition

670

1220

4.73

263.18

1.2

1.3

464.21

602.77

mg/l

4.79

602

1157

Spirochaetal infections, other/unspecified

434

724

6.71

253.76

1.2

1.4

619.67

522.49

mg/l

3.11

418

681

Alzheimer disease

795

1475

4.10

251.97

1.2

1.3

474.97

592.18

mg/l

4.66

716

1400

Syncope and collapse

995

2625

3.33

248.06

1.4

1.2

468.10

527.27

mg/l

3.15

957

2490

Medical observation and evaluation for suspected diseases and conditions

1569

2945

2.79

247.85

1.4

1.3

490.68

566.75

mg/l

1.80

1503

2818

Depression or dysthymia

1463

2914

2.83

244.30

1.3

507.86

560.26

mg/l

1.65

1380

2804

Autoimmune diseases excluding thyroid diseases

2489

6400

2.16

236.79

1.3

1.4

538.39

539.87

mg/l

0.02

2384

6088

Other meningitis

193

123

22.39

235.35

2.2

1.2

913.84

437.40

mg/l

8.15

187

114

General examination and investigation of persons without complaint and reported diagnosis

1504

2944

2.72

229.98

1.5

1.3

528.50

566.74

mg/l

0.43

1438

2817

Autoimmune diseases excluding thyroid diseases, strict definition

2404

6219

2.16

227.52

1.3

1.4

538.09

536.43

mg/l

0.02

2304

5912

Other soft tissue disorders, not elsewhere classified

2240

6099

2.20

225.29

1.4

493.17

547.90

mg/l

1.73

2149

5807

Stroke, excluding SAH

1369

3810

2.70

225.20

1.5

1.3

613.18

560.22

mg/l

0.76

1302

3606

Symptoms and signs involving the skin and subcutaneous tissue

1735

7452

2.34

225.14

1.4

453.28

543.12

mg/l

9.07

1656

7109

Alzheimer’s disease (Early onset)

239

225

11.90

224.45

1.1

1.2

433.26

570.41

mg/l

3.36

228

216

Anxiety disorders

2173

7091

2.18

223.86

1.4

1.3

536.44

524.19

mg/l

0.13

2061

6771

Dorsalgia

2296

5726

2.19

223.74

1.3

509.97

537.05

mg/l

0.55

2193

5451

Autoimmune diseases related-to ILD

2041

8127

2.19

223.11

1.2

1.4

500.91

541.53

mg/l

1.01

1948

7750

Neurotic, stress-related and somatoform disorders

2154

7057

2.18

222.13

1.4

1.3

536.10

523.95

mg/l

0.13

2043

6738

Parkinson's disease, excluding more controls

241

206

11.41

221.67

1.3

1.2

471.37

550.34

mg/l

1.45

227

194

Migraine without aura

637

1624

4.11

221.65

1.4

1.5

422.05

480.81

mg/l

1.01

616

1554

Status epilepticus

228

213

12.43

216.57

1.5

1.7

616.76

505.39

mg/l

0.78

221

202

Diplopia

488

1052

4.98

212.78

1.4

1.3

576.28

521.57

mg/l

0.72

468

995

Bacterial infection, other or unspecified

1285

4335

2.64

212.19

1.6

1.3

620.72

529.81

mg/l

1.87

1216

4125

Migraine with aura

706

1990

3.69

212.03

1.3

1.4

442.30

483.52

mg/l

0.67

674

1902

Optic neuritis

276

344

9.37

212.01

1.2

1.3

401.91

472.26

mg/l

2.05

259

326

ILD medications

2597

7051

2.03

210.47

1.6

1.3

516.38

530.36

mg/l

0.25

2487

6715

Low back pain

1732

5525

2.30

203.98

1.3

506.45

538.65

mg/l

0.69

1646

5259

Bacterial infection, other or unspecified

1361

4676

2.53

203.73

1.6

1.3

612.29

526.49

mg/l

1.86

1291

4453

Certain infectious and parasitic diseases

2166

5093

2.17

202.65

1.5

1.3

527.87

495.39

mg/l

1.07

2073

4846

Other dorsopathies, not elsewhere classified

2275

5743

2.11

201.56

1.3

499.57

536.92

mg/l

1.01

2174

5468

ILD medications: immunosuppressive drugs

1557

6332

2.34

201.21

1.8

1.3

532.88

526.44

mg/l

0.07

1504

6038

Aneurysms, operations, SAH

518

1222

4.48

200.79

1.8

1.2

745.60

535.43

mg/l

1.65

496

1155

Papilloedema, unspecified

202

182

14.08

199.26

1.4

462.00

455.70

mg/l

0.03

194

172

Other disorders of optic [2nd] nerve and visual pathways

333

544

6.88

199.11

1.4

1.6

529.80

512.13

mg/l

0.10

318

516

Parkinson's disease, strict definition, excluding more controls

214

188

11.20

195.77

1.4

1.1

470.36

560.37

mg/l

1.58

202

179

Anxiety (asthma-related co-morbidities)

1484

4938

2.38

192.02

1.3

1.4

474.90

532.13

mg/l

0.78

1406

4727

Recurrent or chronic depression

922

2162

3.07

191.03

1.3

464.43

549.63

mg/l

2.77

878

2076

Sequelae of cerebrovascular disease

815

2260

3.21

190.74

1.5

1.3

648.37

552.42

mg/l

0.89

777

2143

Pain in limb

1878

5913

2.17

189.20

1.4

503.31

537.39

mg/l

0.80

1803

5629

Cerebral palsy and other paralytic syndromes

436

959

4.88

185.65

1.6

1.5

568.19

527.48

mg/l

0.55

407

908

Nerve, nerve root and plexus disorders

2342

7327

1.99

185.51

1.3

545.19

538.21

mg/l

0.11

2236

6979

Viral meningitis

239

297

9.42

184.15

1.4

1.3

691.51

465.66

mg/l

6.02

229

282

Lower back pain or/and sciatica

2343

7883

1.97

183.84

1.3

514.27

538.46

mg/l

0.54

2235

7507

Disorders of thyroid, IBD co-morbidities

298

269

7.97

183.42

1.5

1.2

601.69

428.83

mg/l

1.33

281

250

Nontraumatic intracranial haemmorrhage

525

1338

4.09

182.54

2.0

1.3

811.21

560.93

mg/l

2.06

498

1261

Ischaemic Stroke, excluding all haemorrhages

1208

3585

2.57

182.50

1.4

1.3

581.41

567.72

mg/l

0.14

1148

3393

Anaemias

580

955

4.09

177.31

1.6

1.2

497.51

428.92

mg/l

1.91

546

913

Use of donepezil

490

1151

4.25

177.16

1.2

1.3

473.84

598.78

mg/l

3.39

440

1085

Subjective visual disturbances

714

2277

3.27

176.81

1.3

1.4

461.34

524.05

mg/l

1.52

682

2163

Used for control exclusion in common control thyroid runs

2295

5953

1.98

170.31

1.3

1.4

514.81

537.53

mg/l

0.46

2196

5660

Depression medications

735

1066

3.55

169.28

1.3

1.2

444.20

424.00

mg/l

0.56

687

1019

All anxiety disorders

1506

5455

2.23

168.67

1.3

473.70

514.89

mg/l

0.52

1428

5219

Examination and observation for other reasons

1242

2924

2.50

167.44

1.4

1.3

467.73

566.69

mg/l

3.01

1201

2799

Pain in joint

1207

3136

2.50

166.85

1.2

1.3

508.53

564.87

mg/l

1.04

1136

2992

Pain (limb, back, neck, head abdominally)

1491

3264

2.33

164.94

1.6

1.3

495.95

562.31

mg/l

2.78

1415

3111

Opioids

2155

5724

1.99

163.02

1.3

504.17

512.38

mg/l

0.16

2043

5461

Persons encountering health services for specific procedures and health care

2365

7593

1.90

162.25

1.4

547.22

520.41

mg/l

0.59

2232

7272

Other special examinations and investigations of persons without complaint or reported diagnosis

1369

2945

2.39

161.66

1.4

1.3

499.28

566.75

mg/l

1.55

1284

2818

Other bacterial diseases

2019

6989

1.98

159.75

1.7

1.3

605.59

520.74

mg/l

2.66

1915

6679

Other anxiety disorders

1164

4286

2.41

159.19

1.3

486.56

488.77

mg/l

0.02

1108

4103

Care involving use of rehabilitation procedures

1460

6305

2.17

158.59

1.4

539.38

523.63

mg/l

0.24

1373

6040

Dorsopathies

2197

5795

1.96

158.40

1.3

1.4

488.03

534.93

mg/l

1.89

2092

5520

Speech disturbances, not elsewhere classified

333

669

5.37

158.16

1.3

524.87

545.68

mg/l

0.28

317

626

Autoimmune diseases

2372

6437

1.90

157.70

1.3

1.4

516.03

538.78

mg/l

0.48

2271

6123

ILD medications: prednisolone, methylprednisolone, prednisone

2311

6918

1.90

156.08

1.4

1.3

540.33

532.33

mg/l

0.12

2206

6586

Dementia in Alzheimer disease

372

666

4.88

154.64

1.2

1.3

475.03

626.54

mg/l

3.89

333

636

Selective serotonin reuptake inhibitors

2025

5423

1.98

151.93

1.3

499.24

546.50

mg/l

1.71

1918

5187

Alzheimer’s disease (Atypical or mixed), excluding more controls

157

14.73

151.60

1.2

1.1

504.10

558.49

mg/l

0.40

140

Intracranial injury

1321

5778

2.21

150.02

1.4

503.88

522.62

mg/l

0.27

1247

5515

First line medication for Crohn's disease

2377

7010

1.86

149.94

1.6

1.3

546.80

513.59

mg/l

0.70

2275

6676

Subarachnoid haemorrhage

336

710

5.03

149.84

2.1

1.3

855.00

536.17

mg/l

1.65

320

672

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

666

2246

3.04

147.74

1.3

465.18

493.73

mg/l

0.74

630

2155

Extrapyramidal and movement disorders

861

3351

2.65

146.79

1.3

536.71

537.95

mg/l

0.01

809

3183

Abnormal involuntary movements

400

987

4.27

146.20

1.5

1.3

566.18

541.19

mg/l

0.11

379

931

Alzheimer’s disease (Late onset)

476

1088

3.80

143.47

1.2

1.3

483.00

607.68

mg/l

3.19

415

1030

Diseases of the eye and adnexa

1776

4451

2.03

141.33

1.5

1.4

485.00

543.01

mg/l

1.88

1693

4252

Use of rivastigmine

363

859

4.40

139.11

1.2

1.3

472.20

634.53

mg/l

3.33

335

807

Benzodiazepine use

2130

8062

1.85

138.83

1.3

487.91

546.76

mg/l

2.66

2016

7695

Tramadol

1655

5092

2.03

138.75

1.3

537.13

514.77

mg/l

0.44

1576

4854

Any gastric operation

1695

4209

2.05

138.65

1.7

1.2

496.54

514.42

mg/l

0.36

1618

4002

GASTRO-related operations

1695

4209

2.05

138.65

1.7

1.2

496.54

514.42

mg/l

0.36

1618

4002

Parasetamol

1593

3915

2.09

137.92

1.4

1.3

488.09

515.54

mg/l

0.76

1514

3735

Other bacterial diseases

2112

7328

1.86

137.61

1.6

1.3

626.30

513.19

mg/l

3.11

2008

6998

Nausea and vomiting

671

2324

2.92

137.34

1.7

1.5

598.52

517.53

mg/l

0.74

648

2201

Primary_lymphoid and hematopoietic malignant neoplasms

604

2027

3.09

136.98

2.9

1.3

614.39

542.31

mg/l

1.57

587

1912

Sciatica+with lumbago

1095

4495

2.29

135.11

1.3

538.12

544.66

mg/l

0.06

1051

4275

Bell's palsy

382

968

4.18

134.93

1.5

1.3

570.82

513.45

mg/l

1.10

368

912

Use of other anti-dementia drugs

537

1370

3.35

133.50

1.2

1.3

474.76

599.97

mg/l

4.54

477

1292

Use of memantine

537

1370

3.35

133.50

1.2

1.3

474.76

599.97

mg/l

4.54

477

1292

Substance abuse, excluding more controls

1080

4078

2.30

133.22

1.3

521.81

560.69

mg/l

0.88

1022

3919

Cardiovascular diseases (excluding rheumatic etc)

1488

4193

2.08

130.35

1.5

1.4

485.34

468.28

mg/l

0.37

1426

3994

Other intervertebral disc disorders

1655

5107

1.98

129.36

1.3

550.54

551.67

mg/l

0.01

1574

4861

Injuries to the head

2311

8123

1.77

129.05

1.4

532.32

528.63

mg/l

0.05

2196

7755

Migraine without aura and triptan purchases

502

1595

3.29

125.46

1.4

1.3

432.11

467.59

mg/l

0.40

485

1536

Codeine

1916

5626

1.88

124.83

1.3

522.73

514.76

mg/l

0.10

1828

5366

Other reaction to severe stress, and adjustment disorders

888

3798

2.40

123.45

1.5

1.3

523.59

484.37

mg/l

0.40

841

3632

Explicit Sepsis

865

3406

2.42

122.02

2.0

1.4

648.99

539.14

mg/l

1.64

815

3238

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1810

5908

1.88

122.01

1.4

1.3

588.01

514.70

mg/l

1.79

1713

5646

1810

5908

1.88

122.01

1.4

1.3

588.01

514.70

mg/l

1.79

1713

5646

Cardiovascular diseases

1401

3673

2.09

121.98

1.5

1.4

470.67

468.64

mg/l

0.03

1345

3509

Any reimbursement code in KELA

1308

3104

2.15

120.29

1.6

1.2

471.10

504.33

mg/l

0.85

1242

2957

Other disorders of fluid, electrolyte and acid-base balance

681

2479

2.69

119.19

1.5

1.4

610.80

552.53

mg/l

0.58

647

2346

Influenza and pneumonia

2174

7971

1.76

118.83

1.5

1.3

565.30

517.45

mg/l

1.19

2065

7614

Other disorders of urethra and urinary system

1440

5312

1.99

118.51

1.4

1.3

526.26

516.83

mg/l

0.13

1370

5068

Oral corticosteroids

2178

7433

1.76

118.27

1.3

539.97

534.07

mg/l

0.08

2070

7086

Provisional assignment of new diseases of uncertain etiology

1160

5616

2.11

117.88

1.5

1.3

535.97

511.08

mg/l

0.37

1116

5343

Memory loss

263

554

5.04

117.77

1.2

1.3

446.77

595.91

mg/l

7.10

237

531

Codes for special purposes

1160

5625

2.10

117.38

1.5

1.4

535.97

511.09

mg/l

0.37

1116

5351

Disorders of ocular muscles, binocular movement, accommodation and refraction

1085

5103

2.16

116.85

1.5

1.4

470.48

504.77

mg/l

1.02

1028

4882

Persons encountering health services for examination and investigation

1248

2945

2.16

116.27

1.4

1.3

510.86

566.75

mg/l

1.17

1181

2818

Covid-19 confirmed case

813

3458

2.41

114.52

1.6

1.4

570.29

521.68

mg/l

0.60

776

3282

Inflammatory bowel disease treatment related agents

2336

7708

1.72

114.44

1.6

1.3

534.00

527.84

mg/l

0.09

2226

7350

Pain in throat and chest

1754

5738

1.86

114.34

1.3

515.60

555.23

mg/l

0.86

1660

5472

Personality disorders, excluding more controls

584

2120

2.83

114.17

1.2

1.3

429.25

501.57

mg/l

3.11

552

2038

Paralytic strabismus

256

544

5.07

114.05

1.5

1.4

564.82

552.50

mg/l

0.07

249

513

Bleeding

1634

6284

1.88

113.29

1.6

1.3

634.33

540.50

mg/l

1.68

1542

5998

Oedema, not elsewhere classified

563

1987

2.86

112.46

1.3

1.2

535.88

520.82

mg/l

0.10

544

1875

Hypothyroidism (congenital or acquired)

548

1011

3.13

109.65

1.3

1.2

464.34

423.12

mg/l

1.26

525

966

Migraine with aura and triptan purchases

463

1521

3.17

109.38

1.3

431.17

470.38

mg/l

0.41

442

1460

Bacterial meningitis

176

279

7.11

108.67

2.0

1.2

1370.61

490.10

mg/l

10.49

170

260

Soft tissue disorders

2082

6179

1.76

108.51

1.4

480.77

546.63

mg/l

3.34

1977

5884

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1293

5987

1.97

107.21

1.3

514.24

565.28

mg/l

1.26

1231

5702

Hypothyroidism, levothyroxine purchases

541

1007

3.10

106.91

1.3

1.2

462.18

423.41

mg/l

1.14

519

962

Hypothyroidism and >3 levothyroxin purchases

541

1007

3.10

106.91

1.3

1.2

462.18

423.41

mg/l

1.14

519

962

Symptoms and signs involving speech and voice

736

3099

2.44

106.24

1.3

499.14

523.29

mg/l

0.64

708

2937

Systemic atrophies primarily affecting the central nervous system

187

322

6.44

105.95

1.5

1.4

561.23

526.44

mg/l

0.13

181

299

Unspecified dementia

232

419

5.15

105.10

1.2

603.31

598.62

mg/l

0.01

216

404

Spondylopathies

1466

4630

1.92

104.65

1.3

624.47

550.95

mg/l

1.27

1400

4410

Abnormalities of breathing

1817

5961

1.79

104.61

1.3

1.4

498.36

549.21

mg/l

1.41

1743

5686

Metabolic disorders

1858

6500

1.77

102.80

1.4

560.19

531.66

mg/l

0.64

1770

6197

Other spirochaetal diseases

702

2940

2.46

102.73

1.2

1.4

576.02

523.58

mg/l

1.75

679

2794

Spirochaetal infections, other/unspecified

695

2900

2.47

102.56

1.2

1.4

576.41

524.81

mg/l

1.68

672

2757

Nonorganic sleeping disorders, excluding more controls

450

1511

3.07

101.79

1.4

405.29

514.17

mg/l

8.35

433

1453

Other spirochaetal diseases

694

2910

2.46

101.31

1.2

1.4

578.76

522.73

mg/l

1.92

671

2768

Lyme disease

688

2881

2.46

100.74

1.2

1.4

578.44

524.19

mg/l

1.80

665

2741

Liquid cancers, helper endpoint

821

3196

2.30

100.67

2.5

1.3

626.37

543.27

mg/l

1.28

794

3025

Symptoms and signs involving the circulatory and respiratory systems

2042

5990

1.73

100.15

1.4

479.58

548.67

mg/l

3.06

1941

5714

Certain infectious and parasitic diseases

1422

3727

1.94

99.88

1.5

1.3

518.33

500.95

mg/l

0.40

1356

3550

Lumbar disc prolapse

1228

4861

1.97

99.56

1.3

560.73

544.00

mg/l

0.18

1174

4630

Pneumonia, organism unspecified

1798

7291

1.75

99.31

1.4

589.65

526.21

mg/l

1.42

1705

6966

Hypo-osmolality and hyponatraemia

405

1294

3.22

98.92

1.4

638.93

564.27

mg/l

0.46

381

1225

Non-Hodgkin lymphoma, all, including Hilmo

359

1077

3.49

98.73

1.8

1.2

686.42

526.49

mg/l

3.01

348

1010

Persons encountering health services in other circumstances, wide

2291

7168

1.66

98.56

1.4

543.64

538.70

mg/l

0.06

2192

6821

All pneumoniae

2014

8037

1.70

98.18

1.4

577.70

518.58

mg/l

1.51

1911

7682

Strabismus

656

2724

2.48

97.35

1.5

484.78

498.85

mg/l

0.22

627

2590

Symptoms and signs involving the digestive system and abdomen

1957

5724

1.73

96.98

1.5

1.4

517.13

535.69

mg/l

0.50

1864

5446

Pneumonias (Asthma/COPD co-morbidities)

1994

8015

1.69

96.34

1.4

577.91

518.84

mg/l

1.49

1892

7660

Other diseases of urinary system

1956

6491

1.71

95.77

1.4

1.3

527.30

529.47

mg/l

0.04

1855

6206

Codeine or tramadol medication

2223

7443

1.65

94.54

1.3

534.14

529.85

mg/l

0.06

2118

7087

Myalgia

550

2138

2.65

94.28

1.3

464.48

506.93

mg/l

1.05

526

2029

Dysphagia

533

2041

2.68

94.12

1.3

545.82

538.80

mg/l

0.08

506

1931

Schizophrenia or delusion, excluding more controls

599

2397

2.53

94.03

1.2

1.3

477.73

554.52

mg/l

2.02

566

2300

Hard cardiovascular diseases

1610

5429

1.79

93.09

1.4

587.60

547.38

mg/l

0.56

1539

5177

Fall on same level

2270

7657

1.64

92.90

1.3

1.4

540.68

523.69

mg/l

0.30

2174

7311

Non-follicular lymphoma

278

737

3.99

92.41

1.9

1.3

627.31

545.43

mg/l

1.52

270

690

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1941

7966

1.68

92.30

1.4

583.37

521.69

mg/l

1.53

1841

7616

Septicaemia

812

3517

2.20

92.00

2.0

1.4

619.50

526.65

mg/l

1.88

766

3343

Complications of surgical and medical care, not elsewhere classified

1924

7923

1.68

91.86

1.5

1.3

555.73

526.83

mg/l

0.59

1848

7539

Non-invasive ventilation

508

1696

2.74

91.57

1.5

1.4

551.93

502.39

mg/l

0.98

452

1623

Other extrapyramidal and movement disorders in other diseases

528

2048

2.66

91.10

1.2

1.4

577.14

539.41

mg/l

0.23

490

1945

Complications of medical and surgical care

1435

7445

1.80

90.89

1.5

1.3

584.00

524.67

mg/l

0.99

1368

7095

Other/unspecified dorsalgia

740

3303

2.27

90.86

1.3

547.48

537.59

mg/l

0.07

709

3149

Transient ischemic attack

914

3587

2.10

89.30

1.3

530.29

565.72

mg/l

1.10

875

3397

Other septicaemia

728

3156

2.26

88.68

2.1

1.4

595.81

518.45

mg/l

1.38

684

2996

Enlarged lymph nodes

320

953

3.46

88.37

1.5

1.3

593.68

515.66

mg/l

0.51

302

905

COPD/asthma related infections

1962

5912

1.68

87.14

1.4

1.3

552.67

514.54

mg/l

0.77

1852

5650

COPD/asthma/ILD related infections

1962

5912

1.68

87.14

1.4

1.3

552.67

514.54

mg/l

0.77

1852

5650

Asthma

1456

4233

1.83

86.86

1.3

524.21

536.27

mg/l

0.15

1382

4044

Second line medication for Crohn's disease

1180

6410

1.87

86.08

1.9

1.3

538.55

523.93

mg/l

0.14

1139

6102

Asthma (mode)

1434

4260

1.83

85.90

1.3

529.74

535.68

mg/l

0.07

1361

4071

Neuromuscular dysfunction of bladder

262

702

3.93

85.68

1.4

1.3

611.28

535.49

mg/l

0.42

243

660

Cervicalgia

447

1650

2.79

84.96

1.3

468.07

494.27

mg/l

0.48

423

1573

Asthma, excluding more controls

1419

4105

1.83

84.49

1.3

522.50

536.70

mg/l

0.18

1349

3922

Cerebral aneurysm, nonruptured

251

660

4.01

84.39

1.6

1.2

549.55

526.87

mg/l

0.25

240

627

L04AX Other immunosuppressants

1145

6210

1.88

83.98

1.9

1.3

533.66

525.00

mg/l

0.08

1105

5913

Symptoms and signs involving the urinary system

1441

6288

1.77

83.94

1.4

1.3

608.90

542.96

mg/l

0.78

1368

5995

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1879

7933

1.65

83.89

1.7

1.3

547.28

528.08

mg/l

0.35

1789

7572

L04AA Selective immunosuppressants

543

2233

2.51

83.03

1.6

1.4

543.62

508.26

mg/l

0.29

521

2118

Spondylosis

965

4018

1.99

81.75

1.3

595.84

564.57

mg/l

0.31

931

3829

Diseases of the musculoskeletal system and connective tissue

1105

2861

1.96

80.91

1.6

1.4

473.78

532.75

mg/l

1.33

1044

2728

Hypertensive diseases (excluding secondary)

1050

3151

1.97

80.02

1.3

550.78

496.56

mg/l

0.87

996

2999

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2096

7161

1.61

79.96

1.4

544.22

538.56

mg/l

0.07

2017

6814

Hemiplegia

177

372

5.10

79.89

1.6

1.3

462.33

494.40

mg/l

0.57

166

349

ILD differential diagnosis

1489

4260

1.77

79.71

1.4

1.3

508.14

535.68

mg/l

0.64

1412

4071

COPD differential diagnosis

1489

4261

1.77

79.66

1.4

1.3

508.14

535.71

mg/l

0.64

1412

4072

Undefined dementia

232

544

4.05

79.03

1.2

1.3

603.31

558.55

mg/l

0.15

216

507

Abdominal and pelvic pain

1867

5723

1.66

78.70

1.4

501.22

535.41

mg/l

1.42

1785

5445

Other pulmonary diagnosis

1489

4281

1.76

78.41

1.4

1.3

515.53

535.92

mg/l

0.40

1410

4091

Benign neoplasm of meninges

278

823

3.55

78.32

1.4

1.2

697.55

533.33

mg/l

3.08

264

778

Excluding asthma or asthma-COPD overlap

1487

4281

1.76

77.95

1.4

1.3

508.50

535.92

mg/l

0.64

1409

4091

Implicit fungal Sepsis

193

444

4.60

77.69

1.4

1.3

471.99

522.80

mg/l

0.93

180

419

Other and unspecified visual disturbances

281

845

3.49

77.21

1.2

1.3

447.48

515.80

mg/l

1.74

264

798

Somatoform disorder

394

1441

2.83

76.56

1.3

1.4

575.94

510.34

mg/l

0.33

370

1370

Benign neoplasm: Cerebral meninges

260

749

3.65

76.49

1.3

697.96

536.68

mg/l

2.72

247

708

Other disorders of eye and adnexa

373

1329

2.92

76.39

1.4

1.5

460.90

502.29

mg/l

1.16

359

1260

Antihypertensive medication - note that there are other indications

1302

3856

1.81

76.29

1.4

453.39

499.99

mg/l

1.17

1239

3674

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

181

400

4.75

76.20

1.4

1.3

513.32

565.78

mg/l

0.84

173

373

Bipolar affective disorders

444

1741

2.63

74.99

1.3

442.11

498.02

mg/l

1.79

429

1667

Other disorders of lacrimal gland

711

3421

2.12

74.26

1.4

1.3

525.93

514.48

mg/l

0.10

666

3239

Cystitis

1579

5628

1.69

74.20

1.4

1.3

529.64

515.38

mg/l

0.22

1497

5373

Migraine, single triptan purchase ok & required. ICD-code if available is included

1520

6177

1.69

73.30

1.3

452.80

533.27

mg/l

3.74

1451

5901

Triptan medication for migraine, single purchase ok

1520

6177

1.69

73.30

1.3

452.80

533.27

mg/l

3.74

1451

5901

Diseases of the myoneural junction and muscle

306

1000

3.19

73.17

1.5

1.4

565.11

540.79

mg/l

0.20

292

940

Traumatic subarachnoid haemorrhage

11.89

72.85

1.3

1.1

644.06

476.52

mg/l

0.49

Asthma, unspecified (mode), excluding more controls

955

3766

1.92

72.56

1.4

1.3

530.51

536.58

mg/l

0.07

909

3602

Other specific joint derangements/joint disorders

1472

5660

1.70

72.53

1.2

1.4

512.19

512.17

mg/l

0.00

1388

5406

Systemic connective tissue disorders

688

3307

2.12

72.01

1.3

577.68

525.54

mg/l

0.34

648

3129

Asthma, unspecified (mode)

967

3873

1.91

71.57

1.4

1.3

528.55

536.51

mg/l

0.09

921

3704

Acute upper respiratory infections of multiple and unspecified sites

1437

6395

1.69

70.22

1.5

1.3

515.18

517.41

mg/l

0.02

1368

6096

2088

6970

1.56

70.12

1.4

1.3

543.02

530.44

mg/l

0.17

1984

6648

Asthma (only as main-diagnosis), excluding more controls

1259

4105

1.77

70.10

1.3

481.94

536.70

mg/l

1.62

1197

3922

Viral infections characterized by skin and mucous membrane lesions

845

4414

1.95

69.71

1.6

1.4

572.14

522.59

mg/l

1.00

817

4206

Asthma (only as main-diagnosis)

1274

4233

1.76

69.52

1.3

482.42

536.27

mg/l

1.63

1210

4044

Cervicobrachial syndrome

453

1859

2.50

69.35

1.4

1.3

485.64

496.18

mg/l

0.22

436

1774

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

129

140

6.65

69.20

1.2

1.3

753.99

446.92

mg/l

0.80

118

130

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

666

3214

2.12

69.15

1.3

465.18

480.39

mg/l

0.34

630

3071

Somnolence, stupor and coma

133

248

5.71

68.67

1.5

416.88

516.76

mg/l

2.41

127

236

Bronchitis

1993

8141

1.56

68.66

1.4

1.3

511.85

536.26

mg/l

0.42

1896

7759

Hypertension, essential

1467

4982

1.69

68.14

1.3

554.91

524.25

mg/l

0.57

1392

4749

Dental caries

537

2298

2.30

67.76

2.0

1.3

595.00

540.37

mg/l

0.41

515

2207

Intracerebral haemorrhage

256

791

3.34

66.89

2.1

1.3

816.71

583.29

mg/l

1.61

241

738

Follow-up examination after treatment for conditions other than malignant neoplasms

743

2423

2.06

66.55

1.3

501.40

541.26

mg/l

0.55

701

2322

Acute upper respiratory infections

1896

7545

1.56

66.23

1.4

1.3

552.57

527.39

mg/l

0.36

1799

7192

Falls/tendency to fall

2030

6603

1.55

66.16

1.4

528.29

527.43

mg/l

0.01

1935

6303

Factors influencing health status and contact with health services

536

1126

2.42

65.54

1.4

1.2

546.14

565.98

mg/l

0.14

503

1071

Sleep disorders (combined)

2075

7146

1.54

65.33

1.3

1.4

483.13

537.72

mg/l

3.06

1971

6821

Diagnoses used for exclusion with ILD

502

2216

2.32

65.16

1.5

1.3

674.07

536.37

mg/l

1.04

475

2101

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1118

6419

1.74

64.63

1.6

1.3

582.03

526.06

mg/l

0.84

1070

6109

Diarrhoea and gastroenteritis of presumed infectious origin

1339

7331

1.67

64.57

1.4

573.74

506.02

mg/l

0.71

1272

6973

Dementia in other diseases classified elsewhere

128

244

5.57

64.50

1.2

1.3

530.95

589.02

mg/l

0.52

117

235

Other functional intestinal disorders

872

4378

1.88

63.80

1.4

1.5

577.43

531.78

mg/l

0.46

821

4166

Intestinal infectious diseases

1756

8609

1.56

63.76

1.4

534.49

521.98

mg/l

0.19

1676

8203

Non-selective monoamine reuptake inhibitors

630

2946

2.09

63.69

1.3

519.77

573.28

mg/l

0.67

592

2830

Other general symptoms and signs

134

266

5.24

63.40

1.7

1.5

421.98

514.93

mg/l

1.54

127

256

All influenza

511

2319

2.25

62.02

1.5

1.4

550.64

531.45

mg/l

0.12

484

2214

All kidney diseases

1821

8128

1.55

61.87

1.4

626.89

506.98

mg/l

1.99

1731

7757

Oxycodone

683

3110

2.02

61.77

1.5

1.3

645.00

538.45

mg/l

1.11

651

2968

Other diseases of spinal cord

108

184

6.36

61.65

1.8

1.2

931.31

520.60

mg/l

0.89

101

172

Paraplegia, diplegia of upper limbs

100

159

7.01

61.55

1.6

1.5

887.17

468.42

mg/l

2.73

148

Disorders of lacrimal system

798

4277

1.89

60.56

1.5

1.3

530.24

528.76

mg/l

0.01

751

4064

Viral infections characterized by skin and mucous membrane lesions

1594

8761

1.57

60.40

1.5

1.4

525.01

524.84

mg/l

0.00

1534

8340

Symptoms and signs concerning food and fluid intake

201

568

3.64

60.26

1.6

1.2

471.24

530.46

mg/l

0.84

192

533

Shoulder lesions

1332

4899

1.67

60.06

1.3

499.27

572.22

mg/l

3.75

1285

4657

Complications of other internal prosthetic devices, implants and grafts

135

288

5.02

60.00

2.6

1.3

503.61

505.26

mg/l

0.01

130

274

Persons encountering health services in other circumstances

772

4098

1.90

59.79

1.4

530.56

508.95

mg/l

0.22

730

3895

Poisoning by drugs, medicaments and biological substances

538

2542

2.17

59.21

1.2

1.3

436.52

497.35

mg/l

3.29

508

2426

Poisoning by medicine

500

2298

2.23

59.09

1.2

1.3

439.01

492.75

mg/l

2.52

471

2188

Caries of dentine

469

2036

2.29

59.09

1.7

1.3

637.00

545.19

mg/l

0.68

450

1955

Acute sinusitis

988

5262

1.76

58.89

1.4

1.3

571.46

513.05

mg/l

0.58

936

5027

Other diseases of intestines

1974

7499

1.51

58.28

1.3

1.4

508.99

531.58

mg/l

0.48

1883

7157

Unspecified mental disorder

805

4397

1.86

58.01

1.2

1.3

486.79

520.70

mg/l

0.80

761

4204

Use of hypnotics and sedatives

1937

7415

1.51

57.81

1.3

1.4

519.13

547.86

mg/l

0.69

1846

7082

Substance abuse

1080

6025

1.71

57.58

1.3

521.81

550.67

mg/l

0.59

1022

5750

Exposure to unspecified factor

1826

8740

1.52

57.54

1.3

1.4

547.19

525.85

mg/l

0.38

1746

8330

Exclusions for E4_PCOS_BROAD

406

1733

2.41

57.27

1.4

1.7

526.05

499.94

mg/l

0.48

384

1649

Visual field defects

209

630

3.46

57.27

1.6

1.3

623.49

532.87

mg/l

0.78

200

596

Unspecified fall

917

5157

1.78

56.82

1.3

1.4

519.24

522.32

mg/l

0.04

870

4905

Radiculopathy

310

1169

2.72

56.70

1.3

495.91

534.05

mg/l

0.65

300

1103

Mental and behavioural disorders due to psychoactive substance use

1104

6135

1.69

56.53

1.3

519.32

548.98

mg/l

0.63

1044

5855

Other external causes of accidental injury

1488

4674

1.61

56.48

1.4

500.26

530.59

mg/l

0.77

1409

4462

Renal tubulo-interstitial diseases

1554

7484

1.56

56.14

1.4

616.69

511.82

mg/l

1.95

1467

7154

Disorders of eyelid, lacrimal system and orbit

1515

7410

1.57

55.93

1.4

1.3

526.12

537.93

mg/l

0.21

1439

7067

Complications of procedures, not elsewhere classified

1438

7612

1.58

55.51

1.5

1.3

543.58

527.15

mg/l

0.24

1378

7246

Endovascular or surgical operations to intracerebral aneurysms

169

453

3.93

55.47

1.8

1.2

571.34

537.99

mg/l

0.28

164

431

Diarrhoea and gastroenteritis of presumed infectious origin

1840

8119

1.51

55.38

1.4

505.97

530.12

mg/l

0.48

1755

7734

Retention of urine

593

2409

2.06

55.31

1.4

1.3

613.83

544.41

mg/l

0.75

561

2288

Disorders of adult personality and behaviour

621

3173

2.00

55.14

1.2

1.3

429.71

483.29

mg/l

2.46

587

3030

Behavioural syndromes associated with physiological disturbances and physical factors

1686

7891

1.53

55.04

1.4

468.23

538.37

mg/l

3.87

1605

7523

Disorders of lipoprotein metabolism and other lipidaemias

1370

5313

1.61

54.89

1.3

565.53

557.28

mg/l

0.16

1308

5066

Hypertensive diseases

1452

5188

1.60

54.63

1.3

1.4

552.53

520.89

mg/l

0.60

1379

4944

Other sleep disorders

230

754

3.15

54.59

1.2

1.3

420.00

543.60

mg/l

5.72

216

719

Endocrine, nutritional and metabolic diseases

1522

4904

1.59

54.58

1.4

505.77

513.76

mg/l

0.14

1448

4678

Hypertension

1450

5180

1.60

54.55

1.3

1.4

550.75

521.24

mg/l

0.55

1378

4937

Constipation

1558

7004

1.56

54.52

1.4

533.95

541.83

mg/l

0.13

1462

6706

Disorders of vestibular function (Vertigo)

816

4484

1.82

54.46

1.3

479.46

532.87

mg/l

2.56

788

4243

Diseases of the ear and mastoid process

2124

7292

1.47

54.39

1.4

1.3

537.17

529.22

mg/l

0.12

2026

6948

Cervical disc disorders

617

3161

1.98

54.10

1.4

1.3

496.34

561.82

mg/l

1.51

589

3008

Herpesviral [herpes simplex] infections

280

1031

2.81

54.02

1.5

1.4

574.03

502.68

mg/l

1.48

271

974

Acute tubulo-interstitial nephritis

1124

5897

1.66

53.96

1.4

629.05

507.45

mg/l

1.58

1059

5622

Pain in thoracic spine

312

1214

2.64

53.66

1.4

441.43

492.18

mg/l

1.88

300

1154

Neoplasms

1516

5146

1.58

53.45

1.9

1.3

546.59

498.26

mg/l

0.60

1443

4914

Accidents

1471

4674

1.59

53.27

1.4

508.87

530.59

mg/l

0.48

1388

4462

Certain disorders involving the immune mechanism

407

1800

2.32

52.95

2.2

1.4

572.24

515.57

mg/l

0.40

388

1716

Triptan medication for migraine, min. 3 purchases

1109

5140

1.67

52.53

1.3

431.93

498.55

mg/l

2.13

1060

4913

Fibromyalgia

217

705

3.19

52.49

1.2

1.3

396.44

490.02

mg/l

3.90

204

673

Speech and linguistic disorders, excluding more controls

202

588

3.35

52.14

2.0

553.99

456.72

mg/l

0.76

197

562

Post-traumatic stress disorder

221

729

3.15

52.12

1.3

379.19

479.52

mg/l

3.05

204

697

Invasive ventilation

200

626

3.35

51.80

1.5

1.6

1212.61

539.05

mg/l

1.27

187

593

Gastrointestinal diseases

1161

3505

1.68

51.67

1.6

1.3

460.87

525.16

mg/l

2.07

1099

3354

Ocular pain

225

757

3.11

51.47

1.4

1.5

431.92

499.15

mg/l

2.12

218

721

Personality disorders

584

2993

1.99

51.46

1.2

1.3

429.25

486.68

mg/l

2.26

552

2857

Pure hypercholesterolaemia

1203

4854

1.63

51.40

1.3

586.64

563.71

mg/l

0.39

1147

4628

Sleep disorders

1607

7710

1.52

51.24

1.3

461.99

535.61

mg/l

4.40

1529

7350

External causes of morbidity and mortality

1203

3677

1.66

51.05

1.4

517.52

505.79

mg/l

0.24

1130

3511

Spinal stenosis

782

3297

1.82

50.82

1.4

1.3

722.17

580.02

mg/l

1.51

744

3134

Diseases of oesophagus, stomach and duodenum

1886

7695

1.48

50.77

1.3

1.4

507.27

536.99

mg/l

0.79

1771

7365

Intestinal infectious diseases

2047

8091

1.46

50.75

1.4

1.3

525.23

532.21

mg/l

0.11

1954

7712

Zoster [herpes zoster]

356

1513

2.41

50.71

1.7

1.3

592.79

529.13

mg/l

1.44

345

1427

severe traumatic brain injury, does not include concussion

403

1806

2.28

50.58

1.5

1.3

661.26

546.97

mg/l

0.67

378

1703

Any death

1037

4465

1.69

50.48

1.5

1.3

743.99

546.79

mg/l

3.21

983

4249

Dissociative [conversion] disorders

127

297

4.55

50.35

1.2

1.5

466.96

496.27

mg/l

0.14

121

278

Nonorganic sleeping disorders

450

2120

2.18

50.06

1.4

405.29

495.46

mg/l

7.58

433

2015

310

1248

2.56

49.85

1.6

1.3

506.16

505.41

mg/l

0.01

296

1177

Other medical care

773

3914

1.80

49.52

1.6

1.3

613.49

514.90

mg/l

3.49

738

3725

Other joint disorders

1652

5789

1.52

49.36

1.3

1.4

479.18

511.35

mg/l

1.19

1571

5525

Asthma-related infections

1050

6335

1.64

48.82

1.4

541.84

524.88

mg/l

0.19

1003

6042

Asthma, hospital admission 2, infections

1050

6335

1.64

48.82

1.4

541.84

524.88

mg/l

0.19

1003

6042

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1002

6110

1.66

48.54

1.6

1.3

584.11

527.40

mg/l

0.75

958

5811

Benign neoplasm of brain and other parts of central nervous system

178

541

3.46

48.41

1.7

1.4

630.88

534.40

mg/l

1.09

171

510

Specific personality disorders

507

2530

2.05

48.28

1.2

1.3

426.05

482.18

mg/l

2.22

478

2414

Mental and behavioural disorders due to alcohol

918

5267

1.70

48.26

1.2

1.3

519.65

547.59

mg/l

0.58

869

5017

Kela-code for severe mental illness

701

3889

1.83

48.20

1.2

1.3

482.40

526.95

mg/l

1.22

663

3712

Other necrotizing vasculopathies (FG)

156

437

3.74

48.03

1.3

468.10

526.31

mg/l

1.27

146

408

Alcohol abuse, main dg, excluding more controls

275

1066

2.64

47.67

1.2

1.3

594.27

543.72

mg/l

0.36

264

1023

Focal brain injury

142

6.05

47.64

1.4

1.1

903.32

490.13

mg/l

0.83

133

Mental and behavioural disorders due to alcohol, excluding acute intoxication

797

4590

1.75

47.28

1.2

1.3

533.11

558.22

mg/l

0.42

752

4377

Alcohol use disorder, Swedish definition

966

5386

1.66

46.91

1.3

528.86

553.14

mg/l

0.46

914

5128

Generalized anxiety disorder

350

1531

2.34

46.72

1.2

1.3

411.92

488.74

mg/l

2.89

335

1467

Psychotic depression

127

313

4.20

46.57

1.2

1.5

454.04

536.69

mg/l

1.13

118

306

Other systemic involvement of connective tissue (FG)

470

2279

2.07

46.49

1.3

609.27

508.99

mg/l

0.50

442

2160

Dyspnoea

1552

7722

1.50

46.46

1.3

1.4

517.77

538.82

mg/l

0.43

1494

7347

Use of levodopa decarboxylase inhibitor

258

984

2.70

46.37

1.3

1.2

518.91

569.23

mg/l

0.84

247

918

Other viral diseases

748

4248

1.78

46.23

1.6

1.4

503.31

478.23

mg/l

0.27

717

4064

Disorders of other endocrine glands

799

4591

1.74

45.77

1.4

1.5

504.51

498.74

mg/l

0.10

754

4382

1020

5717

1.63

45.69

1.3

525.10

549.96

mg/l

0.51

966

5443

Other and unspecified myopathies

195

648

3.12

45.49

1.5

1.4

584.07

555.44

mg/l

0.15

186

609

Diseases of the respiratory system

1125

3485

1.63

45.40

1.4

1.3

521.82

510.36

mg/l

0.25

1056

3339

Suicide or other Intentional self-harm

508

2594

2.00

45.33

1.3

479.79

503.19

mg/l

0.48

476

2474

Diseases of inner ear

907

5309

1.67

45.29

1.3

479.85

557.33

mg/l

4.15

876

5040

1067

5910

1.61

44.93

1.3

519.42

555.02

mg/l

0.80

1011

5630

816

4811

1.71

43.90

1.4

1.5

550.72

501.16

mg/l

0.57

782

4585

Alzheimer’s disease (Atypical or mixed)

160

479

3.40

43.48

1.3

500.27

638.31

mg/l

1.41

143

457

Other symptoms and signs involving general sensations and perceptions

103

229

4.73

43.41

1.2

1.4

472.93

497.07

mg/l

0.22

219

Injuries to the abdomen, lower back, lumbar spine and pelvis

686

3859

1.78

43.28

1.4

530.53

525.60

mg/l

0.06

644

3661

Other viral diseases

594

3234

1.86

43.13

1.6

1.5

517.17

483.88

mg/l

0.30

570

3089

Other CVD (FINNGEN)

229

643

2.84

42.83

1.4

1.2

551.72

516.33

mg/l

0.42

216

596

Other diseases of blood and blood-forming organs, wide

420

2049

2.10

42.65

2.0

1.4

602.41

528.85

mg/l

0.55

403

1941

Insomnia

1535

7648

1.48

42.50

1.3

464.65

534.73

mg/l

3.85

1456

7287

Other and unspecified nonorganic psychotic disorders

418

2041

2.10

42.38

1.2

1.3

453.01

503.20

mg/l

1.33

395

1943

Other necrotizing vasculopathies

173

561

3.22

42.25

1.3

472.22

536.57

mg/l

1.57

162

529

Hypothyroidism, strict autoimmune

1175

4990

1.56

41.94

1.3

467.98

522.59

mg/l

2.72

1122

4734

Abnormalities of heart beat

620

3385

1.82

41.93

1.3

440.53

535.14

mg/l

5.49

581

3215

Other heart diseases

836

3244

1.70

41.78

1.4

495.05

491.49

mg/l

0.05

801

3092

Genitourinary diseases

1071

3356

1.62

41.50

1.4

1.5

513.38

523.41

mg/l

0.19

1010

3212

Gastro-oesophageal reflux disease

1162

6561

1.54

40.99

1.3

1.4

488.84

548.70

mg/l

3.20

1089

6289

Alcohol use disorder, ICD-based

724

4249

1.73

40.97

1.2

1.3

534.33

550.11

mg/l

0.22

681

4048

Other systemic involvement of connective tissue

480

2488

1.96

40.96

1.3

604.73

523.65

mg/l

0.39

452

2358

Other strabismus

444

2237

2.02

40.81

1.4

1.6

436.39

497.50

mg/l

2.65

421

2130

Other and unspecified nerve root and plexus disorders, also in other diseases

373

1773

2.15

40.58

1.3

518.33

506.62

mg/l

0.15

352

1686

Other disorders of nervous system

148

447

3.45

40.55

1.7

1.2

636.21

546.19

mg/l

0.62

140

416

Schizophrenia, schizotypal and delusional disorders

604

3389

1.81

40.14

1.2

1.3

479.08

513.06

mg/l

0.86

571

3226

Hypothyroidism, drug reimbursement

231

606

2.74

39.97

1.3

1.2

483.71

428.19

mg/l

1.25

220

580

Osteopathies and chondropathies

938

5507

1.60

39.59

1.5

1.3

593.28

533.27

mg/l

0.69

885

5244

Fungal Sepsis

110

277

4.19

39.57

1.6

1.2

761.58

519.29

mg/l

0.47

102

262

Schizophrenia or delusion

599

3376

1.80

39.22

1.2

1.3

477.73

512.86

mg/l

0.89

566

3214

Cervicocranial syndrome

214

812

2.71

38.95

1.2

1.3

583.27

491.51

mg/l

0.33

206

778

Arthropathies

1649

5813

1.45

38.93

1.3

1.4

512.32

510.40

mg/l

0.03

1562

5549

Sleep apnoea

1572

7084

1.45

38.90

1.3

565.12

552.53

mg/l

0.12

1494

6752

Panic disorder

308

1385

2.28

38.59

1.3

595.40

487.94

mg/l

0.26

296

1330

Dermatitis and eczema

1911

8535

1.40

38.57

1.4

514.52

534.08

mg/l

0.45

1822

8136

Herpesviral [herpes simplex] infections

482

2555

1.92

38.56

1.4

524.13

481.64

mg/l

1.08

468

2428

Vascular dementia

134

374

3.53

38.55

1.4

1.3

757.66

588.79

mg/l

0.39

125

356

Sarcoidosis

277

1197

2.38

38.28

1.5

1.3

634.86

536.36

mg/l

0.50

265

1127

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

561

3087

1.83

38.24

2.4

1.3

399.29

464.34

mg/l

4.80

535

2956

Unknown and unspecified causes of morbidity

130

375

3.57

38.08

1.3

888.58

523.96

mg/l

0.93

120

356

Brain meningioma, including Hilmo

137

413

3.49

37.87

1.4

1.2

800.31

489.13

mg/l

3.92

131

390

Asthma (diagnoses ohter than nonallergic)

1494

8656

1.44

37.81

1.4

524.49

520.64

mg/l

0.05

1417

8263

Injury, poisoning and certain other consequences of external causes

938

2911

1.63

37.76

1.5

1.4

495.08

504.54

mg/l

0.20

886

2769

ILD medications: azathioprine

297

1330

2.29

37.62

1.4

1.3

505.56

487.48

mg/l

0.30

288

1262

Rotator cuff syndrome

971

4435

1.59

37.61

1.3

526.79

579.71

mg/l

1.61

937

4225

Finngen Rheumatological endpoints

1700

6850

1.42

37.29

1.3

538.48

520.68

mg/l

0.23

1620

6528

Superficial injury of head

418

2138

1.99

37.10

1.3

1.5

560.08

507.40

mg/l

0.26

405

2041

Open wound of head

868

5263

1.61

37.10

1.4

526.93

540.67

mg/l

0.25

825

5023

Implicit fungal Sepsis

102

255

4.23

37.10

1.6

1.2

497.72

504.70

mg/l

0.05

241

Brachial plexus disorders

211

820

2.66

36.75

1.3

519.75

485.06

mg/l

0.45

203

785

Polyuria

381

1898

2.05

36.54

1.3

487.31

534.17

mg/l

1.29

360

1799

Hypotension

274

1200

2.33

36.49

1.4

1.3

549.39

579.03

mg/l

0.34

256

1125

Use of glatiramer acetate

132

5.82

36.21

1.1

1.5

421.94

421.25

mg/l

0.01

122

Brain meningioma

132

401

3.46

36.07

1.4

1.2

757.78

476.75

mg/l

3.60

126

378

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

202

777

2.69

35.96

1.4

1.3

555.99

515.06

mg/l

0.12

190

737

Hypopituitarism

185

683

2.82

35.84

1.4

2.1

505.71

495.90

mg/l

0.11

177

648

Diffuse brain injury

7.27

35.72

1.3

1.2

489.38

464.48

mg/l

0.21

Optic atrophy

130

5.79

35.66

1.6

1.9

617.63

423.12

mg/l

0.75

121

Pneumonitis due to solids and liquids

167

584

2.95

35.61

1.6

1.4

785.73

555.09

mg/l

0.67

154

546

Other acute lower respiratory infections

883

5366

1.58

35.60

1.4

523.80

523.67

mg/l

0.00

842

5112

Sleep apnoea, including avohilmo

1665

7363

1.41

35.53

1.3

556.86

546.11

mg/l

0.10

1578

7023

Transport accidents

782

4164

1.63

35.18

1.3

1.4

505.36

528.37

mg/l

0.28

745

3974

Optic atrophy

132

5.72

35.12

1.6

1.9

617.63

431.04

mg/l

0.71

122

Other shoulder lesions

198

764

2.67

34.95

1.3

483.13

516.23

mg/l

0.45

192

724

Coxibs

466

1269

1.96

34.87

1.3

1.4

485.17

543.36

mg/l

1.18

436

1205

Use of galantamine

142

459

3.19

34.75

1.2

1.3

494.00

570.60

mg/l

1.26

133

433

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

353

1746

2.07

34.72

1.2

1.3

429.23

487.73

mg/l

2.43

332

1667

Vocal cord dysfunction

237

887

2.44

34.49

1.3

1.4

522.21

529.85

mg/l

0.06

227

840

Hyperkinetic disorders, excluding more controls

231

919

2.46

34.41

1.3

1.7

442.17

443.75

mg/l

0.01

224

879

Other problems related to primary support group, including family circumstances

265

1148

2.31

34.05

3.7

1.4

377.79

461.64

mg/l

4.10

257

1099

Injuries to the thorax

725

4468

1.64

33.99

1.4

1.3

525.34

551.39

mg/l

0.48

678

4258

Emotionally unstable personality disorder

278

1266

2.25

33.97

1.2

1.3

416.79

477.31

mg/l

1.52

261

1207

Cough

677

3875

1.67

33.93

1.6

1.4

469.40

560.68

mg/l

2.84

641

3694

Dermatitis

1014

6741

1.51

33.49

1.5

1.4

532.51

534.84

mg/l

0.03

969

6425

Parkinson's disease, including avohilmo

266

1195

2.28

33.48

1.3

470.56

583.05

mg/l

3.74

251

1117

Azathioprine

297

1416

2.14

32.25

1.4

505.56

489.18

mg/l

0.26

288

1347

Visual impairment including blindness (binocular or monocular)

141

476

3.06

32.11

1.4

1.5

571.98

522.88

mg/l

0.32

132

454

Other CVD

302

1451

2.12

31.98

1.4

1.3

548.90

566.99

mg/l

0.21

282

1362

Asthma-related pneumonia or sepsis

576

3398

1.71

31.85

1.5

585.83

523.81

mg/l

0.54

543

3226

Asthma, hospital admissions 3, pneumonia

576

3398

1.71

31.85

1.5

585.83

523.81

mg/l

0.54

543

3226

Special screening examination for infectious and parasitic diseases

402

1548

1.94

31.60

1.3

510.55

529.61

mg/l

0.14

381

1484

Neuralgia and neuritis, unspecified

123

388

3.30

31.57

1.4

483.48

515.27

mg/l

0.32

118

366

Asthma-related pneumonia

573

3386

1.71

31.50

1.5

577.56

524.31

mg/l

0.45

540

3215

Inflammatory diseases of female pelvic organs

1023

5046

1.51

31.48

1.3

434.93

497.35

mg/l

2.97

966

4817

Asthma, including avohilmo

2004

8419

1.35

31.48

1.3

1.4

507.05

536.14

mg/l

0.70

1912

8026

Exposure to other specified factors

1290

8356

1.43

31.46

1.4

505.13

530.39

mg/l

0.47

1242

7963

Phobic anxiety disorders

265

1224

2.21

31.07

1.4

424.01

493.83

mg/l

2.25

253

1176

Agranulocytosis

227

987

2.37

31.07

2.2

1.3

660.90

514.91

mg/l

0.64

218

928

Other disorders of ear

1501

7075

1.40

30.94

1.4

565.62

539.98

mg/l

0.43

1433

6753

Other and unspecified dermatitis

856

5608

1.54

30.94

1.5

1.4

535.74

533.84

mg/l

0.02

818

5346

Other viral diseases, not elsewhere classified

499

2858

1.76

30.47

1.7

1.5

465.93

481.66

mg/l

0.28

483

2727

Injuries to the neck

430

2373

1.84

30.43

1.3

1.4

440.02

503.36

mg/l

3.17

408

2257

Other and unspecified effects of external causes

514

2987

1.75

30.43

1.3

1.5

481.15

490.83

mg/l

0.08

495

2846

Persistent mood disorders

330

1672

2.01

30.27

1.2

1.3

483.23

523.80

mg/l

0.82

308

1594

Zoster [herpes zoster]

768

4858

1.57

30.23

1.5

1.3

535.14

527.18

mg/l

0.17

739

4598

Cramp and spasm

125

410

3.20

30.19

1.4

804.11

530.55

mg/l

0.52

118

387

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

577

3482

1.68

29.66

1.4

1.5

554.94

499.37

mg/l

0.65

550

3317

Diseases of the skin and subcutaneous tissue

1711

6307

1.37

29.55

1.4

1.3

513.76

526.33

mg/l

0.23

1630

6015

Irritable bowel syndrome

483

2782

1.76

29.49

1.3

438.44

499.26

mg/l

3.04

460

2640

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

721

2849

1.61

29.46

1.4

1.3

497.73

476.63

mg/l

0.51

692

2711

Disorders of psychological development

269

1182

2.16

29.39

1.8

1.9

507.92

426.88

mg/l

0.82

263

1120

Infections of the skin and subcutaneous tissue

985

6649

1.48

29.34

1.7

1.4

521.67

533.43

mg/l

0.14

946

6341

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

419

2053

1.85

29.32

1.7

1.6

455.24

431.92

mg/l

0.23

400

1965

Congenital malformations of the nervous system

205

4.25

29.26

1.8

3.2

632.08

403.43

mg/l

1.25

196

Other and unspecified paralytic syndromes

6.14

29.23

1.3

1.2

459.09

411.36

mg/l

0.62

Rheumatism, unspecified

241

1102

2.23

29.13

1.3

455.57

531.97

mg/l

1.72

230

1047

Benign paroxysmal vertigo

458

2608

1.78

29.12

1.3

500.69

533.30

mg/l

0.68

440

2465

Sequelae of external causes of morbidity and mortality

424

2362

1.82

29.07

1.5

1.3

601.92

524.00

mg/l

1.03

402

2238

Acute bronchitis

643

3922

1.62

29.06

1.4

1.5

496.32

527.07

mg/l

0.56

611

3726

Chronic sinusitis

714

4554

1.58

29.06

1.3

468.30

533.43

mg/l

2.51

673

4351

Brain glioblastoma

6.00

28.85

1.5

1.2

862.98

455.81

mg/l

1.87

Other and unspecified drugs and medicaments

184

754

2.52

28.84

1.4

420.26

525.28

mg/l

3.51

174

712

Abnormal findings on examination of blood, without diagnosis

720

4224

1.58

28.81

1.3

1.4

584.61

562.75

mg/l

0.20

688

4024

Other bacterial intestinal infections

303

1519

2.03

28.69

1.7

1.3

555.76

529.46

mg/l

0.36

286

1431

Other disorders of bladder

203

870

2.39

28.65

1.3

1.2

531.96

552.13

mg/l

0.15

193

818

Functional dyspepsia

453

2585

1.78

28.60

1.3

480.75

523.95

mg/l

1.18

434

2472

Injuries to the ankle and foot

1212

7647

1.42

28.54

1.4

482.87

521.31

mg/l

1.35

1156

7294

Other viral diseases, not elsewhere classified

359

1907

1.91

28.49

1.8

1.6

475.26

481.23

mg/l

0.08

348

1825

Enthesopathies of lower limb, excluding foot

353

1877

1.91

28.07

1.3

490.94

504.20

mg/l

0.25

329

1795

Other and unspecified mood [affective] disorders

156

598

2.69

28.04

1.3

1.4

502.39

498.89

mg/l

0.02

142

572

Trigeminal neuralgia

130

454

2.97

27.99

1.4

1.3

462.60

510.11

mg/l

0.68

122

429

Disorders of refraction and accommodation

479

2786

1.74

27.90

1.6

1.5

427.25

490.61

mg/l

3.66

451

2661

Pain and other conditions associated with female genital organs and menstrual cycle

390

1965

1.85

27.85

1.3

408.99

488.11

mg/l

2.13

371

1889

Hypothyreosis and Thyroxine purchase for inclusion criteria

1504

7241

1.37

27.64

1.3

500.23

526.33

mg/l

0.62

1436

6894

Hypothyroidism, other/unspecified

1455

6987

1.38

27.63

1.3

496.68

526.46

mg/l

0.74

1388

6650

Other and unspecified anaemias

614

3642

1.62

27.62

1.6

1.3

547.13

549.51

mg/l

0.03

576

3456

Irregular menses

826

4321

1.53

27.49

1.4

1.3

489.37

477.07

mg/l

0.09

788

4135

Viral pneumonia

239

1118

2.19

27.35

1.5

1.4

706.18

535.86

mg/l

0.76

225

1061

Hypokalaemia

209

926

2.31

27.32

1.8

1.3

615.27

533.82

mg/l

0.51

200

874

Hypersomnia

108

5.56

27.25

1.2

410.85

447.90

mg/l

0.34

Dental pulpitis, including avohilmo

1567

7530

1.36

27.22

1.3

525.62

527.52

mg/l

0.02

1479

7208

Other bacterial intestinal infections

374

2047

1.86

27.19

1.6

1.4

526.10

515.76

mg/l

0.14

351

1941

Other anaemias

617

3670

1.62

27.15

1.6

1.3

547.19

550.30

mg/l

0.04

579

3482

Benign neoplasm: Pituitary gland, craniopharyngeal duct

127

447

2.96

27.07

1.3

530.36

507.43

mg/l

0.22

121

420

Volume depletion

163

649

2.57

27.02

1.4

1.5

549.75

565.13

mg/l

0.08

148

612

Aplastic and other anaemias

664

3942

1.59

27.02

1.6

1.4

548.76

547.56

mg/l

0.02

623

3738

Lesion of lateral popliteal nerve

115

383

3.13

27.01

1.3

473.37

525.39

mg/l

0.58

106

357

Parkinson's disease

241

1137

2.16

26.95

1.3

1.2

471.37

588.51

mg/l

3.70

227

1066

Supplementary factors related to causes of morbidity and mortality classified elsewhere

533

3232

1.67

26.95

1.5

1.4

633.79

508.91

mg/l

0.84

500

3075

Injuries to the wrist and hand

1669

8672

1.34

26.85

1.3

1.4

535.85

528.07

mg/l

0.09

1597

8268

Disorders of the thyroid gland

1543

7442

1.36

26.72

1.3

508.19

530.95

mg/l

0.52

1473

7088

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

849

5565

1.50

26.62

1.3

1.4

514.77

539.69

mg/l

0.56

811

5316

Fasciculation

6.22

26.62

1.3

387.81

438.20

mg/l

0.51

Chronic lower respiratory diseases

2031

8296

1.31

26.60

1.3

1.4

502.80

535.78

mg/l

0.85

1929

7921

Cluster headache, wide,, including avohilmo

128

457

2.91

26.56

1.4

1.3

430.80

506.90

mg/l

1.81

123

429

Cardiac arrhythmias

964

4282

1.47

26.50

1.2

1.3

485.90

479.90

mg/l

0.11

906

4095

Type of accident

494

2951

1.70

26.48

1.6

1.4

628.64

505.16

mg/l

0.76

463

2805

Speech and linguistic disorders

205

877

2.31

26.36

2.0

548.08

409.85

mg/l

1.33

200

830

Substance use, excluding alcohol

363

1990

1.86

26.34

1.3

529.13

503.15

mg/l

0.29

343

1891

Disorders of sclera, cornea, iris and ciliary body

884

6040

1.48

26.15

1.3

556.70

528.90

mg/l

0.52

848

5750

Restless leg syndrome

243

1170

2.12

25.87

1.2

1.3

546.55

522.58

mg/l

0.11

228

1108

Obesity related asthma

564

3518

1.62

25.48

1.3

546.36

522.80

mg/l

0.18

535

3357

Undetermined asthma, excluding more controls

218

1012

2.19

25.36

1.5

1.3

507.43

501.35

mg/l

0.05

204

959

Lung diseases due to external agents

218

1016

2.19

25.16

1.5

1.3

719.57

574.13

mg/l

0.51

204

957

Benign neoplasms

1650

6837

1.34

25.15

1.3

1.4

514.05

525.97

mg/l

0.27

1562

6536

Giant cell arteritis with polymyalgia rheumatica

266

3.51

25.10

1.2

1.3

466.93

511.57

mg/l

0.51

252

Temporal arteritis

267

3.50

24.95

1.2

1.3

466.93

518.23

mg/l

0.60

253

Polyarthropathies

1080

4985

1.43

24.94

1.3

1.4

614.26

516.03

mg/l

1.46

1037

4758

Giant cell arteritis

307

3.30

24.92

1.2

1.3

456.67

529.85

mg/l

1.11

290

Heterophoria

173

738

2.41

24.88

1.6

1.7

432.73

488.48

mg/l

1.16

162

703

Undetermined asthma

218

1020

2.18

24.88

1.5

1.3

507.43

502.66

mg/l

0.04

204

967

Other nutritional deficiencies

1092

7357

1.41

24.86

1.3

1.4

522.02

514.39

mg/l

0.09

1027

7028

Emotional disorders starting during childhood or adolecense, excluding more controls

103

329

3.15

24.69

3.0

2.1

419.91

383.21

mg/l

0.24

311

Asthma, hospital admissions , main diagnosis only

1335

8700

1.36

24.68

1.4

475.39

525.95

mg/l

2.36

1268

8294

Fracture of lumbar spine and pelvis

330

1789

1.87

24.65

1.3

551.89

553.83

mg/l

0.01

303

1685

Other infectious diseases

171

732

2.40

24.35

1.4

463.55

545.02

mg/l

2.41

161

691

Urticaria and erythema

622

4014

1.57

24.29

1.5

1.4

508.76

492.16

mg/l

0.25

584

3835

Temporomandibular joint disorders, including avohilmo

757

5023

1.50

24.19

1.3

526.97

475.56

mg/l

0.46

719

4792

Mycoses

1387

8994

1.35

24.11

1.3

515.96

533.36

mg/l

0.30

1320

8579

Type 2 diabetes, wide definition

1223

5684

1.39

24.03

1.3

638.39

545.00

mg/l

2.20

1155

5428

Injuries to the shoulder and upper arm

1328

7918

1.36

24.00

1.4

1.3

536.60

550.44

mg/l

0.24

1272

7542

Dislocation, sprain and strain of joints and ligaments at neck level

294

1558

1.93

23.87

1.3

1.4

408.60

484.80

mg/l

4.69

280

1482

Drug-induced neutropenia

151

621

2.51

23.63

1.9

1.3

742.96

516.02

mg/l

0.68

144

586

Other infectious diseases

148

604

2.52

23.46

1.4

460.81

534.59

mg/l

1.98

139

569

Continuous positive airway pressure

283

1240

1.95

23.41

1.5

674.01

519.38

mg/l

0.87

263

1193

Fracture of rib(s), sternum and thoracic spine

452

2726

1.68

23.40

1.4

1.3

501.98

570.44

mg/l

1.82

427

2593

Sequelae of injuries, of poisoning and of other consequences of external causes

400

2339

1.74

23.32

1.3

516.73

522.83

mg/l

0.07

378

2227

Other specified/unspecified arthritis

436

2609

1.69

23.27

1.2

1.4

506.56

495.88

mg/l

0.17

425

2483

Voice disturbances

421

2500

1.71

23.17

1.3

475.31

533.17

mg/l

1.89

408

2371

Inflammatory disease of uterus

268

1397

1.96

22.89

1.2

1.3

380.88

466.72

mg/l

4.72

248

1333

Persons encountering health services for specific procedures, not carried out

163

704

2.37

22.77

1.3

1.4

578.53

495.86

mg/l

0.24

151

669

Dystonia

120

450

2.76

22.72

1.3

430.78

503.36

mg/l

1.85

114

428

Other symptoms and signs involving the urinary system

187

857

2.23

22.67

1.5

1.4

544.53

544.06

mg/l

0.00

175

808

Mycoses

428

2569

1.69

22.63

1.5

1.3

565.13

514.38

mg/l

0.35

409

2438

Other enthesopathies

457

2788

1.66

22.63

1.3

547.73

572.31

mg/l

0.15

437

2661

Parkinson's disease, strict definition

214

1035

2.11

22.52

1.4

1.2

470.36

595.30

mg/l

3.58

202

967

Other arthritis (FG)

494

3079

1.62

22.45

1.3

1.4

516.60

493.38

mg/l

0.47

482

2923

Other diseases of upper respiratory tract

1763

7079

1.30

22.37

1.3

1.4

508.69

537.61

mg/l

0.80

1662

6754

Sequelae of injuries of head

120

454

2.74

22.36

1.5

1.4

466.99

532.63

mg/l

1.36

107

428

Benign neoplasm of other and unspecified endocrine glands

234

1175

2.03

22.30

1.3

520.93

525.26

mg/l

0.05

221

1107

Bacterial intestinal infections, IBD co-morbidities

291

1576

1.88

22.03

1.6

1.4

551.05

544.36

mg/l

0.07

274

1490

Problems related to lifestyle

199

946

2.15

21.98

1.4

1.3

470.91

506.91

mg/l

0.53

188

896

Candidiasis

476

2967

1.63

21.70

1.4

1.3

538.24

508.59

mg/l

0.21

455

2819

Erysipelas

776

4733

1.46

21.59

1.3

560.22

530.35

mg/l

0.69

732

4511

Deforming dorsopathies

407

2445

1.68

21.42

1.3

1.4

476.41

498.94

mg/l

0.55

385

2325

Vascular dementia (subcortical)

127

4.39

21.27

1.3

622.08

593.70

mg/l

0.16

122

Fracture of skull and facial bones

352

2040

1.75

21.23

1.3

1.4

514.59

519.12

mg/l

0.07

329

1946

Exclusions for E4_PCOS_CONSORTIUM

1191

5505

1.36

21.18

1.3

1.4

518.24

490.94

mg/l

0.49

1138

5254

Injuries to the knee and lower leg

1928

8416

1.28

21.12

1.3

1.4

537.83

524.07

mg/l

0.23

1851

8016

Statin medication

1122

4601

1.38

21.05

1.3

524.26

532.00

mg/l

0.13

1066

4376

Osteoporosis

364

1992

1.73

20.90

1.7

1.3

615.48

542.42

mg/l

0.43

335

1883

Superficial injury of abdomen, lower back and pelvis

270

1454

1.89

20.89

1.4

470.02

503.04

mg/l

0.71

258

1371

Secondary and unspecified malignant neoplasm of lymph nodes

154

675

2.34

20.87

1.8

1.2

528.49

493.00

mg/l

0.52

145

629

Disorders of conjunctiva

1341

8152

1.33

20.83

1.4

485.25

527.20

mg/l

0.96

1285

7768

Disorders of muscles

173

796

2.22

20.77

1.2

1.3

563.89

512.39

mg/l

0.18

163

753

Other disorders of skin and subcutaneous tissue

1033

6702

1.38

20.73

1.4

1.3

588.32

538.88

mg/l

0.60

972

6389

Superficial injury of lower leg

412

2509

1.66

20.65

1.2

1.4

519.36

503.37

mg/l

0.14

391

2387

Erysipelas

1027

5703

1.38

20.63

1.3

614.13

527.32

mg/l

1.24

973

5440

Other and unspecified tonsillitis

577

3179

1.54

20.56

1.4

1.3

478.39

496.89

mg/l

0.27

547

3044

Allergic asthma (mode), excluding more controls

365

2109

1.71

20.45

1.3

537.01

464.54

mg/l

0.46

350

2016

Other symptoms and signs involving the circulatory and respiratory systems

131

540

2.49

20.38

1.4

500.79

545.05

mg/l

0.62

120

509

Chronic apical periodontitis

1808

8084

1.28

20.23

1.3

542.63

525.68

mg/l

0.21

1706

7716

All influenza (not pneumonia)

257

1378

1.90

20.15

1.5

560.16

510.31

mg/l

0.19

241

1311

Allergic asthma (mode)

365

2120

1.70

20.08

1.3

537.01

466.51

mg/l

0.44

350

2029

Hyperosmolality and hypernatraemia

5.28

20.05

1.4

513.74

477.31

mg/l

0.22

Monoamine oxidase A inhibitors

178

841

2.16

19.97

1.2

1.3

417.20

539.50

mg/l

7.14

171

808

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1567

7906

1.30

19.91

1.7

1.3

548.08

520.33

mg/l

0.49

1494

7548

Infections with a predominantly sexual mode of transmission

676

4309

1.48

19.84

1.3

460.07

456.20

mg/l

0.06

649

4107

Propionic acid derivatives

445

1360

1.66

19.62

1.5

1.6

486.87

530.43

mg/l

0.81

411

1295

Iridocyclitis

362

2162

1.70

19.61

1.3

1.4

524.99

512.53

mg/l

0.16

344

2053

Disorders of synovium and tendon

789

4867

1.43

19.61

1.4

1.3

536.97

551.89

mg/l

0.14

753

4637

Carpal tunnel syndrome

876

5539

1.40

19.60

1.3

583.84

538.76

mg/l

0.50

843

5279

Acute alcohol intoxication

395

2419

1.65

19.38

1.2

1.3

555.87

554.11

mg/l

0.01

371

2301

Vitamin deficiency

102

383

2.75

19.33

1.2

1.5

452.47

500.78

mg/l

0.68

363

Vitamin deficiency, wide

102

383

2.75

19.33

1.2

1.5

452.47

500.78

mg/l

0.68

363

Other metabolic disorders

228

1193

1.95

19.32

1.5

1.4

480.89

484.68

mg/l

0.05

215

1139

Acetic acid derivatives and related substances

402

1243

1.69

19.29

1.2

1.3

514.10

545.29

mg/l

0.43

379

1179

Conjunctivitis

1219

7700

1.33

19.27

1.4

455.22

514.05

mg/l

3.57

1170

7338

Alcohol abuse, main dg

275

1530

1.83

19.22

1.2

1.4

594.27

514.07

mg/l

0.68

264

1457

Persons with potential health hazards related to communicable diseases

653

4437

1.47

19.19

1.6

1.4

482.09

463.84

mg/l

0.27

620

4242

Disorders of lens

979

4442

1.39

19.19

1.3

569.05

581.86

mg/l

0.14

941

4230

Bacterial pneumoniae

581

3417

1.51

19.18

1.5

1.4

603.37

520.24

mg/l

0.95

548

3259

Bacterial pneumonia, not elsewhere classified

550

3198

1.53

19.07

1.5

1.3

605.55

523.79

mg/l

0.86

520

3049

Paracetamol or NSAID medication

264

697

1.93

19.07

1.9

1.7

483.68

489.38

mg/l

0.05

247

669

Mixed and other personality disorders

161

748

2.21

19.01

1.2

1.3

391.14

498.35

mg/l

5.39

155

708

Social phobias

158

728

2.22

18.96

1.5

1.4

397.10

475.83

mg/l

2.67

151

696

Ptosis of eyelid

183

893

2.09

18.96

1.4

1.3

474.54

535.49

mg/l

1.56

178

841

Covid-19 suspected case

378

2305

1.66

18.93

1.3

1.4

444.85

483.33

mg/l

0.97

370

2186

Polycystic ovarian syndrome, consortium definition

1125

4958

1.35

18.89

1.4

1.3

491.80

485.81

mg/l

0.06

1068

4735

Sequelae with surgical and medical care as external cause

314

1830

1.74

18.67

1.5

1.3

610.34

542.36

mg/l

0.67

298

1733

Urticaria

504

3298

1.55

18.67

1.5

490.69

495.20

mg/l

0.06

471

3153

Malignant neoplasm, wide definition for exclusion

1408

6358

1.31

18.50

2.0

1.3

622.90

524.49

mg/l

1.39

1353

6054

Alcohol dependence

403

2513

1.62

18.42

1.2

1.3

541.07

566.61

mg/l

0.26

380

2402

Adrenocortical insufficiency

293

2.99

18.37

1.5

1.4

617.49

504.83

mg/l

0.83

277

Other and unspecified iron deficiency

485

3157

1.55

18.31

1.3

1.4

501.31

534.84

mg/l

0.67

460

2981

Acute alcohol intoxication, ICD10

336

2008

1.70

18.23

1.2

1.4

544.75

522.30

mg/l

0.18

318

1910

KRA_PSY_EATING, excluding more controls

142

633

2.27

18.23

1.2

1.4

356.99

467.74

mg/l

2.77

135

609

Diaphragmatic hernia

513

3386

1.53

18.23

1.3

547.08

541.57

mg/l

0.03

482

3207

Other disorders of bone

329

1956

1.71

18.20

1.3

530.84

504.34

mg/l

0.28

317

1865

Hyperlipidaemia, other/unspecified

517

3153

1.52

17.81

1.3

557.71

575.50

mg/l

0.27

491

2988

Hypoglycaemia, other or unspecified

134

594

2.32

17.78

1.6

1.7

448.37

505.56

mg/l

1.37

126

564

Other heart diseases, wide

1528

7318

1.28

17.77

1.3

1.4

492.70

534.97

mg/l

1.52

1448

6987

Use of pramipexole

321

1910

1.70

17.70

1.3

570.19

558.76

mg/l

0.06

303

1809

Any event in cancer register

1473

6767

1.29

17.56

2.0

1.3

625.40

512.81

mg/l

1.77

1412

6451

Dental caries, including avohilmo

1126

4316

1.34

17.52

1.5

1.4

526.55

558.84

mg/l

0.73

1057

4136

Diseases of pulp and periapical tissues, including avohilmo

1681

6888

1.27

17.47

1.3

1.4

496.17

526.06

mg/l

0.83

1586

6583

Conductive and sensorineural hearing loss

1141

5827

1.33

17.44

1.3

589.50

555.29

mg/l

0.47

1080

5554

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

625

4311

1.46

17.42

1.3

1.4

459.50

480.01

mg/l

0.49

592

4125

Dentofacial anomalies [including malocclusion]

1124

6849

1.33

17.37

1.4

1.3

517.71

505.32

mg/l

0.13

1076

6541

Other disorders of glucose regulation and pancreatic internal secretion

156

742

2.15

17.36

1.6

1.7

470.08

523.57

mg/l

1.05

147

705

Leisure time condition

297

1741

1.73

17.35

1.6

1.5

589.92

507.51

mg/l

0.28

278

1646

Coagulation defects, purpura and other haemorrhagic conditions

311

1846

1.71

17.34

1.9

1.5

543.14

514.67

mg/l

0.33

298

1749

Bacterial pneumonia (organism specified)

628

3944

1.46

17.28

1.5

1.4

600.99

538.27

mg/l

0.69

595

3748

Conjunctivitis (acute, non atopic)

460

2994

1.55

17.22

1.5

483.09

491.93

mg/l

0.14

442

2852

Malignant neoplasm

1343

6143

1.30

17.21

2.0

1.3

624.95

529.71

mg/l

1.23

1285

5847

Disorders of mineral metabolism

145

673

2.20

17.17

1.3

1.4

461.79

535.59

mg/l

1.64

136

634

Excessive, frequent and irregular menstruation

637

2389

1.47

17.15

1.4

1.3

442.24

492.47

mg/l

1.19

600

2293

Diseases of male genital organs

771

2750

1.43

17.14

1.3

1.5

583.80

596.66

mg/l

0.09

731

2626

Hypermobility syndrome

116

492

2.43

17.11

1.2

1.4

402.86

460.77

mg/l

1.00

111

470

Diseases of liver

503

3361

1.51

16.91

1.3

558.33

554.36

mg/l

0.04

479

3205

Soft tissue disorders related to use, overuse and pressure

382

2403

1.61

16.86

1.3

483.44

555.10

mg/l

1.76

365

2279

Sensorineural hearing loss

1062

5429

1.34

16.86

1.3

599.37

553.98

mg/l

0.63

1005

5176

Fall on and from stairs and steps

399

2539

1.59

16.81

1.3

1.4

503.99

522.16

mg/l

0.23

377

2416

Disorders of skin appendages

755

5439

1.40

16.80

1.3

534.75

495.51

mg/l

0.40

720

5193

Adverse effects, not elsewhere classified

336

2053

1.66

16.79

1.3

1.5

487.70

488.79

mg/l

0.01

324

1947

Missing teeth due to accident, extraction or parodontitis

842

5816

1.37

16.77

1.4

1.3

555.24

559.33

mg/l

0.04

779

5566

Congenital malformations, deformations and chromosomal abnormalities

945

6721

1.35

16.70

1.4

487.77

507.11

mg/l

0.40

902

6419

Internuclear ophthalmoplegia

17.60

16.68

1.1

1.3

713.58

506.89

mg/l

0.33

Caries of dentine, including avohilmo

1211

4721

1.32

16.64

1.4

520.58

555.48

mg/l

0.83

1140

4529

Internal derangement of knee

570

3897

1.47

16.63

1.3

503.68

525.82

mg/l

0.25

547

3721

Anterior Iridocyclitis

321

1948

1.67

16.48

1.3

1.4

519.14

512.37

mg/l

0.08

306

1851

Secondary uncertain malignant neoplasm

198

1044

1.93

16.47

1.7

1.2

567.83

543.92

mg/l

0.19

188

975

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

139

650

2.19

16.22

1.4

632.67

473.16

mg/l

1.03

132

618

Other respiratory disorders and diseases

278

1631

1.73

16.17

1.7

1.4

492.05

556.46

mg/l

1.80

264

1536

Other diseases of the respiratory system

278

1631

1.73

16.17

1.7

1.4

492.05

556.46

mg/l

1.80

264

1536

196

3.30

16.11

1.3

433.91

503.47

mg/l

1.01

186

Other and unspecified injuries of head

122

544

2.30

15.98

1.4

1.6

495.09

555.73

mg/l

0.89

114

518

Vascular syndromes of brain in cerebrovascular disorders

249

2.97

15.93

1.3

567.14

567.25

mg/l

0.00

238

Fitting and adjustment of other devices

465

2785

1.52

15.93

1.4

1.3

571.36

531.62

mg/l

0.61

432

2636

Diseases of oral cavity, salivary glands and jaws

881

3321

1.37

15.91

1.4

1.3

513.00

557.78

mg/l

1.09

825

3178

Disturbance of activity and attention

225

1226

1.83

15.83

1.3

1.7

439.53

420.37

mg/l

0.18

220

1167

Other symptoms and signs involving the digestive system and abdomen

245

1397

1.78

15.80

1.4

504.99

527.94

mg/l

0.25

225

1321

Acute and subacute iridocyclitis

301

1818

1.68

15.76

1.3

526.36

509.87

mg/l

0.19

287

1727

Pulmonary heart disease

395

2546

1.57

15.72

1.5

1.3

596.06

552.28

mg/l

0.66

379

2404

Anti-inflammatory and antirheumatic products, non-steroids

425

1360

1.58

15.70

1.5

1.6

491.83

530.43

mg/l

0.67

394

1295

Iron deficiency anaemia

591

4072

1.44

15.69

1.4

511.37

524.87

mg/l

0.24

559

3865

Unspecified haematuria

563

3221

1.46

15.66

1.4

702.16

567.15

mg/l

0.73

541

3064

Chronic rhinitis, nasopharyngitis and pharyngitis

489

3304

1.49

15.61

1.3

1.4

474.51

504.99

mg/l

0.77

462

3163

Pulmonary embolism

395

2551

1.56

15.58

1.5

1.3

596.06

552.15

mg/l

0.66

379

2409

Pain associated with micturition

193

1030

1.91

15.54

1.4

507.19

513.76

mg/l

0.08

178

969

Other disorders of eyelid

586

3901

1.44

15.49

1.3

538.67

547.78

mg/l

0.13

559

3694

Noninfective enteritis and colitis

710

5136

1.39

15.44

1.3

1.4

510.03

520.70

mg/l

0.20

671

4903

Chronic diseases of tonsils and adenoids

1254

6176

1.29

15.37

1.3

1.4

494.94

526.59

mg/l

0.61

1190

5900

Degeneration of the brain due to alcohol

152

3.59

15.33

1.2

1.3

451.11

573.12

mg/l

1.94

139

Venous thromboembolism

735

5173

1.38

15.31

1.4

1.3

590.09

546.92

mg/l

0.73

709

4904

Hypothyroidism, strict autoimmune, 3 medication purchases required

1272

6721

1.28

15.26

1.3

472.31

524.15

mg/l

2.46

1216

6401

Nutritional anaemias

682

4736

1.40

15.22

1.3

1.4

506.92

528.01

mg/l

0.49

645

4491

Alcohol withdrawal state with delirium

124

569

2.23

15.21

1.2

1.3

562.44

553.59

mg/l

0.03

118

536

Other noninfective gastroenteritis and colitis

379

2439

1.57

15.20

1.4

1.6

490.07

496.26

mg/l

0.09

355

2322

Acute pharyngitis

259

1505

1.73

15.19

1.5

1.4

455.98

483.52

mg/l

0.41

251

1440

Diseases of pulp and periapical tissues and dental caries

1005

3878

1.33

15.19

1.5

1.4

522.97

548.05

mg/l

0.54

943

3715

Congenital malformations, deformations and chromosomal abnormalities

1021

7206

1.31

15.09

1.4

483.13

515.88

mg/l

0.85

974

6877

Unspecified/other endometriosis

173

902

1.95

14.98

1.3

366.15

447.80

mg/l

3.63

161

874

Assault

238

1371

1.76

14.92

1.2

1.4

474.06

490.17

mg/l

0.24

226

1304

Diseases of arteries, arterioles and capillaries (FINNGEN)

329

1404

1.64

14.90

1.4

1.2

547.20

536.72

mg/l

0.13

316

1327

Lesion of ulnar nerve

210

1169

1.82

14.77

1.3

501.48

523.20

mg/l

0.30

199

1112

Postprocedural endocrine and metabolic disorders, not elsewhere classified

198

1083

1.86

14.76

1.5

1.3

465.08

489.52

mg/l

0.43

186

1033

Diseases of the digestive system

635

4530

1.41

14.69

1.4

492.31

545.76

mg/l

1.18

597

4301

Disorders of choroid and retina

1139

6284

1.29

14.67

1.4

1.3

544.98

562.14

mg/l

0.41

1082

5987

Oter anti-inflammatory and antirheumatic agents, non-steroids

297

976

1.69

14.66

1.2

1.3

631.67

579.16

mg/l

0.21

272

929

Obesity and other hyperalimentation

976

7201

1.31

14.57

1.3

526.49

513.93

mg/l

0.15

928

6866

Infections with a predominantly sexual mode of transmission

506

3487

1.46

14.56

1.4

1.3

481.54

457.49

mg/l

0.37

486

3323

Enterocolitis due to Clostridium difficile

162

834

1.98

14.54

1.8

1.4

526.57

533.82

mg/l

0.06

153

785

Asthma and allergy

208

1145

1.82

14.46

1.3

456.42

460.12

mg/l

0.04

202

1093

Asthma and allergy, excluding more controls

208

1146

1.81

14.43

1.3

456.42

457.92

mg/l

0.01

202

1091

Trochanteric bursitis

202

1121

1.83

14.35

1.3

461.47

541.13

mg/l

2.02

195

1067

Dental operations

904

3476

1.34

14.30

1.4

1.3

516.63

564.02

mg/l

1.15

848

3319

Superficial injury of hip and thigh

211

1187

1.80

14.29

1.2

1.3

516.07

519.47

mg/l

0.02

202

1115

Obesity

970

7184

1.31

14.25

1.3

525.54

513.33

mg/l

0.14

922

6852

Insulin, intermediate and long-acting

781

5649

1.35

14.25

1.3

1.4

668.30

532.01

mg/l

2.41

745

5384

Hernia of abdominal wall, postoperative

234

1357

1.74

14.24

1.3

1.2

507.08

511.69

mg/l

0.05

224

1291

DVT of lower extremities and pulmonary embolism

548

3838

1.43

14.18

1.4

1.3

573.53

552.99

mg/l

0.32

528

3633

Other obstetric conditions, not elsewhere classified

549

2433

1.45

14.04

1.3

415.41

411.94

mg/l

0.06

529

2319

Paralytic ileus and intestinal obstruction

346

2224

1.57

13.98

1.4

511.37

550.03

mg/l

0.70

327

2103

Convergent concomitant strabismus

115

532

2.22

13.89

1.2

1.8

449.81

487.00

mg/l

0.54

108

507

Fall on same level involving ice and snow

838

6333

1.33

13.88

1.3

528.92

540.87

mg/l

0.19

792

6037

Other and unspecified urticaria

319

2020

1.60

13.87

1.5

493.76

489.26

mg/l

0.04

299

1917

Tinnitus

342

2200

1.57

13.86

1.2

1.3

513.49

520.46

mg/l

0.09

329

2100

Spondyloarthritis

260

1564

1.68

13.86

1.2

1.3

690.96

519.34

mg/l

0.72

247

1478

Pulmonary heart disease, diseases of pulmonary circulation

415

2781

1.51

13.84

1.5

1.3

589.97

550.96

mg/l

0.59

398

2625

Decubitus ulcer and pressure area

406

2.39

13.79

1.6

1.3

626.13

569.52

mg/l

0.20

380

Other disorders of adrenal gland

389

2.44

13.77

1.5

1.6

608.70

521.86

mg/l

0.61

369

Appendectomy

1001

7413

1.30

13.74

1.3

508.65

531.19

mg/l

0.33

954

7066

Fenamates

215

819

1.80

13.70

1.4

1.3

482.86

548.72

mg/l

1.46

206

780

Heart failure, not strict

1053

5548

1.30

13.60

1.4

581.39

566.93

mg/l

0.18

1000

5292

Immunodeficiencies

429

2.35

13.57

2.2

1.7

463.61

491.47

mg/l

0.33

406

Mental disorders, not otherwise specified

157

821

1.95

13.56

1.1

1.4

518.04

482.96

mg/l

0.20

150

781

Hyperkinetic disorders

233

1343

1.73

13.52

1.3

1.9

439.73

416.75

mg/l

0.23

226

1274

Degeneration of nervous system due to alcohol

165

3.30

13.52

1.2

451.11

547.68

mg/l

1.45

152

Purpura and other haemorrhagic conditions

210

1202

1.77

13.51

2.2

1.4

548.36

531.87

mg/l

0.17

204

1136

Non-allergic asthma (mode)

257

1536

1.67

13.50

1.3

462.11

493.74

mg/l

0.55

237

1464

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

535

2380

1.44

13.31

1.3

405.95

410.81

mg/l

0.10

516

2268

Unspecified acute lower respiratory infection

233

1379

1.71

13.28

1.4

1.5

596.53

517.57

mg/l

0.31

224

1318

Haemorrhage from respiratory passages

459

2848

1.46

13.21

1.5

1.4

511.09

580.48

mg/l

1.73

434

2705

Oxicams

311

1098

1.62

13.16

1.3

503.03

557.85

mg/l

0.84

298

1043

Non-allergic asthma (mode), excluding more controls

257

1547

1.66

13.15

1.3

462.11

491.23

mg/l

0.50

237

1474

Cutaneous abscess, furuncle and carbuncle

394

2644

1.51

13.14

1.3

557.60

514.48

mg/l

0.27

378

2512

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

127

624

2.08

13.12

1.2

1.4

437.15

515.64

mg/l

0.97

119

592

Senile cataract

843

3901

1.33

13.06

1.3

549.20

593.58

mg/l

1.08

808

3716

Hypermetropia

132

660

2.04

12.97

1.7

2.0

381.12

504.50

mg/l

4.12

124

628

Agoraphobia

239

2.80

12.95

1.2

1.3

423.49

505.72

mg/l

1.09

225

Obesity due to excess calories

719

5375

1.35

12.91

1.3

1.4

550.49

508.02

mg/l

0.47

679

5143

Excessive vomiting in pregnancy

150

789

1.94

12.76

1.3

1.2

354.45

449.60

mg/l

5.53

139

745

Menorrhagia

528

2055

1.44

12.72

1.3

489.29

514.18

mg/l

0.31

495

1976

Disorders of calcium metabolism

105

488

2.20

12.55

1.3

1.4

465.82

538.37

mg/l

1.17

458

Ovarian cyst

555

2277

1.42

12.47

1.3

447.67

498.10

mg/l

1.04

525

2185

Assault by bodily force

145

763

1.94

12.34

1.2

1.4

472.66

486.75

mg/l

0.20

139

728

Obsessive-compulsive disorder

118

578

2.08

12.29

1.2

1.4

365.02

468.05

mg/l

3.17

112

549

Diabetic neuropathy

152

809

1.90

12.24

1.4

1.3

867.34

594.03

mg/l

0.68

142

759

Injuries to the hip and thigh

631

4214

1.36

12.22

1.3

1.4

559.86

537.52

mg/l

0.28

593

4002

Insulin, combination of fast acting with intermediate-acting or long-acting

861

6070

1.30

12.18

1.3

1.4

660.37

528.83

mg/l

2.61

821

5774

Spondylolisthesis/Spondylolysis

237

1443

1.66

12.13

1.2

1.3

501.77

502.10

mg/l

0.00

221

1372

Mental and behavioural disorders due to sedatives or hypnotics

126

636

2.03

12.13

1.2

1.3

472.48

520.04

mg/l

0.50

117

605

Abnormal findings on diagnostic imaging of other body structures

204

1196

1.73

12.10

1.3

497.63

534.90

mg/l

0.83

192

1131

Misadventures to patients during surgical and medical care

211

1250

1.71

12.04

1.5

1.3

570.79

525.21

mg/l

0.38

203

1181

Metatarsalgia

144

762

1.92

12.01

1.2

1.4

683.90

509.78

mg/l

0.45

137

724

Striking against or struck by other objects

508

3635

1.41

12.00

1.3

1.5

479.00

521.95

mg/l

1.16

481

3473

Beningn neoplasm: Meninges, unspecified

117

3.60

11.88

1.6

1.2

985.10

475.37

mg/l

1.60

110

Insulin medication

860

5592

1.30

11.87

1.3

1.4

660.57

521.23

mg/l

2.85

820

5330

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

417

2890

1.46

11.84

1.4

1.3

483.42

517.94

mg/l

0.97

400

2754

Candidiasis

212

1264

1.70

11.84

1.4

1.3

622.95

510.44

mg/l

0.41

199

1191

Cellulitis

324

2138

1.53

11.79

1.7

1.4

571.21

518.62

mg/l

0.79

315

2030

Emotional disorders starting during childhood or adolescence

104

490

2.16

11.79

3.0

2.1

418.42

374.59

mg/l

0.30

460

Other enthesopathy of foot (+metatarsalgia)

151

817

1.88

11.76

1.2

1.4

668.42

507.75

mg/l

0.43

144

777

Fracture of foot, except ankle

374

2543

1.49

11.76

1.4

515.97

499.11

mg/l

0.23

356

2427

Keratitis

514

3702

1.40

11.75

1.3

579.71

525.93

mg/l

0.82

492

3528

Abnormal blood-pressure reading, without diagnosis

373

2.34

11.72

1.4

1.5

552.26

540.15

mg/l

0.05

356

Emotional disorders and disorders of social functioning with onset specific to childhood

111

533

2.10

11.69

2.9

2.1

416.85

381.02

mg/l

0.25

102

503

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

265

1677

1.60

11.66

1.3

403.90

456.96

mg/l

1.86

250

1603

Diseases of middle ear and mastoid

889

5661

1.29

11.60

1.6

1.3

562.63

495.32

mg/l

1.02

850

5396

Other diseases of hard tissues of teeth

837

3310

1.31

11.59

1.5

1.3

536.77

557.93

mg/l

0.36

788

3168

Acute renal failure

279

1788

1.58

11.58

1.4

1.3

644.41

566.39

mg/l

0.69

258

1691

Superficial injury of wrist and hand

321

2123

1.53

11.58

1.4

528.01

490.81

mg/l

0.13

309

2024

Schizoaffective disorder

138

731

1.93

11.55

1.2

1.4

451.36

507.54

mg/l

0.67

129

693

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

216

1304

1.68

11.50

1.6

1.3

527.48

525.94

mg/l

0.02

204

1225

Secondary hypertension

114

558

2.05

11.47

1.3

1.4

524.88

499.34

mg/l

0.15

105

523

Arthrosis

1031

4462

1.27

11.36

1.3

546.18

529.10

mg/l

0.35

980

4256

All chronic kidney diseases

723

4490

1.32

11.35

1.4

614.23

512.44

mg/l

1.38

690

4277

Acute appendicitis, no complications

847

6572

1.29

11.25

1.3

502.60

530.09

mg/l

0.39

805

6285

Chronic gastritis

342

2307

1.49

11.18

1.2

1.3

566.65

555.88

mg/l

0.05

320

2197

Heartburn

162

911

1.80

11.15

1.3

456.28

522.99

mg/l

1.22

155

861

Hyperplasia of prostate

458

1823

1.44

11.15

1.3

563.47

610.85

mg/l

1.09

432

1741

Fentanyl

130

684

1.92

10.98

1.4

1.3

797.05

530.45

mg/l

0.63

121

647

Other specified and unspecified personality disorders

156

873

1.82

10.97

1.3

1.4

409.05

508.87

mg/l

3.67

150

832

Abnormal findings on diagnostic imaging of lung

604

4325

1.35

10.90

1.3

564.60

568.36

mg/l

0.03

578

4104

Intestinal stricture

398

2779

1.44

10.89

1.4

508.55

557.82

mg/l

1.13

377

2633

Weight loss

153

855

1.82

10.81

1.6

1.5

492.49

537.39

mg/l

0.47

144

807

Acute and transient psychotic disorders

189

1122

1.71

10.79

1.2

1.3

472.33

501.60

mg/l

0.38

179

1068

Maternal care for other conditions predominantly related to pregnancy

330

2187

1.49

10.73

1.2

1.3

434.63

428.55

mg/l

0.10

313

2080

Budesonide

209

1277

1.66

10.66

1.3

494.65

498.84

mg/l

0.04

200

1213

Abnormal weight loss

142

780

1.85

10.63

1.2

1.5

496.16

546.67

mg/l

0.51

133

735

Failure and rejection of transplanted organs and tissues

111

3.52

10.62

3.1

1.2

550.30

461.62

mg/l

0.48

103

Early lumbar disc prolapse operation

182

1078

1.71

10.50

1.2

1.3

517.68

499.17

mg/l

0.12

177

1038

Other female pelvic inflammatory diseases

238

1508

1.60

10.48

1.3

434.53

504.56

mg/l

1.86

222

1437

Faecal incontinence

126

670

1.91

10.42

1.5

1.3

448.03

512.80

mg/l

1.21

118

639

Viral and other specified intestinal infections

431

2969

1.41

10.38

1.5

452.47

471.21

mg/l

0.23

415

2829

Lateral epicondylitis

185

1104

1.70

10.34

1.2

1.3

485.21

515.93

mg/l

0.35

179

1049

Inflammatory diseases of prostate (prostatitis)

166

962

1.75

10.33

1.4

1.3

527.12

563.26

mg/l

0.74

161

914

Amblyopia ex anopsia

350

2.29

10.28

1.5

2.4

502.62

455.59

mg/l

0.28

332

Impingement syndrome of shoulder

316

2137

1.49

10.27

1.4

1.3

575.64

586.85

mg/l

0.09

302

2034

Unspecified privation

165

958

1.75

10.24

1.4

505.19

527.29

mg/l

0.30

158

908

Other fall from one level to another

337

2310

1.47

10.23

1.9

1.5

530.00

498.05

mg/l

0.41

322

2194

Other diseases of the digestive system

400

2830

1.42

10.20

1.4

505.89

547.08

mg/l

0.56

372

2683

Insulin, fast-acting

506

3725

1.37

10.14

1.3

1.4

700.24

515.27

mg/l

2.04

480

3548

Gingivitis and periodontal diseases

1547

6653

1.20

10.10

1.4

519.84

531.53

mg/l

0.20

1462

6351

Other hearing loss

325

2172

1.47

10.00

1.3

563.26

537.35

mg/l

0.14

315

2050

Viral and other specified intestinal infections

329

2201

1.47

9.98

1.5

466.25

464.33

mg/l

0.02

318

2097

Noninfectious colitis NAS

206

1277

1.63

9.96

1.3

1.5

500.21

510.38

mg/l

0.13

193

1211

Diverticular disease of intestine

946

4811

1.26

9.93

1.3

530.43

576.88

mg/l

1.54

906

4592

Fracture at wrist and hand level

500

3682

1.37

9.92

1.3

1.4

492.03

517.82

mg/l

0.78

476

3515

Amenorrhoea

123

661

1.89

9.91

1.3

413.12

430.24

mg/l

0.24

116

639

Endometriosis

515

2211

1.38

9.90

1.3

441.15

503.40

mg/l

1.71

485

2126

Adhesive capsulitis of shoulder

215

1348

1.61

9.89

1.4

1.3

470.27

548.17

mg/l

1.88

209

1281

Tubulo-interstitial nephritis, not specified as acute or chronic

102

516

2.01

9.81

1.4

1.3

588.12

513.02

mg/l

0.77

490

Secondary thrombocytopenia

3.67

9.81

1.7

1.2

583.31

460.14

mg/l

0.50

Myeloid leukaemia

187

2.76

9.77

2.6

1.2

497.94

517.46

mg/l

0.13

177

Other gastritis (incl. Duodenitis)

287

1926

1.50

9.72

1.3

615.61

569.02

mg/l

0.18

276

1841

Other/unspecified enthesopathies of lower limb, excluding foot

106

546

1.97

9.69

1.3

1.4

484.48

503.39

mg/l

0.22

521

Tonsillectomy and adenotomy

909

5045

1.26

9.63

1.4

489.40

478.41

mg/l

0.06

856

4835

Disorders of vitreous body and globe

658

4872

1.30

9.58

1.3

585.19

561.02

mg/l

0.16

626

4632

Early onset COPD, excluding more controls

239

1546

1.56

9.57

1.3

544.55

569.61

mg/l

0.26

221

1482

GI-bleeding

394

2813

1.41

9.57

1.4

498.80

549.18

mg/l

0.73

366

2665

Other abnormal immunological findings in serum

156

2.93

9.53

1.3

1.6

714.23

450.30

mg/l

0.56

148

Paroxysmal tachycardia

300

1699

1.49

9.50

1.3

1.4

498.82

499.65

mg/l

0.01

284

1605

Asthma/COPD (KELA code 203)

1443

8279

1.20

9.50

1.3

1.4

480.01

536.15

mg/l

2.58

1369

7905

Atopic dermatitis

888

5813

1.26

9.48

1.3

1.4

462.71

497.90

mg/l

1.00

851

5559

Nephropathy related operations

179

1086

1.67

9.48

1.6

1.5

546.42

539.55

mg/l

0.09

171

1031

Fissure and fistula of anal and rectal regions

333

2317

1.45

9.39

1.3

561.50

526.88

mg/l

0.23

311

2210

Dialysis, with operation codes

187

1151

1.65

9.36

1.6

1.5

545.98

541.89

mg/l

0.05

178

1089

Speech therapy

349

2453

1.44

9.32

1.3

1.4

579.59

525.30

mg/l

0.44

339

2327

Insulin, fast-acting or short human

508

3795

1.35

9.30

1.3

1.4

699.81

519.82

mg/l

1.97

482

3612

Unspecified urinary incontinence

127

704

1.83

9.28

1.3

622.12

517.87

mg/l

0.37

121

670

Reimbursement for rheumatic diseases

800

6325

1.27

9.25

1.3

1.4

588.32

529.27

mg/l

0.49

765

6020

Unspecified visual impairment (binocular)

116

3.24

9.22

1.2

1.9

425.69

463.10

mg/l

0.29

110

Diseases of appendix

1103

8164

1.22

9.22

1.3

516.30

537.47

mg/l

0.34

1047

7803

False labour

474

2168

1.37

9.18

1.3

402.04

449.12

mg/l

0.81

453

2069

Meniscus derangement

767

4061

1.28

9.15

1.3

511.71

538.58

mg/l

0.73

723

3876

Sicca syndrome [Sjögren]

128

715

1.82

9.14

1.4

1.2

401.54

503.98

mg/l

4.07

123

677

Osteoporosis with pathological fracture (FG)

468

2.02

9.11

1.6

1.3

829.41

496.00

mg/l

0.59

447

Contact with and exposure to communicable diseases

489

3635

1.35

9.05

1.4

464.04

447.14

mg/l

0.20

462

3477

Respiratory insufficiency

488

1.99

9.03

1.5

1.3

475.44

521.44

mg/l

0.93

459

Viral pneumonia (unknown virus, not influenza)

114

619

1.88

8.95

1.5

1.4

814.11

525.01

mg/l

0.63

106

587

Childhood asthma (age<16), excluding more controls

191

932

1.63

8.94

1.4

457.12

422.75

mg/l

0.37

181

886

Appendicitis, broad definition

1092

8131

1.22

8.93

1.3

516.48

537.93

mg/l

0.35

1037

7771

Other condition

216

1393

1.57

8.90

1.7

1.4

660.21

507.78

mg/l

0.82

205

1318

Open wound of wrist and hand

647

4917

1.29

8.89

1.3

1.4

523.31

532.16

mg/l

0.11

620

4694

Generalized epilepsy

359

2.17

8.88

1.2

1.8

539.24

490.42

mg/l

0.18

343

Disorders of vitreous body

636

4767

1.30

8.86

1.3

581.97

563.28

mg/l

0.12

607

4529

Injuries to the elbow and forearm

1014

7288

1.23

8.85

1.3

1.4

524.02

526.15

mg/l

0.02

956

6956

Childhood asthma (age<16)

191

935

1.62

8.85

1.4

457.12

424.55

mg/l

0.34

181

889

Other viral hepatitis

109

586

1.90

8.84

1.3

536.34

494.94

mg/l

0.25

104

555

Diabetic retinopathy, excluding more controls

320

1232

1.47

8.82

1.4

1.3

587.35

551.23

mg/l

0.57

301

1167

Other or unspecified ileus, impaction or obstruction

231

1517

1.54

8.71

1.4

531.11

556.38

mg/l

0.28

221

1438

Renal failure

554

3737

1.32

8.66

1.4

646.46

554.36

mg/l

0.91

520

3543

Acute appendicitis

1027

7883

1.22

8.66

1.3

517.15

538.93

mg/l

0.33

976

7530

Other disorders of patella

250

1676

1.51

8.59

1.3

448.61

487.02

mg/l

0.98

241

1600

Other maternal disorders predominantly related to pregnancy

831

4163

1.26

8.59

1.3

452.85

498.72

mg/l

1.20

795

3966

Superficial injury of thorax

208

1342

1.57

8.56

1.3

573.30

524.70

mg/l

0.37

191

1266

Crohn disease

202

1296

1.58

8.54

1.3

1.4

474.51

498.19

mg/l

0.36

193

1231

Benign neoplasm of colon, rectum, anus and anal canal

805

5598

1.25

8.53

1.3

562.64

576.42

mg/l

0.14

758

5331

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

418

3079

1.37

8.50

1.3

1.4

577.22

495.84

mg/l

0.58

401

2936

Gout

320

1976

1.43

8.50

1.5

1.3

650.81

547.79

mg/l

2.21

308

1869

Familial hypercholesterolemia

182

1140

1.61

8.49

1.3

734.26

576.04

mg/l

0.71

173

1081

Panniculitis affecting regions of neck and back

262

2.34

8.48

1.3

517.47

500.80

mg/l

0.12

251

Vasomotor and allergic rhinitis

550

4139

1.31

8.44

1.3

1.4

434.67

494.67

mg/l

2.34

527

3962

Astigmatism

104

559

1.89

8.42

2.3

2.1

384.43

490.75

mg/l

2.36

531

Dislocation, sprain and strain of joints and ligaments of knee

894

6691

1.24

8.41

1.3

501.29

524.53

mg/l

0.39

856

6382

Other retinal disorders

817

5108

1.25

8.38

1.4

1.3

551.08

558.30

mg/l

0.12

774

4857

Other diseases of anus and rectum

381

2766

1.38

8.35

1.3

1.4

553.06

539.33

mg/l

0.09

359

2623

Diseases of salivary glands

440

3277

1.35

8.33

1.3

471.76

515.14

mg/l

1.17

421

3121

Disease of hard tissues of teeth, NOS

781

3241

1.27

8.32

1.4

1.3

527.03

550.76

mg/l

0.44

748

3104

Complications of genitourinary prosthetic devices, implants and grafts

186

2.60

8.26

1.4

1.3

687.64

465.22

mg/l

0.58

172

Malignant neoplasm of digestive organs

242

2808

0.68

8.21

1.3

572.97

554.41

mg/l

0.19

237

2653

Cerebral oedema

12.92

8.20

2.7

1.5

599.79

402.69

mg/l

0.94

Other arrhythmias

939

5784

1.23

8.19

1.2

1.3

514.68

539.80

mg/l

0.39

880

5521

Glomerular diseases

243

1639

1.50

8.15

1.4

556.43

528.64

mg/l

0.27

235

1548

Anogenital herpesviral [herpes simplex] infection

175

1099

1.61

8.14

1.3

414.22

451.80

mg/l

0.92

170

1038

Suppurative and unspecified otitis media

555

3793

1.30

8.09

1.8

1.4

568.00

480.09

mg/l

0.85

532

3622

Car occupant injured in other and unspecified transport accidents

279

1936

1.45

8.09

1.3

474.66

498.95

mg/l

0.39

265

1834

Care involving dialysis

109

603

1.84

8.08

1.4

1.5

574.77

544.20

mg/l

0.34

103

571

Acute lymphadenitis

525

1.90

8.07

2.0

1.5

432.90

512.25

mg/l

1.49

496

Fibroblastic disorders

272

1878

1.46

8.06

1.2

1.3

535.45

565.48

mg/l

0.35

260

1788

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

800

6278

1.24

8.04

1.4

437.54

504.23

mg/l

4.07

767

5979

Urolithiasis

411

3047

1.36

8.03

1.3

740.32

550.23

mg/l

0.75

395

2895

Superficial injury of forearm

154

941

1.66

8.01

1.3

1.6

538.05

493.60

mg/l

0.17

145

890

Other arthrosis

697

3823

1.27

7.93

1.3

570.30

542.05

mg/l

0.31

675

3649

Benign neoplasm: Colon

672

5086

1.27

7.92

1.3

570.83

574.97

mg/l

0.03

635

4833

Haemorrhage, not elsewhere classified

172

2.60

7.88

2.5

1.2

489.00

532.57

mg/l

0.31

161

Injury of muscle and tendon at shoulder and upper arm level

449

3389

1.33

7.80

1.2

1.3

545.36

571.71

mg/l

0.42

432

3225

Orchitis and epididymitis

117

668

1.77

7.80

1.4

1.5

600.42

565.99

mg/l

0.32

110

629

Other diseases of pleura

548

3717

1.30

7.77

1.5

1.4

601.54

559.98

mg/l

0.31

519

3524

Spondylopathies (FG)

200

1312

1.54

7.69

1.3

587.57

487.81

mg/l

0.48

188

1243

Hernia

1341

7624

1.18

7.65

1.3

1.4

571.99

544.24

mg/l

0.33

1282

7272

Viral hepatitis

120

696

1.75

7.63

1.3

1.4

532.63

506.57

mg/l

0.16

114

660

Procreative management

500

3197

1.31

7.59

1.5

501.13

502.50

mg/l

0.01

472

3042

Mouth breathing

548

4262

1.29

7.57

1.3

1.5

493.19

544.49

mg/l

1.91

522

4069

Acute suppurative otitis media

414

2892

1.35

7.56

2.0

1.4

519.20

457.16

mg/l

1.07

399

2762

Persistent delusional disorders

111

631

1.79

7.56

1.2

1.3

456.69

532.42

mg/l

1.81

105

595

Calculus of kidney and ureter

382

2831

1.36

7.53

1.3

743.18

548.87

mg/l

0.71

368

2689

Thyroiditis, ILD-related definition

159

996

1.62

7.50

1.4

587.55

500.00

mg/l

0.26

151

942

Diseases of external ear

452

3437

1.32

7.47

1.3

1.5

604.26

519.65

mg/l

0.56

422

3281

Disorders of gallbladder, biliary tract and pancreas

1406

7560

1.18

7.46

1.4

1.3

562.98

536.48

mg/l

0.35

1340

7208

Collagenous colitis

134

806

1.69

7.45

1.3

1.4

490.72

523.11

mg/l

0.28

126

762

Other diseases of liver

245

1687

1.47

7.44

1.3

1.4

589.85

523.92

mg/l

0.52

236

1601

Other specified/unspecified hearing loss

115

664

1.76

7.42

1.3

525.32

547.61

mg/l

0.17

110

627

Obesity, other/unspecified

485

3731

1.31

7.37

1.3

449.58

487.50

mg/l

1.31

468

3565

Other disorders of the musculoskeletal system and connective tissue

197

1301

1.53

7.37

1.4

1.3

541.54

535.60

mg/l

0.04

191

1229

Retinal detachments and breaks

428

3239

1.33

7.32

1.3

529.72

556.91

mg/l

0.56

408

3071

Fracture of shoulder and upper arm

462

3532

1.31

7.28

1.5

1.4

521.49

525.01

mg/l

0.04

435

3350

Lesion of radial nerve

287

2.17

7.27

1.3

503.25

503.81

mg/l

0.00

269

Gonarthrosis [arthrosis of knee](FG)

1015

4899

1.21

7.25

1.3

570.02

544.83

mg/l

0.33

970

4667

Diabetes mellitus

1525

7670

1.17

7.17

1.3

1.4

589.24

522.45

mg/l

1.72

1449

7329

Chondropathies

222

1514

1.48

7.12

1.4

529.94

500.33

mg/l

0.32

213

1436

Polymyalgia rheumatica

156

986

1.60

7.10

1.2

1.3

995.59

571.65

mg/l

0.77

141

928

Haemorrhage in early pregnancy

396

2903

1.34

7.03

1.2

1.3

417.58

472.67

mg/l

2.06

383

2765

Other cataract

547

3240

1.28

7.02

1.3

575.96

565.94

mg/l

0.07

531

3075

Other skin changes

227

1561

1.47

6.97

1.4

1.3

509.32

544.68

mg/l

0.60

212

1474

Gonarthrosis

853

3985

1.22

6.91

1.2

1.3

550.35

536.61

mg/l

0.17

816

3801

Other peripheral vertigo

122

732

1.69

6.88

1.3

439.32

543.21

mg/l

2.73

117

688

Eating disorders

170

1104

1.56

6.87

1.2

1.5

394.86

454.23

mg/l

1.32

160

1050

Diabetes medication

1527

7820

1.16

6.87

1.3

1.4

590.98

524.23

mg/l

1.73

1443

7473

Chronic viral hepatitis

489

1.85

6.85

1.3

1.4

569.90

481.72

mg/l

0.51

465

Rheumatoid arthritis

401

2720

1.33

6.83

1.3

701.95

526.96

mg/l

0.85

379

2585

Allergic conjunctivitis

830

6676

1.22

6.81

1.4

438.79

505.90

mg/l

4.19

796

6362

Toxic effects of substances chiefly nonmedicinal as to source

172

1124

1.55

6.81

1.3

1.5

431.36

507.38

mg/l

2.42

163

1063

Type 1 diabetes

357

2662

1.35

6.75

1.4

1.5

563.83

484.36

mg/l

1.78

339

2540

Diabetes, varying definitions

1511

7656

1.16

6.74

1.3

1.4

591.74

522.71

mg/l

1.79

1435

7316

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1356

7452

1.17

6.72

1.3

577.28

539.13

mg/l

0.51

1299

7099

Fracture of lower leg, including ankle

746

6046

1.23

6.67

1.3

1.4

552.55

538.81

mg/l

0.20

717

5753

Sequelae of other external causes

465

1.86

6.64

1.6

1.3

669.54

533.80

mg/l

0.58

440

Cardiodefibrillation

229

3239

0.70

6.59

1.3

563.75

589.39

mg/l

0.30

218

3071

Heart failure and antihypertensive medication

306

1451

1.39

6.56

1.5

1.3

528.73

583.31

mg/l

0.64

293

1369

Type 2 diabetes

1423

7171

1.16

6.53

1.3

590.95

529.52

mg/l

1.38

1349

6848

Methotrexate

185

1240

1.51

6.50

1.2

1.3

674.34

506.67

mg/l

0.57

173

1173

Cholecystectomy

942

6810

1.20

6.49

1.3

587.59

533.94

mg/l

0.56

897

6481

Complications of internal orthopaedic prosthetic devices, implants and grafts

258

1844

1.41

6.44

1.3

647.38

547.73

mg/l

0.87

242

1729

Acute laryngitis and tracheitis

178

1168

1.51

6.40

1.9

1.4

452.12

471.18

mg/l

0.19

169

1119

Other specified/unspecified inflammatory spondylopathies

365

1.95

6.34

1.3

488.92

502.48

mg/l

0.08

352

Superficial injury of shoulder and upper arm

157

1023

1.55

6.33

1.3

1.4

635.13

517.78

mg/l

0.48

151

969

Atopic dermatitis, strict definition with reimbursement

446

3347

1.29

6.32

1.4

1.5

446.20

460.51

mg/l

0.21

428

3196

Chronic laryngitis and laryngotracheitis

180

1208

1.50

6.31

1.3

479.08

521.76

mg/l

0.86

173

1145

Phlebitis and thrombophlebitis (not including DVT)

286

2088

1.38

6.30

1.3

504.87

525.76

mg/l

0.32

273

1987

Use of disulfiram, acamprosate or naltrexone

132

828

1.62

6.30

1.3

636.06

531.72

mg/l

0.48

125

783

Corneal ulcer

255

1828

1.41

6.28

1.2

1.3

612.26

515.04

mg/l

1.01

243

1734

Colonic or urogenital fistula

351

2645

1.34

6.28

1.3

580.05

516.32

mg/l

0.49

329

2512

Polyarthrosis

240

1577

1.42

6.28

1.3

575.96

527.92

mg/l

0.24

230

1489

Raynaud syndrome

128

801

1.62

6.18

1.2

1.3

424.29

507.48

mg/l

1.70

121

761

Rash and other nonspecific skin eruption

129

809

1.61

6.15

1.7

1.4

439.15

531.28

mg/l

3.03

122

765

Gout, FINNGEN

320

2379

1.35

6.15

1.5

1.3

650.81

567.92

mg/l

1.43

308

2250

Nonsuppurative otitis media

344

2238

1.34

6.15

1.7

1.4

588.82

465.49

mg/l

0.85

332

2120

Fracture of neck

470

1.82

6.13

1.2

1.3

558.72

561.38

mg/l

0.02

439

Medical abortion

880

3975

1.21

6.12

1.3

465.06

477.60

mg/l

0.20

839

3781

Other local infections of skin and subcutaneous tissue

142

913

1.57

6.10

2.1

1.4

499.85

534.48

mg/l

0.27

136

860

Amyloidosis, other/unspecified

129

2.64

6.04

1.3

1.2

733.45

490.02

mg/l

1.59

118

Ischemic heart diseases

1138

5836

1.17

6.03

1.3

1.4

556.96

561.15

mg/l

0.04

1085

5568

Congenital iodine-deficiency syndrome/hypothyroidism

203

2.27

6.01

1.3

1.6

428.37

501.06

mg/l

0.92

190

Eating disorder

142

916

1.57

5.98

1.2

1.5

356.99

432.55

mg/l

2.03

135

873

Other and unspecified local infections of skin and subcutaneous tissue

134

855

1.59

5.96

2.2

1.5

499.91

537.83

mg/l

0.28

128

804

Otitis media, unspecified

178

1109

1.49

5.96

1.9

1.5

608.98

453.27

mg/l

0.48

166

1049

Atrial fibrillation and flutter

364

1786

1.33

5.95

1.2

521.23

518.75

mg/l

0.03

343

1696

Pedestrian injured in transport accident

579

1.72

5.93

1.2

1.4

457.44

521.84

mg/l

1.47

546

Deviated nasal septum

423

3295

1.29

5.90

1.3

630.19

557.10

mg/l

0.51

400

3144

Dipeptidyl peptidase 4 (DPP-4) inhibitors

673

4416

1.23

5.88

1.3

648.96

551.50

mg/l

1.40

631

4201

Carrier of infectious disease

180

2.33

5.86

1.4

1.5

489.75

421.11

mg/l

0.67

171

Presence of other functional implants

723

4133

1.22

5.85

1.3

583.30

575.45

mg/l

0.07

679

3929

Endometriosis of pelvic peritoneum

230

1563

1.41

5.85

1.3

415.31

504.53

mg/l

1.89

213

1505

Disorders of tooth development and eruption

232

1336

1.42

5.83

1.7

1.3

493.55

496.39

mg/l

0.01

218

1288

Wegener granulomatosis

114

2.72

5.83

1.4

1.3

527.97

468.80

mg/l

0.45

107

Caries of enamel

1313

8218

1.16

5.82

1.5

1.3

469.68

533.08

mg/l

2.65

1268

7829

Schizophrenia

224

1594

1.42

5.81

1.2

1.3

533.64

508.96

mg/l

0.25

212

1518

Eosinophilic disease (BM)

2.87

5.80

1.2

1.5

484.59

492.16

mg/l

0.04

Ganglion

266

1949

1.37

5.77

1.3

521.86

507.38

mg/l

0.14

261

1856

Crushed, pushed or stepped on by crowd or human stampede

116

722

1.63

5.76

1.3

1.7

463.98

489.93

mg/l

0.34

111

682

Gastric ulcer

198

1380

1.44

5.74

1.4

1.3

488.56

577.34

mg/l

1.90

186

1313

Other peripheral vascular diseases

112

692

1.64

5.72

1.2

1.3

428.36

529.80

mg/l

1.89

107

651

Other predominantly sexually transmitted diseases, not elsewhere classified

306

2296

1.34

5.70

1.3

516.29

450.74

mg/l

0.76

296

2190

Abnormal serum enzyme levels

358

2674

1.31

5.70

1.3

533.99

587.40

mg/l

1.12

336

2540

Solid cancers, helper endpoint

1193

6067

1.16

5.67

1.4

1.3

645.99

531.39

mg/l

1.38

1135

5774

Myopia

183

1263

1.46

5.63

1.3

1.5

448.58

496.35

mg/l

1.01

172

1207

Disorder of the sleep-wake schedule

146

2.47

5.63

1.5

1.9

406.54

463.78

mg/l

0.48

139

Disorder of lipoprotein metabolism, unspecified

149

989

1.52

5.55

1.2

1.3

602.72

540.33

mg/l

0.65

144

937

Other disorders of skin and subcutaneous tissue, not elsewhere classified

178

1225

1.47

5.55

1.2

1.3

538.89

529.35

mg/l

0.08

170

1158

Dermatophytosis

830

6991

1.19

5.54

1.2

1.3

503.30

530.95

mg/l

0.69

784

6676

Inflammatory bowel disease

433

3417

1.27

5.53

1.3

1.4

505.37

507.51

mg/l

0.03

414

3250

Open wound of ankle and foot

146

967

1.53

5.53

1.3

1.5

549.36

509.41

mg/l

0.43

139

916

Cholecystitis

166

1129

1.48

5.50

1.3

546.71

558.42

mg/l

0.06

154

1062

Dermatophytosis

166

1131

1.48

5.47

1.4

515.09

536.80

mg/l

0.19

160

1066

Localized swelling, mass and lump of skin and subcutaneous tissue

389

3035

1.29

5.45

1.6

1.4

482.20

531.88

mg/l

1.36

373

2890

Other and unspecified mononeuropathies of upper limb

226

2.12

5.40

1.7

1.3

544.13

505.67

mg/l

0.20

211

Redundant prepuce, phimosis and paraphimosis

254

1850

1.37

5.39

1.2

1.5

685.26

560.10

mg/l

0.58

237

1769

Other diseases of intestine

173

1192

1.46

5.38

1.3

699.85

540.81

mg/l

0.50

165

1130

Chronic periodontitis, including avohilmo

1342

7857

1.15

5.37

1.3

549.31

542.09

mg/l

0.08

1282

7483

Event of undetermined intent

604

1.66

5.36

1.4

1.5

532.43

504.88

mg/l

0.13

563

Gastroduodenal ulcer

281

2096

1.34

5.35

1.3

541.39

580.06

mg/l

0.55

258

2001

Other/unspecified enthesopathies, not elsewhere classified

102

628

1.64

5.30

1.3

501.68

539.45

mg/l

0.34

591

Diseases of peritoneum

130

848

1.55

5.30

1.4

1.3

476.53

529.94

mg/l

0.91

120

802

Other inflammation of eyelid

172

1188

1.46

5.30

1.6

1.3

456.35

514.48

mg/l

1.75

164

1126

Periodontitis

1344

7866

1.15

5.25

1.3

549.09

541.89

mg/l

0.08

1284

7492

Presbyopia

563

1.68

5.20

1.3

1.2

499.01

530.66

mg/l

0.36

534

Achilles tendinitis

125

812

1.55

5.19

1.2

1.3

533.39

511.88

mg/l

0.19

116

772

Biguanides

1326

7068

1.15

5.17

1.3

599.24

530.68

mg/l

1.61

1248

6751

Other embolism and thrombosis

161

1104

1.47

5.16

1.4

1.3

561.90

526.69

mg/l

0.24

155

1046

Later onset COPD

153

1775

0.68

5.15

1.2

1.3

525.88

583.20

mg/l

0.90

143

1675

Pruritus

140

934

1.51

5.14

1.4

624.43

513.88

mg/l

1.07

133

886

Burkitt lymphoma

14.93

5.12

3.9

1.3

306.13

571.29

mg/l

—

Burkitt lymphoma, including Hilmo

14.93

5.12

3.9

1.3

306.13

571.29

mg/l

—

Otitis externa

295

2240

1.33

5.11

1.2

1.4

588.24

508.24

mg/l

0.39

275

2133

Other disorders of penis

120

776

1.56

5.09

1.2

1.8

479.49

531.49

mg/l

0.75

111

738

Other diseases of oesophagus

115

737

1.58

5.07

1.3

482.58

558.39

mg/l

0.95

106

691

Dementia due to Parkinson's disease

147

2.37

5.06

1.2

589.24

520.24

mg/l

0.30

136

Necrosis of pulp, including avohilmo

814

6893

1.18

5.05

1.3

499.01

527.83

mg/l

0.48

766

6588

Scleritis

111

2.61

5.05

1.1

1.2

360.82

430.62

mg/l

1.05

105

Hereditary hypogammaglobulinemia

6.48

5.04

1.7

1.2

389.17

520.30

mg/l

0.66

Haemophagocytic lymphohistiocytosis

10.70

5.02

1.4

1.6

394.11

563.10

mg/l

—

Noninflammatory disorders of female genital tract

593

2433

1.23

5.02

1.3

447.33

489.09

mg/l

0.72

556

2335

Nail disorders

116

749

1.57

4.98

1.3

1.5

769.83

517.70

mg/l

0.53

109

708

Atopic dermatitis, strict definition

434

3400

1.26

4.98

1.4

1.5

437.21

461.60

mg/l

0.41

418

3250

Intracranial nontraumatic haemorrhage of fetus and newborn

6.82

4.98

4.4

8.4

651.33

341.64

mg/l

0.64

Injury of eye and orbit

190

1353

1.42

4.97

1.3

1.4

502.69

518.02

mg/l

0.25

182

1294

Cholelithiasis, broad definition with cholecystitis

1178

6907

1.15

4.95

1.3

568.64

537.45

mg/l

0.36

1118

6583

Moderate visual impairment, binocular

187

2.18

4.95

1.6

1.3

459.43

490.37

mg/l

0.28

178

Other (not insulin) diabetes medications

1352

7047

1.14

4.93

1.3

598.03

529.26

mg/l

1.61

1278

6729

Glaucoma

657

4719

1.20

4.87

1.3

554.03

554.26

mg/l

0.00

627

4467

Papulosquamous disorders

495

4030

1.23

4.86

1.3

491.68

537.32

mg/l

1.47

466

3836

Other keratitis

156

1078

1.46

4.84

1.4

567.11

501.53

mg/l

0.52

151

1021

Disorders of multiple cranial nerves

17.30

4.81

1.3

1.2

469.86

592.20

mg/l

—

Other coagulation defects

103

653

1.60

4.81

1.4

466.52

485.12

mg/l

0.19

623

Diabetic nephropathy, excluding more controls

162

924

1.45

4.80

1.4

1.3

723.67

553.21

mg/l

0.70

154

874

Other maltreatment syndromes

279

1.94

4.79

1.2

1.4

478.04

485.49

mg/l

0.05

266

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

113

733

1.56

4.77

1.2

1.5

462.83

474.82

mg/l

0.13

105

703

Effects of foreign body entering through natural orifice

326

2538

1.29

4.73

1.4

1.5

553.62

516.53

mg/l

0.42

310

2416

Cushing syndrome

2.68

4.73

1.2

1.3

429.12

471.69

mg/l

0.34

Late syphilis

121

2.47

4.71

1.6

1.2

599.96

475.83

mg/l

0.86

113

Diabetic maculopathy, excluding more controls

139

945

1.48

4.70

1.2

1.3

608.33

503.88

mg/l

1.18

128

899

Other ill-defined and unspecified causes of mortality

532

1.65

4.70

1.3

1.2

520.85

566.63

mg/l

0.38

496

Sulfasalazine

360

2840

1.27

4.69

1.2

1.3

667.24

515.50

mg/l

0.68

341

2709

Presence of other devices

266

2011

1.32

4.65

1.4

1.3

576.47

548.42

mg/l

0.27

250

1903

Burns and corrosions

192

1388

1.40

4.64

1.2

1.6

732.87

510.38

mg/l

0.36

182

1322

Disorders of parathyroid gland

226

1655

1.36

4.64

1.3

564.37

550.16

mg/l

0.09

212

1561

Bulimia nervosa (incl. atypical)

304

1.87

4.61

1.2

1.4

399.51

423.66

mg/l

0.20

284

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1327

7051

1.14

4.61

1.3

1.4

608.30

536.39

mg/l

1.59

1262

6729

Other diseases of lip and oral mucosa

514

4227

1.22

4.60

1.4

474.40

520.02

mg/l

1.46

481

4023

Eosinophilia

111

2.50

4.53

1.2

1.8

484.59

429.52

mg/l

0.44

103

Moyamoya

10.49

4.48

1.3

1.4

494.00

359.22

mg/l

—

Pregnancy examination and test

239

1107

1.35

4.45

1.3

1.2

418.00

403.72

mg/l

0.23

233

1049

Hypertrophic disorders of skin

495

1.66

4.43

1.4

408.49

476.73

mg/l

1.25

470

Other predominantly sexually transmitted diseases, not elsewhere classified

245

1855

1.33

4.41

1.3

536.79

465.38

mg/l

0.65

237

1766

Chronic kidney disease

324

2495

1.28

4.39

1.3

1.4

568.76

556.83

mg/l

0.14

311

2357

Glaucoma suspect

411

3321

1.24

4.38

1.3

515.36

540.65

mg/l

0.54

393

3140

Coxarthrosis

601

3312

1.20

4.37

1.3

665.28

552.12

mg/l

1.25

558

3153

Other abnormalities of plasma proteins

107

2.50

4.36

1.5

1.2

639.12

465.42

mg/l

0.42

Excessive attrition of teeth

781

6699

1.17

4.36

1.3

1.4

485.21

518.16

mg/l

0.53

741

6395

Cardiac murmurs and other cardiac sounds

128

860

1.48

4.36

1.7

420.03

504.73

mg/l

1.73

122

815

Recurrent aphthous stomatitis , including avohilmo

187

1362

1.38

4.35

2.9

1.4

485.39

506.89

mg/l

0.16

180

1290

Other Crohn's disease

101

654

1.56

4.35

1.3

1.4

483.36

497.87

mg/l

0.12

618

Other and unspecified injuries of lower leg

107

702

1.54

4.34

1.2

1.4

755.76

507.95

mg/l

0.57

101

666

Disorders of breast

643

4925

1.19

4.33

1.3

450.93

506.35

mg/l

2.01

612

4697

Traumatic cerebral oedema

12.25

4.33

1.6

1.3

480.71

390.00

mg/l

—

Specific developmental disorder of motor function

168

2.16

4.30

2.3

4.6

270.69

343.28

mg/l

1.09

162

Other and unspecified disorders of vitreous body

491

3992

1.22

4.30

1.3

600.77

556.99

mg/l

0.24

472

3786

Vitreous haemorrhage

125

849

1.49

4.29

1.3

543.31

538.29

mg/l

0.05

117

795

Status post-ami

171

1794

0.72

4.22

1.2

1.3

643.43

568.55

mg/l

0.30

164

1693

Rheumatoid arthritis, including avohilmo

455

3734

1.22

4.20

1.3

672.24

525.15

mg/l

0.80

431

3535

Diabetic retinopathy, strict definition

194

1260

1.37

4.19

1.2

1.3

570.15

593.96

mg/l

0.19

183

1194

Fracture of femur

269

1881

1.30

4.18

1.3

582.00

561.03

mg/l

0.15

250

1771

Mixed conductive and sensorineural hearing loss

140

977

1.44

4.18

1.3

490.09

529.73

mg/l

0.59

131

924

Excessive earwax

681

5657

1.18

4.18

1.4

543.88

542.08

mg/l

0.02

646

5386

Congenital malformations and deformations of the musculoskeletal system

165

1180

1.40

4.17

1.4

1.9

403.60

461.67

mg/l

1.19

160

1126

Burkitt lymphoma, helper endpoint

9.42

4.16

3.9

2.5

306.13

496.36

mg/l

—

Open wound of lower leg

186

1365

1.37

4.14

1.3

1.5

511.27

507.37

mg/l

0.03

180

1287

Type 1 diabetes, wide definition, subgroup 1

284

2212

1.29

4.13

1.3

1.4

570.33

485.55

mg/l

1.88

270

2116

Convalescence

405

1.70

4.12

1.4

1.3

869.52

499.40

mg/l

0.44

388

Cholelithiasis

1119

6794

1.14

4.11

1.3

576.60

536.49

mg/l

0.47

1063

6472

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

109

716

1.52

4.10

1.9

2.2

361.38

448.05

mg/l

2.36

103

681

Heart failure and coronary heart disease

319

2848

0.79

4.09

1.3

657.62

579.44

mg/l

0.43

301

2696

Melanocytic naevi

383

3097

1.24

4.09

1.4

1.3

518.44

496.33

mg/l

0.31

358

2948

Haemorrhoids and perianal venous thrombosis

373

3001

1.25

4.07

1.3

497.10

553.79

mg/l

1.29

357

2848

Artrosis, including avohilmo

1187

5736

1.14

4.06

1.3

518.28

539.35

mg/l

0.51

1125

5472

Adenomyosis (Endometriosis of uterus)

169

1226

1.39

4.06

1.4

1.3

436.32

515.29

mg/l

1.80

158

1181

Anorexia (incl.atypical)

546

1.59

4.05

1.2

1.4

427.15

473.59

mg/l

0.51

517

Hypoplasia of dental enamel

105

2.49

4.05

11.5

4.1

243.56

346.23

mg/l

1.60

105

Alcoholic liver disease

123

844

1.47

4.04

1.3

543.07

560.46

mg/l

0.09

115

797

Other diseases of stomach and duodenum

508

1.61

4.02

1.5

1.3

478.07

560.64

mg/l

0.89

476

Ulcer of lower limb, not elsewhere classified

156

1118

1.41

4.02

1.3

773.60

557.70

mg/l

0.65

146

1052

Molar incisor enamel hypoplasia, with caries

2.63

4.01

13.3

2.6

633.77

346.33

mg/l

0.33

Perforation of tympanic membrane

132

921

1.45

3.98

1.4

527.98

510.02

mg/l

0.11

123

869

Intestinal malabsorption

402

1.69

3.98

1.2

1.4

402.48

516.80

mg/l

3.04

378

Postmenopausal osteoporosis with pathological fracture

425

1.67

3.96

1.4

1.2

544.47

533.76

mg/l

0.05

405

Abnormal results of function studies

112

758

1.49

3.95

1.3

1.5

437.19

531.13

mg/l

3.03

103

723

Coxarthrosis [arthrosis of hip](FG)

644

3851

1.18

3.90

1.3

660.92

558.04

mg/l

1.19

599

3657

Retinal vascular occlusion

127

883

1.45

3.89

1.4

1.2

546.82

554.96

mg/l

0.08

116

826

Burns and corrosions of external body surface, specified by site

149

1067

1.41

3.89

1.2

1.6

446.81

504.49

mg/l

1.25

139

1008

Salpingitis and oophoritis

216

1639

1.33

3.89

1.5

1.3

484.92

512.52

mg/l

0.34

204

1568

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

171

1253

1.37

3.88

1.3

526.86

545.99

mg/l

0.15

162

1184

Congenital malformations of the circulatory system

201

1464

1.34

3.88

1.7

1.9

434.94

493.32

mg/l

1.80

191

1396

Nonalcoholic fatty liver disease

129

902

1.44

3.86

1.5

1.3

669.80

522.51

mg/l

0.74

123

855

Coronary artery bypass grafting

170

1718

0.73

3.85

1.2

1.3

595.04

578.31

mg/l

0.20

162

1624

Thyrotoxicosis, other and/or unspecified

246

1902

1.30

3.85

1.5

1.3

623.01

505.11

mg/l

0.60

232

1809

Intentional self-harm by other and unspecified firearm discharge

13.13

3.85

2.3

1.2

386.83

416.40

mg/l

—

Recurrent dislocation and subluxation of joint

625

1.54

3.84

1.3

1.5

444.27

480.10

mg/l

0.56

599

Glomerular disorders in diseases classified elsewhere

140

994

1.42

3.84

1.3

552.43

545.81

mg/l

0.04

134

936

Retinal vascular disorders

128

895

1.44

3.81

1.4

1.2

546.30

553.89

mg/l

0.07

117

837

ILD, hospital admission 2, with pulmonary infections

100

666

1.51

3.81

1.3

1.2

805.42

567.61

mg/l

0.40

633

Benign neoplasm of other and ill-defined parts of digestive system

207

1566

1.33

3.81

1.3

472.54

528.54

mg/l

1.90

198

1481

Drug-induced hypoglycaemia without coma

108

2.37

3.80

1.1

1.4

450.36

461.83

mg/l

0.06

103

308

1.76

3.78

1.3

1.2

428.75

550.41

mg/l

1.74

292

Other contact dermatitis

105

709

1.50

3.76

1.2

1.4

451.01

509.93

mg/l

1.16

100

680

Preterm labour and delivery

334

2689

1.25

3.75

1.3

463.34

505.89

mg/l

0.62

321

2569

Iron deficiency

238

1.88

3.74

1.3

1.8

382.76

442.79

mg/l

0.65

224

Type 2 diabetes, definitions combined

1302

6829

1.12

3.74

1.3

598.76

529.35

mg/l

1.58

1237

6519

Other diseases of arteries and capillaries

108

735

1.48

3.73

1.3

565.62

549.42

mg/l

0.11

688

Encephalocele

9.08

3.72

2.1

1.6

1111.43

325.00

mg/l

—

Allergic rhinitis

436

3575

1.21

3.68

1.3

1.5

416.26

477.21

mg/l

2.48

419

3411

Exposure to other and unspecified inanimate mechanical forces

105

714

1.49

3.66

1.4

1.5

469.60

501.48

mg/l

0.36

675

Lesion of femoral nerve

3.05

3.63

1.1

1.2

491.73

462.80

mg/l

0.20

Bacterial, viral and other infectious agents

124

872

1.44

3.62

1.3

1.5

460.99

518.62

mg/l

1.07

114

829

Seborrhoeic dermatitis

116

806

1.45

3.61

1.5

1.4

557.33

532.17

mg/l

0.24

108

762

Ill-defined and unknown causes of mortality

602

1.52

3.61

1.3

512.21

556.41

mg/l

0.39

563

Diabetic retinopathy

377

1913

1.23

3.60

1.3

588.17

597.85

mg/l

0.11

354

1816

Palmar fascial fibromatosis [Dupuytren]

153

1116

1.38

3.59

1.2

1.3

585.39

574.50

mg/l

0.07

145

1050

Other noninflammatory disorders of vagina

100

676

1.49

3.59

1.7

1.3

570.73

500.27

mg/l

0.31

657

Infectious mononucleosis

124

874

1.43

3.58

1.4

1.5

432.86

446.17

mg/l

0.11

116

828

Acute peritonitis

508

1.57

3.58

1.4

1.3

469.53

534.12

mg/l

1.20

482

Degenerative macular diseases

128

908

1.42

3.56

1.3

1.2

536.63

568.80

mg/l

0.37

123

857

Other congenital malformations of brain

3.05

3.55

1.4

4.3

397.73

430.62

mg/l

0.12

L02BA Anti-estrogens

103

1489

0.69

3.55

1.3

546.56

529.88

mg/l

0.12

1423

Motor disorders

185

1.99

3.55

2.3

4.8

270.69

403.78

mg/l

1.57

180

Sequelae of injuries of upper limb

127

901

1.42

3.54

1.3

1.4

493.88

538.96

mg/l

0.55

121

857

Wide developmental disorders, excluding more controls

239

1.84

3.51

1.5

2.8

364.36

421.23

mg/l

0.54

226

Crohn's disease NAS

607

1.52

3.50

1.4

1.5

508.44

493.25

mg/l

0.11

575

Other specified and unspecified retinal disorders

273

1.79

3.49

2.4

1.3

441.40

508.22

mg/l

0.91

256

Diabetes, insulin treatment (Kela reimbursement)

1381

7512

1.11

3.48

1.3

1.4

611.12

537.87

mg/l

1.73

1311

7156

Torticollis

113

2.26

3.45

1.3

1.4

555.36

471.40

mg/l

0.25

108

Benign neoplasm of eye and adnexa

120

847

1.43

3.45

1.5

1.3

678.86

544.69

mg/l

0.26

115

793

Otitis externa, unspecified

150

1100

1.37

3.45

1.2

1.5

652.87

512.35

mg/l

0.37

143

1044

Type 2 diabetes, strict (exclude DM1)

1303

6871

1.12

3.44

1.3

599.28

529.72

mg/l

1.59

1238

6559

Arthropod-borne viral fevers and viral haemorrhagic fevers

118

831

1.43

3.44

1.5

1.3

535.52

544.78

mg/l

0.07

113

786

Thiazolidinediones

127

907

1.41

3.42

1.2

614.93

532.92

mg/l

0.98

120

855

Type 1 diabetes, wide definition

289

2315

1.25

3.41

1.3

1.5

566.27

483.73

mg/l

1.85

275

2212

Unspecified nephritic syndrome

168

2.00

3.38

1.2

460.12

463.45

mg/l

0.02

155

Fracture of forearm

706

5621

1.15

3.37

1.3

1.4

522.26

516.97

mg/l

0.06

664

5355

Bitten or struck by other mammals

152

1122

1.37

3.36

1.2

1.4

460.68

491.49

mg/l

0.20

146

1068

Other disorders of the genitourinary system

144

1054

1.38

3.35

1.3

603.64

545.47

mg/l

0.35

132

996

Stomatitis and related lesions

253

2003

1.27

3.35

2.5

1.4

488.98

504.91

mg/l

0.15

243

1900

Allergic urticaria

111

778

1.44

3.34

1.8

1.6

484.27

504.46

mg/l

0.14

733

Senility

4.40

3.31

1.2

542.60

504.96

mg/l

—

Autoimmune hyperthyroidism

462

1.57

3.31

1.6

1.3

487.62

501.10

mg/l

0.11

439

L04AC Interleukin inhibitors

551

1.52

3.29

1.2

1.4

894.28

507.57

mg/l

0.39

519

5-aminosalicylic acid

265

2114

1.26

3.29

1.3

518.55

505.29

mg/l

0.15

253

2018

Major coronary heart disease event

1097

5912

1.12

3.26

1.3

1.4

565.85

561.40

mg/l

0.05

1046

5639

Diseases of arteries, arterioles and capillaries

783

5067

1.14

3.25

1.3

606.11

556.64

mg/l

0.47

744

4810

Open wound of forearm

119

849

1.41

3.24

1.2

1.4

534.71

525.45

mg/l

0.05

112

803

Bacterial, viral and other infectious agents

115

816

1.42

3.24

1.4

1.5

469.45

522.07

mg/l

0.85

105

775

Benign neoplasm: Adrenal gland

667

1.47

3.24

1.3

546.00

545.65

mg/l

0.00

631

Retinal detachment with retinal break

145

1069

1.37

3.24

1.2

1.3

544.86

544.91

mg/l

0.00

140

1010

Rosacea

146

1078

1.37

3.24

1.4

1.3

450.19

509.02

mg/l

1.49

139

1022

Percutaneous Coronary Intervention

1023

5580

1.13

3.24

1.3

1.4

565.87

563.83

mg/l

0.02

974

5318

Unspecified kidney failure

104

725

1.44

3.22

1.5

1.3

777.83

546.89

mg/l

0.43

681

Other and unspecified epidermal thickening

214

1.85

3.22

1.7

1.5

492.54

489.90

mg/l

0.02

201

Other sexually transmitted chlamydial diseases

144

1063

1.37

3.20

1.3

380.45

428.12

mg/l

1.35

137

1006

Sub-endpoint used in defining T1D endpoints

359

2918

1.21

3.20

1.4

1.5

575.65

510.55

mg/l

1.23

341

2776

Hypertrophy of breast in women and men

251

1998

1.26

3.19

1.5

1.3

463.93

493.42

mg/l

0.49

237

1898

Viral conjunctivitis

179

1.94

3.19

1.3

1.6

403.76

462.29

mg/l

0.90

168

Type 2 diabetes, definitions combined, including avohilmo

1304

6854

1.11

3.17

1.3

593.15

528.11

mg/l

1.44

1241

6545

Acne

144

1063

1.36

3.17

1.5

435.13

431.44

mg/l

0.04

137

1004

Coronary revascularization (ANGIO or CABG)

1023

5582

1.12

3.16

1.3

1.4

567.67

563.91

mg/l

0.04

975

5320

Injury of other and unspecified intrathoracic organs

516

1.53

3.15

1.4

577.23

550.03

mg/l

0.13

485

Pregnancy with abortive outcome

872

4011

1.14

3.15

1.3

502.06

476.06

mg/l

0.30

827

3817

Other histiocytosis syndromes

8.38

3.15

1.2

1.3

732.67

302.75

mg/l

—

Ovarian dysfunction

109

771

1.43

3.14

1.2

1.3

392.86

445.36

mg/l

0.91

103

729

Osteonecrosis due to drugs

105

2.25

3.14

3.5

1.2

842.17

503.67

mg/l

0.41

Kidney transplant status

493

1.54

3.14

1.4

1.7

546.48

515.70

mg/l

0.28

465

Hallux rigidus

152

1135

1.35

3.13

1.3

637.92

508.64

mg/l

1.00

143

1075

Overexertion and strenuous or repetitive movements

130

949

1.38

3.12

1.4

1.3

512.62

519.73

mg/l

0.06

125

900

Melanocytic naevi of trunk

152

1137

1.35

3.11

1.2

1.3

522.69

511.05

mg/l

0.09

140

1074

IBD patients in KELA-register

303

2471

1.23

3.11

1.3

1.4

503.08

506.53

mg/l

0.04

293

2351

Arthropod-borne viral fevers and viral haemorrhagic fevers

222

1748

1.28

3.10

1.8

1.5

511.76

514.79

mg/l

0.03

216

1656

Coeliac disease

158

1190

1.34

3.09

1.4

1.5

499.83

509.67

mg/l

0.07

151

1123

Endometriosis ASRM stages 1,2

235

1865

1.27

3.09

1.3

421.35

466.90

mg/l

1.08

218

1777

Abscess of anal and rectal regions

110

782

1.42

3.08

1.3

1.4

593.83

532.92

mg/l

0.44

102

740

Ischaemic heart disease, wide definition

965

5321

1.13

3.07

1.3

567.01

568.70

mg/l

0.02

916

5070

Perineal laceration during delivery

151

1673

0.75

3.05

1.2

1.3

467.65

395.95

mg/l

1.02

143

1591

Glucosamine medication

513

3502

1.17

3.03

1.3

594.31

566.72

mg/l

0.23

489

3311

Viral haemorrhagic fevers, not elsewhere classified/unspecified

198

1542

1.29

3.02

1.8

1.5

522.41

519.49

mg/l

0.03

193

1455

Any prescribed medicine buy

5.80

3.01

1.4

1.1

303.00

486.63

mg/l

—

Rhabdomyosarcoma

7.84

3.00

1.2

1.0

211.67

528.00

mg/l

—

Psoriatic and enteropathic arthropathies

140

1042

1.35

2.98

1.2

1.4

480.55

506.12

mg/l

0.36

132

981

Diabetic maculopathy

138

965

1.36

2.96

1.2

1.3

608.33

587.06

mg/l

0.13

128

916

Calcific tendinitis

2.90

2.95

1.2

479.31

422.23

mg/l

0.27

Galactorrhea

2.31

2.92

1.4

1.3

306.20

369.42

mg/l

1.36

Periapical abscess

579

5028

1.16

2.91

1.3

1.4

526.75

534.70

mg/l

0.07

555

4793

Female genital prolapse

363

1703

1.21

2.90

1.2

1.3

458.51

538.24

mg/l

1.74

340

1640

Thyrotoxicosis

299

2455

1.22

2.90

1.4

1.3

612.25

510.60

mg/l

0.64

283

2341

Acute pancreatitis

224

1783

1.26

2.89

1.9

1.3

549.20

546.05

mg/l

0.02

213

1695

Infections of genitourinary tract in pregnancy

127

937

1.37

2.88

1.3

407.20

462.10

mg/l

1.57

122

888

Blepharochalasis

310

2558

1.22

2.86

1.3

526.27

546.39

mg/l

0.21

298

2414

Hyperparathyroidism

184

1415

1.29

2.86

1.3

548.39

549.03

mg/l

0.00

173

1335

Benign neoplasm: Stomach

108

778

1.40

2.84

1.3

1.2

453.26

546.25

mg/l

3.07

103

726

Hordeolum and other deep inflammation of eyelid

505

1.50

2.83

2.1

1.4

504.49

505.96

mg/l

0.01

484

Toxic effect of organic solvents

4.10

2.82

1.3

485.56

634.35

mg/l

—

Diabetic nephropathy

164

1243

1.31

2.82

1.4

1.3

721.74

606.95

mg/l

0.41

156

1175

Myocardial infarction, strict

399

3356

0.84

2.81

1.2

1.3

604.02

582.97

mg/l

0.16

376

3185

Other disorders of breast

158

1209

1.32

2.80

1.3

410.44

486.87

mg/l

2.49

151

1150

Benign neoplasm: Rectum, anus and anal canal

215

1712

1.26

2.78

1.3

509.36

550.94

mg/l

0.77

199

1615

2.36

2.78

1.4

1.2

500.11

490.26

mg/l

0.04

DVT of lower extremities

204

1615

1.27

2.77

1.3

529.95

536.04

mg/l

0.06

196

1530

COPD (mode)

306

1982

1.22

2.77

1.2

1.3

531.02

563.50

mg/l

0.48

285

1892

Other and unspecified psoriasis

565

1.47

2.77

1.3

482.09

526.75

mg/l

0.57

530

Other disorders of conjunctiva

156

1194

1.31

2.76

1.2

1.3

705.66

533.42

mg/l

0.49

149

1123

Thyroiditis

623

1.44

2.76

1.5

1.3

717.54

508.44

mg/l

0.37

594

Bronchitis, not specified as acute or chronic

101

723

1.41

2.76

1.2

1.3

453.35

516.47

mg/l

1.10

683

Seronegative rheumatoid arthritis

129

961

1.35

2.75

1.2

1.3

641.98

502.30

mg/l

1.17

121

907

Mental and behavioural disorders due to tobacco

110

800

1.39

2.75

1.3

549.64

527.98

mg/l

0.12

104

762

Inflammatory bowel disease, strict (require KELA)

303

2508

1.21

2.74

1.3

1.4

503.08

503.99

mg/l

0.01

293

2385

Medicines for HER+ breast cancer

295

3374

0.83

2.73

1.3

563.44

533.54

mg/l

0.25

280

3216

Foreign body entering into or through eye or natural orifice

105

759

1.40

2.72

1.5

1.6

504.38

520.38

mg/l

0.16

100

713

Smoking dependency

110

802

1.38

2.71

1.3

549.64

524.32

mg/l

0.14

104

761

Malignant neoplasm of breast, including Hilmo

387

2959

0.84

2.70

1.2

1.3

539.45

515.10

mg/l

0.32

366

2809

Complications predominantly related to the puerperium

339

2840

1.20

2.70

1.3

438.93

462.91

mg/l

0.40

325

2711

Malignant neoplasm of breast, HER2-negative, including Hilmo

387

2959

0.84

2.70

1.2

1.3

539.45

515.10

mg/l

0.32

366

2809

Drug-induced osteoporosis with pathological fracture

126

2.03

2.69

2.3

1.3

1529.96

518.03

mg/l

0.49

119

Acne vulgaris

115

846

1.37

2.68

1.5

447.72

435.76

mg/l

0.10

109

799

Hallux valgus (acquired)

386

2344

1.19

2.68

1.3

668.22

527.53

mg/l

0.82

367

2229

Malignant neoplasm of breast, HER2-negative

370

2867

0.84

2.68

1.3

556.55

516.00

mg/l

0.59

353

2722

Other inherited muscular atrophy

5.09

2.67

7.9

1.3

325.71

385.00

mg/l

—

Other (seronegative) rheumatoid arthritis, wide

209

1668

1.26

2.67

1.2

1.3

606.16

527.52

mg/l

0.88

195

1584

Prolonged pregnancy

131

1515

0.75

2.67

1.2

1.3

353.96

417.98

mg/l

3.17

123

1449

Schizoid personality disorder

127

2.01

2.63

1.0

1.2

650.24

479.08

mg/l

0.54

119

Malignant melanoma, including Hilmo

186

1467

1.27

2.63

1.3

1.2

554.64

533.07

mg/l

0.25

174

1384

Insulin, fast-acting (human)

177

1389

1.28

2.61

1.2

1.3

542.51

494.09

mg/l

0.56

167

1324

Malignant melanoma of skin, including Hilmo

155

1197

1.30

2.59

1.3

1.2

541.51

533.86

mg/l

0.07

145

1124

Injury of muscle and tendon at wrist and hand level

163

1268

1.29

2.59

1.3

513.81

521.95

mg/l

0.07

152

1210

Other inflammatory liver diseases

565

1.45

2.59

1.3

460.20

524.83

mg/l

1.35

535

Other bursopathies

136

1032

1.33

2.58

1.3

523.34

538.22

mg/l

0.14

129

979

Erosion of teeth , including avohilmo

326

2736

1.20

2.56

1.6

1.4

423.28

490.10

mg/l

3.77

313

2605

Personal history of other diseases and conditions

156

1203

1.30

2.56

1.7

1.5

481.19

456.55

mg/l

0.15

150

1155

Follicular cysts of skin and subcutaneous tissue

219

1767

1.25

2.56

1.4

1.3

579.59

522.00

mg/l

0.28

210

1680

Cutaneous lupus erythematosus

186

1.80

2.56

1.4

1.2

413.64

491.91

mg/l

0.93

174

Chronic pancreatitis

140

1069

1.32

2.56

1.2

1.3

529.88

549.15

mg/l

0.18

134

1009

Diaper [napkin] dermatitis

4.80

2.56

1.3

5.6

375.57

624.13

mg/l

—

Acute pancreatitis (for exclusion)

224

1813

1.24

2.54

1.9

1.3

549.20

534.88

mg/l

0.08

213

1718

Asthma mixed form (mode)

364

1.55

2.51

1.3

490.84

503.21

mg/l

0.07

342

Injuries to unspecified part of trunk, limb or body region

121

908

1.34

2.50

1.2

1.5

776.38

526.59

mg/l

0.56

116

859

Flat foot [pes planus] (acquired)

109

805

1.36

2.50

1.2

1.4

466.02

494.15

mg/l

0.40

102

765

Gout, idiopatic and unspecified

250

2052

1.22

2.49

1.3

660.49

566.68

mg/l

1.49

242

1945

Viral warts

267

2208

1.21

2.47

1.3

1.4

553.11

497.73

mg/l

0.33

254

2098

Cerebral atherosclerosis

2.42

2.47

1.3

1.2

475.20

523.42

mg/l

0.27

Malignant neoplasm of rectosigmoid junction, including Hilmo

223

0.40

2.44

1.2

1.3

643.44

511.24

mg/l

—

212

Malignant neoplasm of breast

380

2903

0.85

2.44

1.3

550.91

517.20

mg/l

0.47

362

2756

Other and unspecified vascular occlusions

681

1.39

2.43

1.4

1.2

507.13

558.04

mg/l

0.69

637

Benign neoplasm: Rectum

191

1528

1.26

2.43

1.3

515.25

544.91

mg/l

0.48

176

1442

Asthma mixed form (mode), excluding more controls

368

1.53

2.41

1.3

490.84

511.68

mg/l

0.12

346

Allergic contact dermatitis

164

1291

1.28

2.40

1.3

1.4

495.42

496.31

mg/l

0.01

158

1225

ILD, hospital admissions 3, with pneumonia sepsis

599

1.41

2.39

1.3

867.92

580.71

mg/l

0.40

562

Cachexia

4.23

2.38

1.3

415.14

628.94

mg/l

—

Spontaneous rupture of synovium and tendon

625

1.40

2.38

1.3

867.77

544.56

mg/l

0.51

589

Chronic myeloproliferative disease

2.09

2.35

1.2

603.30

533.65

mg/l

0.17

Abnormal findings in nipple discharge synovial fluid wound secretions

119

1.97

2.33

1.3

402.43

451.11

mg/l

0.37

113

Unspecified severe protein-energy malnutrition

4.95

2.32

3.7

1.1

310.00

520.00

mg/l

—

Adalimumab

126

964

1.32

2.31

1.3

1.5

523.34

494.67

mg/l

0.18

117

915

Other abnormal findings of blood chemistry

389

1.51

2.30

1.6

1.3

828.76

523.08

mg/l

0.31

365

Dysplasia of cervi uteri

309

1883

1.19

2.29

1.2

1.3

525.32

501.37

mg/l

0.14

294

1812

Hypertrophy of breast

213

1738

1.23

2.29

1.4

1.3

434.11

482.57

mg/l

0.88

200

1655

Female infertility

390

2029

1.17

2.28

1.3

461.59

500.19

mg/l

0.44

372

1945

Malignant melanoma

151

1185

1.28

2.28

1.3

565.85

538.29

mg/l

0.27

142

1113

Human immunodeficiency virus [HIV] disease

149

1.84

2.27

1.1

1.3

500.48

507.54

mg/l

0.04

142

Infective dermatitis

128

984

1.31

2.27

1.3

757.74

523.99

mg/l

0.66

122

927

Atrophic disorders of skin

167

1328

1.26

2.27

1.4

1.3

533.97

527.73

mg/l

0.04

158

1260

Urethral stricture

390

1.50

2.26

1.3

582.28

563.21

mg/l

0.10

366

Other and unspecified abdominal hernia

302

1.57

2.26

1.1

1.4

483.31

496.46

mg/l

0.08

282

Female infertility, associated with anovulation

103

768

1.35

2.26

1.3

489.93

422.66

mg/l

0.25

746

Other congenital malformations

168

1337

1.26

2.26

1.3

1.8

419.71

466.25

mg/l

1.26

162

1277

Benign neoplasm: Ascending colon

145

1135

1.28

2.24

1.3

747.06

549.78

mg/l

0.52

136

1069

Benign mammary dysplasia

153

1206

1.28

2.24

1.3

528.09

541.41

mg/l

0.10

147

1147

Bicipital tendinitis

368

1.51

2.21

1.3

492.67

549.14

mg/l

0.55

347

Combinations of oral blood glucose lowering drugs

314

2668

1.18

2.20

1.3

761.40

559.35

mg/l

1.21

304

2545

Hypertrichosis

188

1.73

2.20

1.2

1.3

408.78

421.68

mg/l

0.08

176

Other abnormal products of conception

420

2407

1.16

2.19

1.2

1.3

441.59

454.35

mg/l

0.17

404

2296

Chronic inflammatory disorders of orbit

3.88

2.19

1.4

1.3

407.43

393.79

mg/l

—

Ulcerative colitis

300

2541

1.19

2.18

1.2

1.4

503.47

514.02

mg/l

0.13

286

2416

Psoriasis

333

2845

1.17

2.18

1.2

1.3

472.91

520.77

mg/l

1.61

311

2712

Other disorders of kidney and ureter

141

1105

1.28

2.17

1.3

698.86

541.73

mg/l

1.11

133

1040

Emergency coronary revascularization (for ACS)

1074

5969

1.10

2.17

1.3

1.4

563.03

566.85

mg/l

0.04

1021

5690

Enteritis due to Yersinia enterocolitica

2.87

2.17

1.6

1.8

469.30

443.58

mg/l

—

Other abnormal uterine and vaginal bleeding

269

1611

1.20

2.17

1.4

1.3

500.96

521.06

mg/l

0.22

246

1546

Peritonsillar abscess

259

2168

1.20

2.16

1.3

509.68

499.07

mg/l

0.04

247

2079

Female infertility, cervical, vaginal, other or unspecified origin

356

1982

1.17

2.15

1.3

453.11

494.12

mg/l

0.46

339

1903

Primary hyperparathyroidism

117

897

1.31

2.14

1.2

1.3

454.82

537.17

mg/l

2.31

109

850

Biological medication for rheuma

221

1825

1.22

2.14

1.3

1.4

689.82

489.87

mg/l

0.58

204

1743

Other and unspecified acne

109

1.96

2.13

1.8

1.7

364.48

394.10

mg/l

0.28

104

Benign neoplasm: Colon, unspecified

257

2153

1.20

2.13

1.2

1.3

657.41

563.50

mg/l

0.41

246

2034

Contraceptive management

558

3465

1.13

2.12

1.3

467.56

512.32

mg/l

1.24

533

3310

Malignant neoplasm of bronchus and lung

114

1230

0.77

2.11

1.2

779.21

555.77

mg/l

0.45

107

1153

Dronedarone medication

250

0.43

2.11

1.1

1.3

739.55

567.66

mg/l

0.40

235

Other endophthalmitis

2.79

2.10

1.2

1.7

434.40

441.95

mg/l

—

Acute nasopharyngitis (common cold)

140

1094

1.28

2.10

1.6

1.3

474.11

537.14

mg/l

1.53

133

1054

Atrial fibrillation and flutter with reimbursement

261

1387

1.20

2.10

1.2

558.52

540.19

mg/l

0.19

240

1310

Disorder of visual pathways, unspecified

4.30

2.09

1.3

3.4

2317.83

314.73

mg/l

—

Need for immunization against certain single viral diseases

4.29

2.09

1.5

2.3

472.00

306.60

mg/l

—

Malignant neoplasm of skin

562

3415

1.13

2.08

1.3

593.39

553.83

mg/l

0.59

530

3234

Other pleural conditions

736

1.34

2.07

1.4

1.3

514.89

592.44

mg/l

0.74

687

Trigger finger

151

1201

1.26

2.07

1.3

524.13

521.11

mg/l

0.03

144

1143

Lichen planus

143

1132

1.27

2.05

1.4

1.3

532.21

534.93

mg/l

0.03

134

1064

Other puerperal infections

107

816

1.32

2.05

1.3

468.89

434.34

mg/l

0.19

102

773

Ulcerative colitis, NAS

170

1373

1.24

2.05

1.3

1.5

468.51

501.81

mg/l

0.49

160

1308

Other overlap syndromes

147

1.80

2.05

1.9

1.2

620.27

462.17

mg/l

0.70

139

Disorders of continuity of bone

114

877

1.31

2.05

1.5

1.3

443.21

515.68

mg/l

1.53

107

833

Drug-induced obesity

2.10

2.05

1.1

1.7

503.18

415.41

mg/l

0.37

Spontaneous abortion

578

3466

1.13

2.04

1.3

504.21

478.90

mg/l

0.21

555

3305

Gonarthrosis,primary

1090

6164

1.09

2.03

1.3

574.67

568.99

mg/l

0.06

1035

5877

Persons encountering health services in circumstances related to reproduction

786

4790

1.11

2.03

1.4

496.54

537.77

mg/l

0.78

747

4568

Pedal cyclist injured in transport accident

273

2311

1.19

2.03

1.3

1.4

583.74

500.66

mg/l

0.49

265

2193

Contact with heat and hot substances

492

1.42

2.03

1.3

1.6

466.47

504.17

mg/l

0.36

460

Other and unspecified rosacea

102

774

1.33

2.03

1.3

465.50

516.48

mg/l

1.11

733

Deep endometriosis

113

870

1.31

2.03

1.2

1.3

379.82

488.45

mg/l

3.78

108

829

Benign neoplasm of other and unspecified sites

263

1.58

2.02

1.2

600.95

498.01

mg/l

0.36

249

Perioral dermatitis

178

1.71

2.01

1.4

433.53

429.35

mg/l

0.02

165

Intestinal adhesions without obstruction

680

1.35

2.01

1.3

1.4

519.85

554.91

mg/l

0.32

639

Hirsutism in women

163

1.75

2.01

1.2

1.4

423.11

387.92

mg/l

0.22

153

Helminthiases

126

1.86

2.00

1.3

1.7

674.61

426.85

mg/l

1.40

119

Psoriatic arthropathies

112

863

1.31

2.00

1.2

1.4

481.79

506.96

mg/l

0.28

105

817

Drug-induced Cushing's syndrome

4.95

1.99

1.4

1.3

436.40

566.36

mg/l

—

COPD, hospital admissions 1, only main diagnosis

254

2575

0.84

1.99

1.2

1.3

502.51

572.91

mg/l

1.94

239

2433

Assault by other and unspecified firearm discharge

4.03

1.98

2.2

1.6

421.67

527.81

mg/l

—

Hypothyroidism, autoimmune, DX-based

2.84

1.97

1.2

1.9

381.78

333.52

mg/l

—

Non-small cell lung cancer, squamous, helper endpoint

296

0.50

1.95

1.5

1.2

587.67

588.88

mg/l

0.00

277

Lichen sclerosus et atrophicus

110

849

1.30

1.95

1.3

590.60

516.59

mg/l

0.39

104

809

Burn and corrosion of shoulder and upper limb, except wrist and hand

157

1.74

1.95

1.5

1.6

474.00

453.26

mg/l

0.09

150

Benign neoplasm: Other/unspecified site

113

1.89

1.94

1.4

1.2

690.29

486.84

mg/l

0.37

106

Other otitis externa (chronic)

565

1.37

1.93

1.2

1.5

470.14

512.61

mg/l

0.38

532

Other superficial mycoses

130

1027

1.27

1.92

1.3

1.4

474.34

488.47

mg/l

0.11

125

969

Benign neoplasm: Sigmoid colon

194

1602

1.22

1.91

1.4

1.3

535.40

546.66

mg/l

0.12

178

1513

Malignant melanoma of skin

116

904

1.29

1.91

1.4

1.2

554.43

492.68

mg/l

0.91

109

843

Exposure to other and unspecified man-made environmental factors

121

1.85

1.90

1.0

1.2

487.55

436.80

mg/l

0.32

114

Early onset COPD

239

2015

1.19

1.89

1.3

544.55

576.14

mg/l

0.36

221

1911

Unspecified threat to breathing

2.02

1.88

1.4

1.6

342.71

448.12

mg/l

0.98

Malignant neoplasm of other endocrine glands and related structures

4.45

1.86

1.8

1.2

681.00

321.67

mg/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

4.39

1.85

3.2

1.3

781.00

450.67

mg/l

—

Blood alcohol or alcohol intoxication level

198

1.64

1.85

1.3

1.4

718.31

485.86

mg/l

0.36

187

Seborrhoeic keratosis

227

1910

1.19

1.84

1.4

1.3

563.19

560.48

mg/l

0.02

217

1801

Nightmares

3.20

1.84

1.4

1.3

389.57

312.74

mg/l

—

Nasal polyp

206

1721

1.20

1.82

1.3

554.36

531.72

mg/l

0.22

194

1643

Colour vision deficiencies

3.13

1.82

1.1

1.3

383.29

487.13

mg/l

—

Benign lipomatous neoplasm

328

2847

1.16

1.81

1.3

541.93

533.10

mg/l

0.11

311

2712

Thyrotoxicosis with diffuse goitre

161

1314

1.23

1.81

1.5

1.3

469.41

485.52

mg/l

0.23

150

1247

Malignant neoplasm of other connective and soft tissue

192

1.64

1.80

1.1

1.2

686.26

504.00

mg/l

1.11

182

Seropositive rheumatoid arthritis

265

2256

1.17

1.80

1.3

776.25

518.88

mg/l

0.84

251

2139

Myocardial infarction, unclassifiable

130

1448

0.80

1.79

1.3

717.08

563.63

mg/l

0.35

125

1352

Pilonidal cyst

108

843

1.29

1.79

1.4

618.89

504.23

mg/l

0.81

103

803

Benign neoplasm: Other and unspecified parts of mouth

264

1.53

1.78

1.4

1.3

598.55

506.42

mg/l

0.52

252

Superficial injury of ankle and foot

153

1245

1.24

1.77

1.7

1.6

522.07

480.79

mg/l

0.29

147

1184

3.49

1.77

1.0

1.2

307.67

331.28

mg/l

—

Malignant neoplasm of breast, HER-positive

271

2461

0.86

1.77

1.3

535.48

531.02

mg/l

0.04

256

2331

Vitamin B12 deficiency anaemia

103

800

1.29

1.76

1.2

1.3

476.12

556.06

mg/l

1.81

751

Malignant neoplasm of bronchus and lung, including Hilmo

144

1485

0.81

1.76

1.3

724.55

561.58

mg/l

0.41

136

1394

Molar incisor enamel hypoplasia

366

1.44

1.75

6.6

2.6

469.63

397.70

mg/l

0.18

353

Pregnancy hypertension

532

4273

1.12

1.75

1.3

472.67

486.16

mg/l

0.18

514

4077

Toxic liver disease

110

1.85

1.75

1.6

1.3

529.05

443.43

mg/l

0.72

104

Umbilical hernia

312

2708

1.16

1.74

1.4

1.3

483.25

541.86

mg/l

1.89

305

2580

Entropion and trichiasis of eyelid

584

1.34

1.74

1.2

630.63

552.76

mg/l

0.47

544

Disorders of puberty

125

1.79

1.74

1.2

3.0

490.14

438.05

mg/l

0.16

117

Single delivery by forceps and vacuum extractor

142

1057

0.81

1.74

1.3

397.70

443.56

mg/l

0.58

135

1010

2.11

1.73

1.2

390.36

430.65

mg/l

0.33

Non-small cell lung cancer, squamous

283

0.53

1.73

1.5

1.2

587.67

610.78

mg/l

0.06

259

L02BG Aromatase inhibitors

240

2806

0.85

1.72

1.3

566.93

547.74

mg/l

0.12

229

2663

Foreign body in respiratory tract

441

1.39

1.71

2.2

1.6

419.11

507.02

mg/l

1.37

414

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

753

5445

1.10

1.70

1.3

482.42

503.45

mg/l

0.31

720

5193

Benign neoplasm: Caecum

110

867

1.28

1.70

1.3

1.2

733.12

560.10

mg/l

0.32

103

811

Impacted cerumen

104

815

1.28

1.68

1.5

742.71

540.67

mg/l

0.53

767

Hernia of abdominal wall

529

4759

1.11

1.68

1.3

498.93

557.96

mg/l

2.06

510

4540

Benign neoplasm of ovary

180

1499

1.21

1.67

1.3

478.33

528.39

mg/l

0.75

168

1432

Other or ill-defined heart diseases

451

1.38

1.67

1.9

1.3

490.45

544.23

mg/l

0.49

428

FESS (DNB20)

148

1210

1.23

1.66

1.3

565.91

512.97

mg/l

0.41

140

1149

Endometriosis diagnosis and infertility diagnosis occurring together

135

1095

1.24

1.64

1.4

1.2

444.66

449.31

mg/l

0.04

126

1046

Other obstructive and reflux uropathy

360

1.43

1.64

1.2

1.5

443.96

488.56

mg/l

0.37

341

Diabetes mellitus in pregnancy

427

2426

1.13

1.63

1.3

474.05

430.27

mg/l

0.64

413

2312

Benign neoplasm: Transverse colon

114

909

1.26

1.62

1.4

1.2

465.16

549.95

mg/l

2.45

106

853

Pedestrian injured in other and unspecified transport accidents

1.94

1.61

1.1

1.2

515.25

452.75

mg/l

0.30

Lichen simplex chronicus and prurigo

506

1.35

1.61

1.5

1.2

666.58

508.43

mg/l

0.67

481

Endometriosis ASRM stages 3,4

269

2327

1.16

1.60

1.3

455.66

491.01

mg/l

0.59

251

2221

Other/unspecified rheumatoid arthritis

123

991

1.25

1.59

1.3

519.47

534.61

mg/l

0.17

115

931

Hydronephrosis

117

939

1.25

1.57

1.4

1.3

483.38

532.40

mg/l

0.70

110

887

Tumor necrosis factor alpha inhibitors

194

1639

1.19

1.56

1.3

1.4

719.59

492.92

mg/l

0.57

179

1565

Other and unspecified injuries of abdomen, lower back and pelvis

107

1.80

1.56

1.5

1.4

446.37

416.41

mg/l

0.21

101

Valvular operations

1226

0.79

1.56

1.1

1.5

693.54

533.88

mg/l

1.22

1163

Mental and behavioural disorders due to cocaine

3.52

1.55

1.4

1.5

678.60

622.80

mg/l

—

Erythrasma

3.48

1.54

1.0

1.1

596.00

491.73

mg/l

—

Endometriosis of ovary

200

1655

1.18

1.54

1.3

477.61

517.99

mg/l

0.45

186

1596

Phakomatoses, not elsewhere classified

1.86

1.54

1.2

2.5

489.94

411.40

mg/l

0.60

Disorder of thyroid, unspecified

1.86

1.53

1.4

1.3

393.82

518.97

mg/l

1.31

Postmenopausal bleeding

296

1373

1.15

1.53

1.4

1.3

487.29

570.12

mg/l

1.32

279

1318

Labyrinthitis

2.95

1.52

1.7

1.2

322.50

394.48

mg/l

—

Toxic effect of carbon monoxide

123

1.73

1.52

1.5

1.2

472.19

465.90

mg/l

0.04

117

Malignant neoplasm of breast, ER-positive, including Hilmo

281

2483

0.87

1.51

1.2

1.3

530.76

529.64

mg/l

0.01

266

2352

Postpartum care and examination

188

1002

1.19

1.50

1.2

449.21

394.73

mg/l

0.43

179

948

Pediculosis, acariasis and other infestations

205

1748

1.18

1.50

1.3

1.5

541.35

479.17

mg/l

0.75

191

1666

Other disorders of veins

466

4173

1.11

1.49

1.2

1.3

561.30

512.89

mg/l

0.63

447

3971

Other and unspecified heterotropia

2.60

1.48

1.1

2.4

314.71

441.57

mg/l

—

Congenital deformities of hip

195

1.56

1.47

1.6

2.7

349.70

411.31

mg/l

0.47

186

Autism spe, excluding more controls

163

1.61

1.47

1.2

2.4

314.15

459.76

mg/l

2.37

152

Iron deficiency anaemia secondary to blood loss (chronic)

160

1338

1.20

1.46

1.5

1.3

512.80

534.95

mg/l

0.22

153

1263

Urticaria due to cold and heat

1.96

1.46

1.1

1.3

454.64

392.34

mg/l

0.56

Isolated growth hormone deficiency

1.87

1.45

2.1

5.6

359.31

313.68

mg/l

0.26

Ethmoidectomy

151

1258

1.21

1.45

1.3

562.65

510.48

mg/l

0.41

143

1196

Pollen allergy

253

2172

1.15

1.44

1.3

1.7

404.23

453.44

mg/l

1.03

242

2075

Barrett oesophagus

396

1.37

1.43

1.2

1.3

579.14

553.47

mg/l

0.13

369

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.88

1.41

1.4

1.2

415.40

486.89

mg/l

0.45

Malignant neoplasm of testis

111

1.73

1.40

1.1

1.2

566.79

536.66

mg/l

0.21

104

Asymptomatic human immunodeficiency virus [HIV] infection status

2.25

1.38

1.1

1.3

561.89

447.22

mg/l

—

Other disorders of amniotic fluid and membranes

172

1422

1.19

1.38

1.2

1.3

390.70

424.07

mg/l

0.92

167

1362

Burns and corrosions confined to eye and internal organs

223

1.50

1.37

1.2

1.4

2003.58

490.28

mg/l

0.46

212

Puerperal sepsis

143

1193

1.20

1.37

1.3

441.87

508.55

mg/l

1.27

137

1134

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

335

2980

1.13

1.37

1.4

1.3

544.47

540.14

mg/l

0.05

319

2852

Glucagon-like peptide-1 (GLP-1) analogues

335

2980

1.13

1.37

1.4

1.3

544.47

540.14

mg/l

0.05

319

2852

Anorexia

120

1.69

1.36

3.9

1.5

485.75

432.07

mg/l

0.23

113

Other disorders of thyroid

105

1.74

1.35

1.6

1.2

439.00

487.42

mg/l

0.30

Chronic periodontitis, complicated

637

5810

1.09

1.33

1.3

607.23

551.93

mg/l

0.38

603

5546

Suggestive for eosinophilic asthma

799

1.25

1.32

1.3

1.2

600.32

522.31

mg/l

0.48

757

Ankyloglossia

176

1.55

1.32

2.6

3.4

444.81

389.69

mg/l

0.21

170

120

989

1.22

1.32

1.2

1.3

412.23

429.12

mg/l

0.19

114

945

Diseases caused by chlamydiae

129

1.65

1.31

1.1

1.3

457.71

462.12

mg/l

0.01

121

Fall on and from ladder

622

1.28

1.30

1.2

1.3

519.58

556.30

mg/l

0.44

582

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

201

1680

1.16

1.30

1.4

1.8

444.32

491.39

mg/l

1.19

189

1600

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

2.88

1.30

2.0

1.3

368.20

397.67

mg/l

—

AV-block

178

1332

1.17

1.29

1.2

1.4

536.09

531.33

mg/l

0.05

172

1259

Gestational diabetes (for exclusion)

483

3053

1.10

1.29

1.3

465.41

426.65

mg/l

0.63

469

2913

Chronic hepatitis NAS

1.74

1.29

1.2

743.18

437.91

mg/l

0.37

Gout, strict definition

164

1395

1.18

1.28

1.3

686.32

553.26

mg/l

1.77

159

1312

Scabies

173

1481

1.17

1.26

1.3

1.5

558.25

463.41

mg/l

1.11

160

1409

Ectropion of eyelid

228

1.46

1.24

1.3

674.21

558.03

mg/l

0.47

214

Nontoxic multinodular goitre

194

1677

1.16

1.24

1.3

480.88

523.07

mg/l

0.75

186

1580

Hypoplasia of dental enamel, prenatal

2.17

1.24

6.2

4.7

1098.80

370.10

mg/l

—

Pedal cyclist injured in noncollision transport accidents

134

1125

1.20

1.23

1.3

1.5

573.60

524.89

mg/l

0.23

129

1064

Chondromalacia

229

1.46

1.23

1.3

602.00

505.10

mg/l

0.27

214

Congenital malformations of aortic and mitral valves

385

0.67

1.23

1.5

2.1

439.12

509.24

mg/l

0.97

365

Hypoplasia of dental enamel , including avohilmo

346

1.36

1.22

7.3

2.6

498.67

391.08

mg/l

0.25

336

Conotruncal defects

145

0.48

1.22

1.0

4.0

430.86

424.80

mg/l

—

138

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

575

4601

1.09

1.21

1.3

465.21

489.70

mg/l

0.40

557

4384

Benign neoplasm: Skin, unspecified

348

0.66

1.21

1.3

1.2

572.74

513.83

mg/l

0.11

327

Gestational [pregnancy-induced] hypertension

318

2841

1.12

1.20

1.3

438.49

446.27

mg/l

0.10

303

2713

Mucosal proctocolitis

148

1257

1.18

1.20

1.1

1.4

476.18

509.51

mg/l

0.44

142

1195

Female infertility, tubal origin

427

1.32

1.19

1.2

1.3

479.63

447.73

mg/l

0.23

417

Disorders of puberty, all

157

1.55

1.19

1.4

3.0

471.54

425.86

mg/l

0.16

148

Malignant neoplasm of bone and articular cartilage

1.80

1.18

1.5

1.3

367.93

476.01

mg/l

0.85

Human immunodeficiency virus [HIV] disease resulting in other conditions

141

1.58

1.18

1.1

1.3

536.50

499.25

mg/l

0.22

134

Malignant neoplasm of rectosigmoid junction

127

0.47

1.18

1.3

1.2

314.83

520.27

mg/l

—

120

Pre-eclampsia or eclampsia

257

2276

1.13

1.18

1.3

480.88

477.99

mg/l

0.02

249

2164

Lichen planus, including avohilmo

197

1714

1.15

1.17

1.4

1.3

512.08

533.38

mg/l

0.32

186

1622

Paget disease

0.00

1.17

0.0

1.2

—

556.48

—

Other papulosquamous disorders

1.75

1.16

1.3

1.4

386.87

473.52

mg/l

0.72

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

210

1782

1.15

1.16

1.4

1.8

453.65

500.43

mg/l

1.16

198

1692

Anoxic brain damage

1.83

1.16

1.5

1.2

430.38

468.07

mg/l

0.19

Lumbosacral root disorders, not elsewhere classified

1.77

1.14

1.9

1.2

354.57

467.65

mg/l

1.28

Lichen ruber planus, wide definition including periferal and oral lichen planus

231

2038

1.14

1.13

1.3

499.91

549.63

mg/l

1.00

218

1936

Disorder of pancreatic internal secretion, other and/or unspecified

2.00

1.12

1.3

625.10

435.96

mg/l

—

Alcohol abuse counselling and surveillance

127

1.59

1.12

1.2

447.60

505.14

mg/l

0.62

121

Viral warts

110

917

1.20

1.12

1.3

1.5

638.96

497.93

mg/l

0.37

104

871

Foreign body on external eye

169

1461

1.16

1.12

1.3

536.18

538.66

mg/l

0.03

159

1385

Pre-eclampsia

240

2126

1.13

1.11

1.3

486.02

464.93

mg/l

0.18

233

2026

Dyshidrosis [pompholyx]

120

1.60

1.09

3.7

1.3

411.63

425.96

mg/l

0.11

115

Idiopathic urticaria

185

1.47

1.09

1.3

1.5

442.04

458.77

mg/l

0.10

172

Haemangioma, any site

774

1.22

1.09

1.2

1.5

491.36

520.42

mg/l

0.25

735

Ventral hernia

243

2158

1.13

1.08

1.4

1.3

508.56

535.80

mg/l

0.39

234

2043

Eustachian salpingitis and obstruction

776

1.22

1.07

1.2

1.4

502.94

470.12

mg/l

0.28

745

Complications of cardiac and vascular prosthetic devices, implants and grafts

145

1.53

1.07

1.4

638.05

495.45

mg/l

0.75

137

Congenital deformities of hip

178

1.48

1.06

1.7

2.8

360.12

419.45

mg/l

0.39

170

Other respiratory diseases principally affecting the interstitium

164

1421

1.16

1.06

1.3

717.56

570.13

mg/l

0.40

150

1336

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.81

1.05

1.2

1.3

326.25

400.55

mg/l

1.13

Other benign neoplasms of skin

397

3627

1.10

1.05

1.2

1.3

526.05

532.43

mg/l

0.08

377

3434

Polycystic ovarian syndrome, broad definition

139

1191

1.17

1.05

1.2

1.3

468.20

420.44

mg/l

0.23

132

1137

Noninfective disorders of pinna

2.35

1.05

1.6

1.0

401.60

500.32

mg/l

—

COPD, hospital admissions

385

3564

0.91

1.04

1.3

523.71

583.28

mg/l

1.67

357

3384

Primary open-angle glaucoma, strict

237

2103

1.13

1.04

1.4

1.3

559.29

570.05

mg/l

0.11

228

1978

Other infections specific to the perinatal period

1.95

1.03

2.7

6.5

202.78

454.32

mg/l

—

Oesophagitis

421

1.29

1.02

1.3

527.98

561.87

mg/l

0.18

395

Other diseases caused by chlamydiae

139

1.53

1.01

1.1

1.3

457.71

471.29

mg/l

0.04

131

COPD, early/later onset

389

3582

0.91

1.01

1.3

536.31

584.03

mg/l

1.01

361

3401

Atherosclerosis, excluding cerebral and coronary sclerosis

329

2869

0.91

1.01

1.3

661.41

566.51

mg/l

0.58

317

2710

Corns and callosities

538

1.25

1.00

1.7

1.3

910.83

540.91

mg/l

0.42

508

Use of ropinirole

300

1.34

1.00

1.3

538.90

541.78

mg/l

0.02

283

Short Achilles tendon (acquired)

189

1.44

0.99

1.3

1.2

438.68

477.48

mg/l

0.29

178

Sequelae of poliomyelitis

1.83

0.99

1.2

1.1

554.00

499.13

mg/l

0.30

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.99

0.0

4.5

—

309.96

—

Malignant neoplasm of vagina, including Hilmo

0.00

0.99

0.0

1.1

—

384.63

—

ILD, hospital admissions

137

1179

1.17

0.99

1.2

1.3

713.19

546.93

mg/l

0.38

125

1107

Procedures for purposes other than remedying health state

181

1.45

0.99

1.6

1.3

422.46

475.67

mg/l

0.53

171

Other congenital malformations of the digestive system

429

1.28

0.99

2.5

2.6

419.84

443.70

mg/l

0.16

412

Presence of cardiac and vascular implants and grafts

385

3125

0.91

0.98

1.2

1.3

563.52

582.37

mg/l

0.30

364

2966

Oesophageal obstruction

249

1.37

0.98

1.4

1.3

616.41

546.21

mg/l

0.19

233

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

208

1847

1.13

0.96

1.3

1.4

497.42

508.95

mg/l

0.11

201

1755

Exposure to other and unspecified animate mechanical forces

250

1.37

0.96

1.1

1.4

636.15

432.97

mg/l

0.36

235

Contact with other sharp object(s)

650

1.22

0.95

1.3

1.4

443.51

508.65

mg/l

1.24

612

Systemic disorders of connective tissue in diseases classified elsewhere

1.94

0.95

1.3

1.7

349.43

481.89

mg/l

—

Congenital malformation of biliary tract

2.30

0.95

1.2

5.0

241.17

400.63

mg/l

—

Arthropathy in ulcerative colitis

109

1.58

0.94

1.1

1.3

455.24

422.45

mg/l

0.19

102

Inflammatory disease of cervix uteri

507

1.25

0.94

1.8

1.3

526.14

500.36

mg/l

0.14

479

Degeneration of macula and posterior pole

465

3421

1.08

0.93

1.3

550.86

566.69

mg/l

0.28

444

3227

Malignant neoplasm of oesophagus, including Hilmo

257

0.66

0.93

1.0

1.2

557.47

526.51

mg/l

0.14

240

Nontoxic goitre/thyroid nodule

303

2753

1.10

0.93

1.3

489.03

524.85

mg/l

0.78

289

2599

Burn and corrosion confined to eye and adnexa

192

1.42

0.93

1.2

1.4

2353.33

475.37

mg/l

0.47

181

Childhood allergy (age < 16)

198

1447

1.13

0.93

1.6

1.8

405.09

417.81

mg/l

0.10

188

1378

Other disorders of pigmentation

339

1.31

0.92

1.1

1.3

473.03

524.95

mg/l

0.30

321

Bacterial sepsis of newborn

1.78

0.91

5.0

6.9

520.64

452.65

mg/l

0.16

HSIL lesion of the vulva

151

1.47

0.91

1.4

1.2

763.55

462.65

mg/l

0.41

139

Other and unspecified nonscarring hair loss

1.78

0.91

1.5

1.2

407.36

342.81

mg/l

0.24

Benign neoplasm of mouth and pharynx

109

929

1.18

0.91

1.2

1.3

577.86

528.27

mg/l

0.35

104

876

Other diseases of gallbladder

323

1.31

0.90

1.5

1.3

436.81

550.59

mg/l

2.11

306

Malignant neoplasm of oesophagus

182

0.60

0.90

1.0

1.2

495.91

510.84

mg/l

0.08

170

Maternal care for other known or suspected fetal problems

305

1755

1.10

0.90

1.2

1.3

421.39

429.75

mg/l

0.09

294

1678

Polyp of the female genital tract

354

1860

1.10

0.89

1.2

1.3

496.03

524.60

mg/l

0.37

340

1791

Interstitial lung disease

137

1192

1.15

0.88

1.2

1.3

713.19

547.54

mg/l

0.38

125

1119

Interstitial lung disease endpoints

137

1192

1.15

0.88

1.2

1.3

713.19

547.54

mg/l

0.38

125

1119

Other interstitial pulmonary diseases

137

1192

1.15

0.88

1.2

1.3

713.19

547.51

mg/l

0.38

125

1119

Bicuspidal aortic valve syndrome

323

0.71

0.88

1.5

1.6

459.35

520.76

mg/l

0.73

306

Maternal care for known or suspected abnormality of pelvic organs

312

1936

1.10

0.88

1.3

407.02

451.70

mg/l

0.97

305

1856

Primary open-angle glaucoma

284

2496

1.10

0.87

1.4

1.3

539.75

565.60

mg/l

0.37

273

2346

Maternal care related to the fetus and amniotic cavity and possible delivery problems

564

3090

1.07

0.86

1.3

505.52

469.04

mg/l

0.22

541

2944

Other mycoses, not elsewhere classified/unspecified

120

1.51

0.86

1.6

1.4

389.44

466.84

mg/l

0.69

115

Benign neoplasm: Liver

187

1.40

0.86

1.2

1.4

462.04

434.22

mg/l

0.14

174

Other nonscarring hair loss

1.65

0.85

1.5

1.2

398.23

354.47

mg/l

0.18

Traumatic ischaemia of muscle

1.58

0.85

1.5

1.2

454.73

473.32

mg/l

0.08

LSIL lesion of the cervix uteri, vagina or vulva

169

1497

1.13

0.85

1.4

1.3

472.55

462.57

mg/l

0.06

161

1435

Malignant neoplasm of respiratory system and intrathoracic organs

151

1428

0.88

0.85

1.3

1.2

754.85

550.62

mg/l

0.59

144

1343

Sequelae of poliomyelitis

1.78

0.84

1.2

1.1

555.30

496.29

mg/l

—

Labour and delivery complicated by fetal stress [distress]

268

1930

0.91

0.83

1.3

396.52

401.91

mg/l

0.10

261

1835

Sulfonylureas

264

2311

0.91

0.83

1.2

1.3

788.32

540.75

mg/l

1.30

248

2185

Myocardial infarction

470

3548

0.93

0.82

1.3

594.82

578.21

mg/l

0.14

444

3367

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

1.57

0.82

1.5

1.3

448.47

507.09

mg/l

0.34

Vasomotor rhinitis (mode)

644

1.20

0.82

1.4

1.3

390.10

521.20

mg/l

6.33

612

Other infective otitis externa

526

1.22

0.81

1.1

1.3

485.41

508.31

mg/l

0.14

494

All dysplastic lesions of the cervix uteri, vagina or vulva

355

3227

1.09

0.81

1.3

514.62

450.29

mg/l

0.59

340

3086

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.81

0.0

4.3

—

330.60

—

Benign neoplasm: Skin of ear and external auricular canal

303

1.29

0.80

1.4

1.3

681.30

506.23

mg/l

0.66

280

Idiopathic gout

720

1.18

0.79

1.2

1.3

803.64

558.26

mg/l

1.73

673

Ulcerative colitis (strict definition, require KELA)

190

1704

1.12

0.79

1.2

1.4

495.64

501.84

mg/l

0.06

184

1617

Mesothelioma, including Hilmo

0.51

0.79

1.2

1.3

1103.00

514.65

mg/l

—

Haemangioma and lymphangioma, any site

832

1.17

0.78

1.2

1.5

487.95

522.94

mg/l

0.33

790

Obstructed labour due to maternal pelvic abnormality

156

1384

1.13

0.78

1.2

1.3

513.83

511.82

mg/l

0.01

147

1318

Benign neoplasm: Tonsil

0.50

0.78

1.2

1.4

541.00

475.91

mg/l

—

Wide developmental disorders

348

1.27

0.78

1.5

3.0

364.36

424.48

mg/l

0.55

334

Psoriasis vulgaris

202

1821

1.11

0.77

1.2

1.3

489.49

515.69

mg/l

0.40

187

1727

Foreign body in ear

157

1.41

0.77

1.7

1.9

788.45

437.15

mg/l

0.67

150

Contact with other hot fluids

261

1.31

0.77

1.2

1.8

373.41

494.23

mg/l

2.33

247

Complications of labour and delivery

786

4143

1.06

0.76

1.3

494.24

492.83

mg/l

0.02

751

3943

Birth asphyxia

1.73

0.76

3.0

5.7

1177.00

367.87

mg/l

—

Use of levodopa decarbox-comt-inhibitor

235

1.33

0.76

1.6

1.2

480.81

552.81

mg/l

0.53

220

Other specified/unspecified spondylopathies

149

1.42

0.76

1.3

454.10

556.17

mg/l

1.04

142

Other congenital malformations of the digestive system

500

1.22

0.76

2.4

2.5

412.72

458.15

mg/l

0.40

477

Congenital retinoschisis

2.14

0.75

1.2

2.5

435.60

426.46

mg/l

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

2.14

0.75

1.4

1.2

460.60

589.54

mg/l

—

Supervision of high-risk pregnancy

253

1386

1.10

0.75

1.2

431.11

435.59

mg/l

0.04

238

1319

Gonarthrosis, primary, with knee surgery

541

4580

0.94

0.75

1.3

580.47

575.62

mg/l

0.04

504

4354

Pre-eclampsia or poor fetal growth

369

3413

1.08

0.75

1.2

1.3

451.65

459.61

mg/l

0.09

356

3257

379

3227

1.08

0.74

1.3

639.25

555.06

mg/l

0.74

359

3036

Coxarthrosis, primary

623

4980

1.06

0.74

1.3

652.77

564.52

mg/l

0.98

581

4738

Malignant neoplasm of testis, including Hilmo

133

1.44

0.74

1.1

1.2

566.79

533.74

mg/l

0.24

125

Evidence of alcohol involvement determined by blood alcohol level

108

1.50

0.74

1.2

468.06

448.98

mg/l

0.14

102

Benign neoplasm: Connective and other soft tissue of head, face and neck

125

1.45

0.73

1.1

1.5

473.06

493.48

mg/l

0.09

119

Other malignant neoplasms of skin (=non-melanoma skin cancer)

474

3042

1.07

0.73

1.2

1.3

598.47

537.98

mg/l

1.02

445

2874

Neurofibromatosis, type 1

1.69

0.73

1.1

1.4

466.90

406.36

mg/l

—

Angina pectoris

633

3985

1.06

0.73

1.2

1.3

576.55

580.08

mg/l

0.03

597

3783

Hypothyroidism due to medicaments and other exogenous substances

1.57

0.72

1.6

1.3

653.69

497.53

mg/l

0.41

Antenatal screening

239

1472

0.91

0.72

1.3

1.2

425.56

431.44

mg/l

0.07

227

1403

Conduction disorders

321

2405

1.08

0.72

1.2

1.4

515.55

539.87

mg/l

0.45

310

2273

Ventricular septal defect, a heart condition

240

0.70

0.71

2.0

3.8

336.18

421.61

mg/l

0.88

232

Actinomycosis

1.96

0.71

1.8

1.2

661.20

569.12

mg/l

—

Malignant neoplasm of prostate

237

1553

0.91

0.70

1.3

1.2

601.60

587.69

mg/l

0.12

221

1478

Chronic tubulo-interstitial nephritis

274

1.28

0.70

1.3

1.2

487.49

495.81

mg/l

0.06

262

Skin changes due to chronic exposure to nonionizing radiation

352

3018

1.08

0.69

1.3

655.11

558.61

mg/l

0.81

332

2834

Injury of muscle and tendon at lower leg level

154

1379

1.12

0.69

1.2

1.3

705.66

528.21

mg/l

0.52

149

1307

Other congenital malformations of tongue, mouth and pharynx

153

1.38

0.66

4.0

3.6

451.57

434.91

mg/l

0.05

148

LSIL lesion of the cervix uteri

136

1214

1.12

0.66

1.2

1.3

478.29

455.61

mg/l

0.12

129

1166

Pleural plaque with presence of asbestos

494

0.81

0.65

1.1

1.3

564.89

582.58

mg/l

0.08

451

In situ neoplasms

391

3662

1.07

0.65

1.3

516.73

524.80

mg/l

0.10

372

3458

Benign neoplasm: Descending colon

578

1.18

0.65

1.2

1.3

595.66

552.52

mg/l

0.22

542

Arthropathic psoriasis

118

1047

1.13

0.63

1.2

1.3

492.47

531.43

mg/l

0.46

111

989

Coxarthrosis, primary, with hip surgery

410

4083

0.94

0.63

1.3

651.72

548.65

mg/l

0.99

385

3870

Male infertility

387

1.22

0.63

1.3

1.4

1265.00

529.81

mg/l

0.48

369

Other specified transport accidents

1.66

0.62

1.5

310.38

459.59

mg/l

—

Congenital malformations of heart and great arteries

149

1300

1.11

0.62

1.4

2.0

404.24

493.74

mg/l

3.61

139

1239

Calcific aortic valvular stenosis, operated

209

2210

0.92

0.62

1.3

590.81

562.91

mg/l

0.32

200

2084

Calcific aortic valvular stenosis

209

2210

0.92

0.62

1.3

590.82

562.91

mg/l

0.32

200

2084

Malignant neoplasm of other and unspecified parts of biliary tract

104

0.57

0.62

1.2

602.00

472.03

mg/l

—

Parapsoriasis

147

1.37

0.62

1.1

1.5

561.00

475.89

mg/l

0.29

138

Vitiligo

1.47

0.62

1.6

1.5

404.07

418.74

mg/l

0.07

Malignant neoplasm of heart, mediastinum and pleura

1.47

0.62

2.2

1.3

660.14

528.04

mg/l

0.38

Pleural plaque

675

0.84

0.62

1.2

1.3

527.35

611.88

mg/l

0.62

619

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

182

1658

1.10

0.61

1.2

1.4

503.49

501.80

mg/l

0.01

176

1575

Anomalies of dental arch relationship, including avohilmo

237

1969

1.09

0.61

2.3

1.5

454.79

460.16

mg/l

0.05

225

1874

Open wound of hip and thigh

271

1.26

0.61

1.3

1.5

723.24

494.51

mg/l

0.41

255

164

1397

1.11

0.61

1.2

1.3

579.56

579.90

mg/l

0.00

153

1305

Use of rasagiline

209

1.30

0.61

1.5

1.3

476.19

555.24

mg/l

0.92

194

Microtia (small ears)

0.00

0.60

0.0

2.5

—

266.50

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

612

4398

1.05

0.60

1.3

469.74

490.66

mg/l

0.25

588

4204

Need for immunization against other single viral diseases

148

1.36

0.60

1.4

1.2

805.30

464.05

mg/l

0.72

140

Calcific aortic valvular stenosis, including rheumatic fever

210

2212

0.92

0.60

1.3

590.09

563.64

mg/l

0.30

201

2085

Retinal breaks without detachment

159

1442

1.11

0.59

1.2

1.3

470.21

537.55

mg/l

2.13

153

1362

Malignant neoplasm of small intestine

157

1.35

0.59

1.5

1.2

527.95

499.98

mg/l

0.17

146

Operations 2 for CAVS

209

2203

0.92

0.59

1.3

590.82

563.86

mg/l

0.30

200

2077

Calcific aortic valvular stenosis, diagnosis (helper)

209

2203

0.92

0.59

1.3

590.82

563.86

mg/l

0.30

200

2077

Carcinoma in situ, bladder

254

0.74

0.59

1.3

1.2

772.79

549.95

mg/l

0.58

234

Erectile dysfunction, exclusion

0.00

0.59

0.0

1.2

—

589.30

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

150

0.66

0.58

1.1

1.3

515.80

514.88

mg/l

—

138

Macular pucker

138

1244

1.11

0.58

1.4

1.3

540.95

548.29

mg/l

0.07

132

1174

Hypertensive Renal Disease

202

1.29

0.57

1.1

1.3

581.23

570.07

mg/l

0.05

184

Seropositive rheumatoid arthritis, wide

264

2454

1.08

0.57

1.3

776.25

531.37

mg/l

0.79

251

2336

Medical treatment for female infertility

220

2367

0.92

0.57

1.3

447.73

423.11

mg/l

0.17

204

2272

Other specific arthropathies, wide

167

1.33

0.57

1.4

1.2

784.41

479.86

mg/l

0.56

159

Actinic keratosis

337

2924

1.07

0.57

1.3

664.11

557.05

mg/l

0.88

318

2745

Autism

238

1.27

0.57

1.1

2.4

307.63

416.72

mg/l

2.15

225

Cutis laxa senilis

1.56

0.56

1.1

1.2

404.70

471.10

mg/l

—

Amputation of ankle bones

150

1.34

0.56

1.5

1.2

534.50

524.29

mg/l

0.05

142

COPD-related respiratory insufficiency

878

1.13

0.56

1.2

530.34

595.38

mg/l

0.64

821

Maternal care for known or suspected malpresentation of fetus

193

1521

0.92

0.55

1.3

367.19

414.29

mg/l

2.35

187

1456

Liposarcoma, including Hilmo

1.48

0.55

1.3

720.42

501.82

mg/l

0.42

Adjustment and management of implanted device

148

1345

1.10

0.54

1.1

1.3

512.05

552.64

mg/l

0.58

142

1273

Malignant neoplasm of vulva, including Hilmo

1.43

0.54

1.6

1.2

1130.79

462.64

mg/l

0.61

Other congenital malformations of tongue, mouth and pharynx

194

1.29

0.54

3.5

3.4

430.76

409.20

mg/l

0.07

188

Keratoconus

213

1.28

0.54

1.1

1.3

827.74

487.77

mg/l

0.51

201

D07AA Corticosteroids, weak (group I)

179

1640

1.09

0.54

1.6

1.7

495.08

469.22

mg/l

0.23

171

1559

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

231

2116

1.08

0.54

1.4

1.3

680.24

542.71

mg/l

1.99

223

1995

Carcinoma in situ of other and unspecified sites

272

0.77

0.54

1.3

1.2

741.24

559.78

mg/l

0.50

252

Dislocation, sprain and strain of joints and ligaments of elbow

618

1.15

0.53

1.7

1.8

498.45

489.25

mg/l

0.05

589

Dermatopolymyositis, unspecified

1.56

0.53

1.2

1.1

399.50

443.18

mg/l

—

Psoriatic arthropathies, ICD10

110

986

1.12

0.53

1.2

1.3

484.06

530.00

mg/l

0.59

103

935

Injury of muscle and tendon at hip and thigh level

101

901

1.12

0.53

1.4

1.3

608.85

544.86

mg/l

0.44

848

Basal cell carcinoma

450

2951

1.06

0.53

1.2

1.3

589.71

539.87

mg/l

0.84

422

2787

Duodenal ulcer

788

1.13

0.52

1.2

1.3

674.46

597.50

mg/l

0.44

740

Exclusion endpoint for clefts

187

1.29

0.52

1.4

3.5

325.92

460.74

mg/l

1.57

180

Primary coxarthrosis, bilateral

260

2427

1.07

0.52

1.3

701.72

542.73

mg/l

1.20

239

2294

Other chronic obstructive pulmonary disease, including avohilmo

500

4339

0.95

0.52

1.2

1.3

554.68

570.45

mg/l

0.16

465

4117

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.51

0.52

1.2

2.0

350.00

421.80

mg/l

—

Primary gonarthrosis, bilateral

527

4303

1.05

0.51

1.3

556.18

574.17

mg/l

0.30

502

4088

Chronic nephritic syndrome

315

1.21

0.51

1.6

1.2

653.87

524.47

mg/l

0.37

290

Calcaneal spur

1.39

0.51

1.4

1.2

443.44

457.49

mg/l

—

Malignant neoplasm of cervix uteri, including Hilmo

202

0.74

0.50

1.2

1.3

559.60

432.59

mg/l

0.43

189

Graves disease, strict definition

106

953

1.12

0.50

1.4

1.3

454.14

484.21

mg/l

0.36

913

Malignant neoplasm, without specification of site

207

1.26

0.49

1.2

1.3

690.19

506.20

mg/l

0.51

198

Other disorders of prostate

207

1.26

0.49

1.5

1.3

699.23

568.52

mg/l

0.50

190

All dysplastic lesions of the cervix uteri

307

2865

1.06

0.49

1.2

1.3

515.68

440.00

mg/l

0.62

293

2744

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

107

0.65

0.49

1.1

1.2

611.71

501.56

mg/l

—

102

Congenital malformations of posterior segment of eye

1.54

0.49

1.7

3.6

397.43

465.26

mg/l

—

Non-small cell lung cancer, including Hilmo

110

1147

0.90

0.49

1.3

1.2

773.00

558.29

mg/l

0.42

105

1073

Tooth eruption problems

176

1585

1.08

0.48

2.3

1.6

397.19

431.24

mg/l

0.49

167

1505

Bronchiectasis

606

1.14

0.48

1.4

1.3

459.48

530.22

mg/l

0.83

573

ILD, hospital admissions 1, main diag only

119

1081

1.10

0.47

1.2

1.3

740.88

549.04

mg/l

0.39

110

1014

Benign neoplasm: Duodenum

209

1.25

0.47

1.5

1.3

550.54

536.98

mg/l

0.08

196

Other conjunctival vascular disorders and cysts

182

1.27

0.47

1.1

1.3

685.30

495.17

mg/l

0.59

171

Colitis, primary sclerosing

118

0.67

0.46

1.1

1.6

351.00

405.90

mg/l

—

112

Aortic aneurysm

178

1883

0.93

0.46

1.4

1.3

517.26

561.61

mg/l

0.87

171

1776

Cystic kidney disease

287

0.80

0.46

1.2

1.6

587.52

505.42

mg/l

0.35

273

Peripheral artery disease

371

3110

0.95

0.45

1.3

725.76

564.37

mg/l

0.92

355

2937

Other psoriatic arthropathies

106

960

1.11

0.45

1.3

482.43

530.50

mg/l

0.60

100

910

HSIL lesion of the cervix uteri, vagina or vulva

229

2145

1.07

0.44

1.2

1.3

550.23

452.62

mg/l

0.62

220

2051

Thyroiditis, unspecified

121

1.33

0.44

1.4

1.5

553.88

484.06

mg/l

0.25

114

Venous complications and haemorrhoids in the puerperium

104

1.36

0.43

1.5

1.3

500.00

412.24

mg/l

0.38

Multiple delivery

830

0.89

0.43

1.3

471.11

491.26

mg/l

0.14

793

Other/unspecified seropositive rheumatoid arthritis

258

2429

1.06

0.43

1.3

782.50

532.60

mg/l

0.79

246

2312

Non-ischemic cardiomyopathy

305

2321

1.06

0.43

1.5

1.3

509.97

562.86

mg/l

1.37

297

2186

Rheumatic valve diseases

131

0.68

0.43

1.3

316.56

464.48

mg/l

—

126

Hypersensitivity pneumonitis due to organic dust

113

1.34

0.43

1.5

1.2

384.13

456.11

mg/l

0.85

105

Idiopathic thrombocytopenic purpura

239

1.22

0.43

1.7

1.4

604.34

462.10

mg/l

0.65

225

Major anomalies of jaw size

230

1.22

0.43

1.3

1.8

376.04

451.00

mg/l

1.50

214

Actinomycosis

1.58

0.42

1.8

1.2

661.20

558.41

mg/l

—

Basal cell carcinoma, including avohilmo

466

3070

1.05

0.42

1.2

1.3

583.19

536.48

mg/l

0.81

437

2899

Other menopausal disorders

308

1641

1.06

0.42

1.3

495.31

539.77

mg/l

0.48

294

1578

Single delivery by caesarean section

202

1241

0.93

0.42

1.5

1.3

455.31

461.80

mg/l

0.04

196

1185

Pulmonary artery stenosis

0.00

0.42

0.0

6.4

—

238.69

—

Noonan syndrome

0.00

0.42

0.0

4.4

—

268.69

—

Other congenital malformations of eye

0.00

0.42

0.0

3.2

—

336.33

—

Single ventricle heart

0.00

0.42

0.0

5.4

—

324.20

—

Supernumerary ureter

0.00

0.42

0.0

4.3

—

248.87

—

Folliculitis decalvans

0.00

0.42

0.0

1.1

—

780.20

—

Other hammer toe(s) (acquired)

154

1315

1.08

0.41

1.3

625.59

518.65

mg/l

0.32

143

1237

Benign neoplasm: Tongue

228

0.79

0.41

1.3

557.00

510.10

mg/l

0.16

213

Medullary cystic kidney disease, nephronophthisis

0.00

0.41

0.0

1.1

—

530.94

—

Traumatic amputation of ankle and foot

0.00

0.41

0.0

1.3

—

633.94

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

254

2397

1.06

0.40

1.3

784.34

532.20

mg/l

0.78

242

2279

Cystic kidney disease

260

0.80

0.40

1.2

1.6

586.19

507.47

mg/l

0.30

246

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

499

3247

1.04

0.40

1.3

599.13

558.94

mg/l

0.53

471

3074

Aggressive periodontitis

171

0.76

0.39

1.0

1.2

497.62

492.80

mg/l

0.01

162

Other chronic obstructive pulmonary disease

388

3346

0.95

0.39

1.3

536.78

583.67

mg/l

0.96

360

3181

Infections of breast associated with childbirth

344

1.17

0.39

1.3

382.35

454.89

mg/l

1.33

326

Artificial joint operation, meniscal resection

1096

6924

1.03

0.38

1.3

573.50

559.76

mg/l

0.17

1035

6606

Juvenile cataract

1.40

0.38

1.2

1.8

1279.20

424.72

mg/l

—

Inguinal hernia

688

4445

1.04

0.38

1.3

1.4

610.81

569.53

mg/l

0.31

655

4243

Pneumothorax

561

1.13

0.38

1.3

714.47

550.56

mg/l

0.31

524

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

133

1232

1.08

0.37

1.2

1.3

488.27

537.19

mg/l

0.86

123

1165

Maternal care for known or suspected fetal abnormality and damage

185

1491

1.07

0.37

1.3

462.83

423.06

mg/l

0.25

178

1428

Primary biliary cholangitis (PBC)

147

0.74

0.37

1.2

1.3

514.45

485.85

mg/l

0.10

138

Malignant neoplasm of prostate, including Hilmo

257

1614

0.95

0.37

1.3

1.2

618.48

584.71

mg/l

0.36

242

1537

Contact with lifting and transmission devices, not elsewhere classified

143

1.27

0.37

1.6

1.3

586.39

518.04

mg/l

0.23

134

Acute nephritic syndrome

152

1.26

0.37

1.4

453.32

468.82

mg/l

0.09

144

Polymorphous light eruption

1.29

0.37

1.6

1.3

318.89

391.68

mg/l

—

Androgenic alopecia

1.29

0.37

3.6

1.3

580.78

366.71

mg/l

—

Malignant neoplasm of vulva

1.29

0.37

1.6

1.2

1275.44

469.35

mg/l

—

Congenital malformations of genital organs

106

969

1.09

0.36

1.5

1.9

416.82

450.64

mg/l

0.36

929

Ectopic pregnancy

186

1749

1.06

0.35

1.3

434.58

485.54

mg/l

1.06

178

1671

Congenital malformations of breast

144

1.26

0.35

1.1

1.3

343.33

419.45

mg/l

1.05

135

Pectus excavatum

1.41

0.35

1.2

1.6

310.67

363.95

mg/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

186

1882

0.94

0.35

1.3

548.27

508.21

mg/l

0.37

176

1777

Premature rupture of membranes

236

1782

0.95

0.35

1.2

1.3

444.78

427.33

mg/l

0.20

225

1699

Serous carcinoma of ovary, including Hilmo

276

0.83

0.34

1.0

1.2

481.17

468.41

mg/l

0.07

257

Myocardial infarction, without ST-elevation

362

3160

1.04

0.34

1.2

1.3

690.67

573.83

mg/l

0.65

334

3000

Maxillary prognathism

1.34

0.34

1.0

2.2

291.17

359.07

mg/l

—

malignant neoplasm of male genital organs

257

1648

0.95

0.34

1.3

1.2

600.03

584.50

mg/l

0.15

241

1566

Corneal degeneration

127

1.27

0.34

1.1

1.4

642.63

475.35

mg/l

0.52

118

Olecranon bursitis

434

1.13

0.33

1.2

1.3

510.77

560.78

mg/l

0.58

407

Postpartum haemorrhage due to retained placenta

120

1291

0.93

0.33

1.3

530.43

451.50

mg/l

0.57

114

1242

Follicular adenocarcinoma of thyroid gland, including Hilmo

0.68

0.33

1.2

588.67

431.65

mg/l

—

Gastrointestinal stromal tumor and sarcoma

0.68

0.33

1.0

1.2

611.00

495.60

mg/l

—

All-cause Heart Failure

553

4036

0.97

0.33

1.4

1.3

589.10

569.43

mg/l

0.15

532

3819

Toxic effect of alcohol

164

1.22

0.33

1.4

1.2

491.10

502.40

mg/l

0.05

154

Obstructed labour due to malposition and malpresentation of fetus

242

2372

0.95

0.32

1.2

1.3

457.86

442.63

mg/l

0.14

231

2257

Mental and behavioural disorders associated with the puerperium

1.31

0.32

1.2

1.5

326.25

360.55

mg/l

0.56

Cervical root disorders

1.36

0.31

4.6

1.2

526.57

457.91

mg/l

—

Varicose veins

667

4892

1.03

0.31

1.3

610.31

552.10

mg/l

0.40

635

4656

Carbimazole or st.post thyroidectomy, condition for graves disease

217

2063

1.05

0.30

1.4

1.3

467.82

514.22

mg/l

0.99

207

1962

Retinoschisis and retinal cysts

175

1.21

0.30

1.1

1.4

578.71

529.99

mg/l

0.39

161

Deep bite

126

1033

1.07

0.30

2.3

1.9

391.21

475.37

mg/l

2.41

117

988

malignant neoplasm of female genital organs

117

1245

0.93

0.30

1.2

1.3

558.03

516.25

mg/l

0.21

112

1165

Thyrotoxicosis with toxic multinodular goitre

483

0.89

0.29

1.3

666.72

520.74

mg/l

1.04

455

Malignant neoplasm of breast, HER-negative

163

1693

0.94

0.29

1.3

566.78

515.03

mg/l

0.45

157

1591

Operations for atrial fibrillation

106

0.75

0.29

1.0

1.2

498.50

525.54

mg/l

—

101

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

185

1.19

0.29

1.4

1.2

473.50

533.42

mg/l

0.29

173

Other and unspecified corneal deformities and disorders

260

1.16

0.29

1.7

1.3

525.23

496.34

mg/l

0.17

246

Adhesive middle ear disease

121

1.25

0.28

1.0

1.4

479.47

403.05

mg/l

0.52

115

Congenital malformations of ovaries, fallopian tubes and broad ligaments

536

1.10

0.28

1.3

455.50

450.90

mg/l

0.02

511

Multiple gestation

939

0.92

0.28

1.6

1.3

509.83

432.18

mg/l

0.76

902

Endometriosis of fallopian tube

1.28

0.28

2.6

1.5

602.38

548.11

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

690

1.09

0.28

1.1

1.3

420.70

434.08

mg/l

0.11

662

Twin gestation

907

0.92

0.27

1.6

1.3

510.48

428.92

mg/l

0.78

871

Congenital malformations of eye, ear, face and neck

653

1.09

0.27

1.3

2.1

389.48

472.36

mg/l

2.47

618

Nephrotic syndrome

262

1.15

0.27

1.6

1.9

773.00

476.13

mg/l

0.67

247

219

1992

0.96

0.25

1.3

593.87

585.22

mg/l

0.08

207

1861

Congenital malformations of anterior segment of eye

1.22

0.25

1.2

2.0

430.78

418.99

mg/l

—

Heart failure, strict

565

4092

0.97

0.25

1.4

1.3

586.14

569.49

mg/l

0.13

543

3870

Femoral hernia

330

1.12

0.25

1.1

1.3

580.30

508.11

mg/l

0.19

307

Mental and behavioural disorders of puerperium, not classified elsewhere

1.26

0.24

1.2

1.3

326.25

361.85

mg/l

0.66

Benign neoplasm: Parathyroid gland

1.17

0.24

1.2

444.33

535.86

mg/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

180

0.83

0.24

2.2

1.2

479.20

498.86

mg/l

0.08

169

Benign neoplasm: Peripheral nerves and autonomic nervous system

124

1.22

0.24

1.1

1.3

544.73

457.21

mg/l

0.70

113

Other disorders of breast and lactation associated with childbirth

152

1.19

0.24

1.2

1.4

365.78

382.48

mg/l

0.16

145

659

1.08

0.23

1.2

1.3

589.68

564.66

mg/l

0.08

618

Malignant neoplasm of cervix uteri

125

0.80

0.23

1.2

1.3

486.90

412.90

mg/l

—

115

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.24

0.23

2.7

3.5

1003.92

369.63

mg/l

0.41

Laparoscopic left hemicolectomy

125

0.80

0.23

1.3

1.2

550.10

513.50

mg/l

—

117

Precocious puberty

1.29

0.23

1.2

3.4

751.80

334.28

mg/l

—

Later onset COPD, excluding more controls

143

1162

0.95

0.23

1.2

1.3

513.43

522.13

mg/l

0.11

134

1100

Other disorders of iris and ciliary body

181

1.16

0.22

1.2

1.3

511.52

496.87

mg/l

0.08

170

Unspecified lump in breast

150

1429

1.05

0.22

1.2

1.3

445.26

509.49

mg/l

1.65

144

1362

Chronic respiratory disease originating in the perinatal period

1.23

0.22

3.8

5.2

445.80

385.44

mg/l

—

Digeorge syndrome

0.00

0.22

0.0

8.0

—

234.18

—

Other noninflammatory disorders of uterus, except cervix

213

1378

1.04

0.22

1.3

492.33

561.39

mg/l

0.92

202

1326

Ascorbic acid deficiency

0.00

0.22

0.0

3.0

—

261.40

—

Disorders of copper metabolism

0.00

0.21

0.0

3.6

—

336.91

—

Juvenile dermatomyositis

0.00

0.21

0.0

2.9

—

326.73

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

836

1.07

0.21

1.1

1.3

439.79

450.65

mg/l

0.09

800

Congenital glaucoma

0.00

0.21

0.0

1.1

—

322.50

—

Injury of blood vessels at ankle and foot level

0.00

0.21

0.0

1.3

—

570.60

—

Lichen striatus

0.00

0.21

0.0

1.2

—

484.00

—

Hypotony of eye

0.00

0.21

0.0

1.2

—

551.27

—

Malignant neoplasm of pyriform sinus, including Hilmo

0.00

0.21

0.0

1.6

—

630.60

—

Transepidermal elimination disorders

0.00

0.21

0.0

1.1

—

322.36

—

Rifle, shotgun and larger firearm discharge

0.00

0.21

0.0

1.0

—

615.50

—

Intentional self-harm by jumping or lying before moving object

0.00

0.21

0.0

1.1

—

448.09

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.21

0.0

1.2

—

400.17

—

Induced delusional disorder

0.00

0.21

0.0

1.2

—

379.58

—

Other recurrent vertebral subluxation

0.00

0.21

0.0

1.3

—

395.50

—

Polydactyly

0.00

0.21

0.0

5.2

—

293.17

—

Secondary lactase deficiency

0.00

0.21

0.0

1.3

—

480.83

—

Disorders of sexual preference

0.00

0.21

0.0

1.3

—

600.83

—

Neuroendocrine tumor and carcinoma of small intestine

105

0.76

0.21

1.0

1.2

452.12

469.72

mg/l

—

Haemolytic disease of fetus and newborn

0.00

0.21

0.0

8.6

—

224.00

—

Hirsprung

0.00

0.21

0.0

4.5

—

630.85

—

Iodine-deficiency-related goitre

0.00

0.21

0.0

1.1

—

327.38

—

Alport

0.00

0.21

0.0

4.2

—

347.92

—

COPD

414

3474

0.97

0.20

1.3

534.37

579.46

mg/l

0.95

385

3299

Heart failure,strict

542

3736

1.02

0.20

1.4

1.3

538.82

573.02

mg/l

0.83

520

3540

Abnormal spermatozoa

933

0.94

0.20

1.2

576.96

567.12

mg/l

0.09

880

Benign neoplasm: Uterine tubes and ligaments

1.21

0.20

1.2

386.33

474.07

mg/l

—

Pleural effusion

125

1191

1.05

0.20

1.4

1.3

565.12

570.01

mg/l

0.03

118

1114

Pacemaker

259

2562

0.97

0.19

1.2

1.3

523.84

555.33

mg/l

0.62

243

2418

Rheumatic fever incl heart disease

186

0.86

0.19

1.3

1.2

376.06

475.92

mg/l

0.68

175

Heart failure and bmi 25plus

300

2087

0.97

0.19

1.3

567.01

606.80

mg/l

0.58

284

1967

Postpartum haemorrhage

288

2498

0.97

0.19

1.2

1.3

458.29

437.49

mg/l

0.26

276

2375

Benign neoplasm: other/unspecified salivary gland

203

1.14

0.19

1.1

1.2

440.83

496.09

mg/l

0.74

192

Unstable angina pectoris

342

2770

0.97

0.18

1.3

631.32

582.96

mg/l

0.26

325

2623

Inguinal hernia, bilateral

833

1.06

0.18

1.2

1.3

599.41

535.97

mg/l

0.42

779

Seropositive rheumatoid arthritis, strict definition

141

1352

1.04

0.18

1.2

1.3

914.75

524.05

mg/l

0.63

133

1274

HSIL lesion of the vagina

121

0.82

0.18

1.4

1.3

1387.40

434.05

mg/l

—

111

Other specified/unspecified nutritional deficiencies

1.17

0.18

1.0

1.3

535.14

430.95

mg/l

—

Inguinal or femoral hernia, bilateral

845

1.05

0.17

1.2

1.3

596.69

535.01

mg/l

0.42

790

Pleural plaque without asbestos

236

0.89

0.17

1.5

1.2

439.57

570.86

mg/l

1.29

220

Leiomyoma of uterus

717

3994

1.02

0.16

1.3

548.37

506.74

mg/l

0.49

686

3811

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

710

1.06

0.16

1.1

1.3

420.70

453.31

mg/l

0.29

677

Traction detachment of retina

1.11

0.16

1.5

1.2

577.38

439.55

mg/l

—

Benign leiomyoma with endometriosis

142

1367

1.04

0.16

1.3

491.33

512.63

mg/l

0.22

132

1308

288

1.10

0.16

2.2

4.0

382.94

408.00

mg/l

0.11

283

Inflammation of lacrimal passages (acute and unspecified)

130

0.84

0.16

3.0

1.3

548.18

489.66

mg/l

0.15

124

Benign neoplasm: Short bones of lower limb

0.78

0.15

1.5

1.2

357.33

442.37

mg/l

—

Pyogenic granuloma

130

1.16

0.15

1.1

1.4

516.33

434.57

mg/l

0.23

122

Impacted teeth

222

2033

0.97

0.15

1.6

1.4

446.93

436.87

mg/l

0.08

210

1938

Carcinoma in situ of skin of lower limb, including hip

140

1.15

0.15

1.3

1.2

486.75

512.93

mg/l

0.19

130

Single spontaneous delivery

439

2372

0.98

0.15

1.2

1.3

547.93

481.92

mg/l

0.67

412

2252

Other disorders originating in the perinatal period

131

1.15

0.14

3.3

4.5

319.87

341.30

mg/l

0.11

131

Coronary atherosclerosis

715

4457

1.01

0.14

1.3

580.98

579.71

mg/l

0.01

671

4237

Pregnancy, childbirth and the puerperium

317

1618

1.02

0.14

1.3

487.11

451.78

mg/l

0.44

296

1529

Malignant neoplasm of other and ill-defined sites, including Hilmo

100

0.80

0.13

4.8

1.3

342.87

514.26

mg/l

—

Lung cancer and mesothelioma

148

1227

1.03

0.13

1.3

744.44

534.90

mg/l

0.60

140

1167

Gender identity disorders

113

1.15

0.13

1.2

1.5

403.15

464.45

mg/l

0.31

108

COPD related to multimorbidity

344

2963

0.98

0.13

1.3

538.41

584.05

mg/l

0.88

318

2808

Colorectal neuroendocrine tumor and carcinoma

109

0.82

0.13

1.4

1.3

433.89

422.57

mg/l

—

100

Malignant neoplasm of larynx

110

0.82

0.13

1.4

1.3

762.89

529.94

mg/l

—

104

Other assisted single delivery

161

1.12

0.13

1.2

1.4

341.17

436.06

mg/l

1.59

155

Delivery, wide proxy

371

1932

1.02

0.12

1.3

515.10

461.11

mg/l

0.83

345

1833

Respiratory and cardiovascular disorders specific to the perinatal period

265

1.08

0.12

5.3

3.9

708.13

396.67

mg/l

0.77

260

Abrasion of teeth

354

3607

0.98

0.12

1.3

446.66

519.31

mg/l

3.18

331

3439

Abscess of external ear

104

1.16

0.12

1.3

1.6

773.42

404.91

mg/l

0.66

Embedded teeth, including avohilmo

103

993

1.04

0.12

1.6

1.5

458.25

450.89

mg/l

0.05

941

Chronic suppurative otitis media

599

0.95

0.11

1.4

1.6

564.94

490.71

mg/l

0.33

561

Benign neoplasm: Vulva

168

0.89

0.11

1.0

1.3

439.07

485.65

mg/l

0.40

158

Cardiomyopathy, other and unspecified

680

0.96

0.11

1.4

1.3

652.63

539.70

mg/l

1.01

647

HSIL lesion of the cervix uteri

205

2007

1.02

0.10

1.2

1.3

517.99

450.79

mg/l

0.37

196

1922

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

860

1.04

0.10

1.1

1.3

439.79

468.34

mg/l

0.27

820

Congenital aortic valve stenosis

1.14

0.10

1.2

3.9

466.60

469.05

mg/l

—

Chronic suppurative otitis media, including avohilmo

707

0.96

0.09

1.4

1.8

876.75

507.63

mg/l

0.54

669

Benign neoplasm: Skin of eyelid, including canthus

138

1345

1.03

0.09

1.2

1.3

549.66

528.31

mg/l

0.20

131

1267

Major coronary heart disease event excluding revascularizations

637

4290

0.99

0.09

1.3

575.83

575.36

mg/l

0.00

605

4072

Short stature starting before birth

1.07

0.09

2.5

5.9

333.33

336.80

mg/l

—

Autism spe

243

1.07

0.08

1.2

2.4

314.15

438.17

mg/l

1.86

231

Non-rheumatic valve diseases

506

3608

1.01

0.08

1.4

562.95

558.70

mg/l

0.06

486

3430

Other and unspecified disorders of pigmentation

1.05

0.08

1.3

1.2

392.00

395.10

mg/l

—

Leiomyosarcoma

1.04

0.08

1.0

1.3

561.00

519.92

mg/l

—

Benign neoplasm of other and unspecified female genital organs

359

0.95

0.08

1.1

1.3

459.18

503.13

mg/l

0.36

342

Malignant neoplasm of other and unspecified female genital organs

123

0.89

0.08

1.0

1.2

531.00

474.57

mg/l

0.13

114

Supervision of normal pregnancy

246

1428

0.98

0.08

1.3

1.2

390.11

430.26

mg/l

1.01

234

1361

Other injuries of spine and trunk, level unspecified

1.05

0.08

1.1

1.6

757.57

445.95

mg/l

—

Personal history of allergy to drugs, medicaments and biological substances

1.13

0.07

1.1

1.2

352.55

427.33

mg/l

1.02

Benign neoplasm: Kidney

276

0.94

0.07

1.2

1.3

416.08

520.42

mg/l

2.01

263

Benign neoplasm of thyroid gland

274

1.06

0.07

1.2

1.4

493.28

500.89

mg/l

0.06

261

Family history of malignant neoplasm

105

1076

0.98

0.07

1.2

1.3

477.48

494.10

mg/l

0.11

1027

Sequelae of tuberculosis

0.86

0.07

2.1

1.2

347.71

514.28

mg/l

—

Other acute skin changes due to ultraviolet radiation

265

1.06

0.07

1.9

1.3

434.14

508.56

mg/l

0.74

250

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.87

0.07

1.5

2.7

399.25

466.53

mg/l

—

Valvular heart disease excluding rheumatic fever

511

3655

1.01

0.06

1.4

570.22

555.96

mg/l

0.22

491

3476

Arterial embolism and thrombosis of lower extremity artery

244

0.94

0.06

1.3

465.48

526.19

mg/l

0.40

225

Inflammation of lacrimal passages (chronic)

101

0.89

0.06

1.7

1.3

564.89

498.43

mg/l

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

103

0.87

0.06

1.1

1.3

379.00

406.59

mg/l

—

Other diseases caused by chlamydiae

105

0.85

0.06

1.3

367.67

471.08

mg/l

—

Oral lichen planus, including avohilmo , including avohilmo

573

1.03

0.05

1.3

1.2

446.90

511.32

mg/l

1.22

544

Acute appendicitis, with complications

180

1825

0.99

0.05

1.3

585.62

529.03

mg/l

0.57

171

1731

Femoral hernia, unilateral

208

1.06

0.05

1.0

1.3

593.09

475.44

mg/l

0.19

194

Inguinal hernia, unilateral

208

1.06

0.05

1.0

1.3

593.09

475.44

mg/l

0.19

194

Inguinal of femoral hernia, unilateral

208

1.06

0.05

1.0

1.3

593.09

475.44

mg/l

0.19

194

COPD, hospital admission 2, with asthma infections

278

2358

1.01

0.05

1.2

1.3

516.54

569.18

mg/l

1.13

254

2231

Other and unspecified haemorrhagic conditions

110

0.91

0.05

1.1

1.4

600.10

434.63

mg/l

—

105

Embedded and impacted teeth

320

2665

0.99

0.05

1.6

1.4

450.23

451.91

mg/l

0.02

304

2545

COPD, hospital admissions 3, with asthma pneumonia sepsis

223

1883

1.01

0.05

1.3

522.17

568.86

mg/l

0.81

203

1776

Delivery

454

2378

1.01

0.04

1.3

560.70

482.18

mg/l

0.85

425

2258

Small cell lung cancer, helper endpoint

140

1.07

0.04

1.2

578.20

511.57

mg/l

0.29

130

260

1.04

0.04

1.8

4.2

401.18

400.45

mg/l

0.00

255

Pathological resorption of teeth

308

1.04

0.04

1.2

1.4

510.28

489.37

mg/l

0.12

291

Mixed hyperlipidaemia

308

1.04

0.04

1.3

1.2

586.00

547.32

mg/l

0.22

288

Benign neoplasm: Vagina

109

0.92

0.04

1.3

1.2

553.60

420.05

mg/l

—

Maternal care for known or suspected disproportion

402

0.97

0.04

1.4

1.3

557.54

442.65

mg/l

0.37

385

Other and unspecified disease of Bartholin gland

220

0.95

0.03

1.2

1.3

430.00

494.48

mg/l

0.51

209

Small cell lung cancer

159

0.94

0.03

1.2

578.20

509.55

mg/l

0.31

150

Small cell lung cancer, including Hilmo

159

0.94

0.03

1.2

578.20

509.55

mg/l

0.31

150

Carcinoma in situ of other and unspecified genital organs

161

1.06

0.03

1.2

1.3

426.94

487.90

mg/l

0.42

149

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

767

1.02

0.03

1.3

529.37

538.00

mg/l

0.05

723

Use of cabergoline

1.09

0.03

2.4

1.3

412.80

406.78

mg/l

—

Migraine without aura, drug-induced

102

1.08

0.03

1.5

1.3

696.18

419.91

mg/l

0.57

Secondary malignant neoplasm of other and unspecified sites

138

0.94

0.02

2.0

1.3

753.15

510.48

mg/l

0.37

127

Ulcerative ileocolitis

349

0.97

0.02

1.1

1.3

480.29

516.05

mg/l

0.14

329

Other specified congenital malformation syndromes affecting multiple systems

157

0.95

0.01

1.1

3.9

279.33

415.45

mg/l

1.92

150

Mandibular prognathia

137

0.95

0.01

1.4

2.3

380.54

458.39

mg/l

0.54

129

Long labour

279

2377

1.00

0.01

1.3

470.23

438.95

mg/l

0.29

269

2261

Orthopaedic devices associated with adverse incidents

147

0.95

0.01

1.3

1.2

447.43

527.67

mg/l

0.84

137

Poor fetal growth

134

1332

1.01

0.01

1.2

1.3

437.89

427.01

mg/l

0.06

128

1273

Postmenopausal atrophic vaginitis

259

1434

1.00

0.01

1.2

1.3

471.68

563.76

mg/l

1.65

250

1377

Malignant neoplasm of other and unspecified parts of tongue

104

1.06

0.01

1.2

452.36

458.12

mg/l

0.03

Crossbite

687

1.00

0.00

3.9

2.1

428.24

446.74

mg/l

0.06

658

Localized scleroderma [morphea]

115

0.96

0.00

1.5

1.3

469.18

483.94

mg/l

0.05

106

Family history of other conditions

125

0.96

0.00

1.2

1.5

418.25

417.92

mg/l

0.00

118

Colectomy operation

143

1435

1.00

0.00

1.2

1.3

534.64

545.70

mg/l

0.08

136

1351

Maxillary retrognathism

165

0.97

0.00

1.1

2.6

451.63

449.06

mg/l

0.01

155

Postpartum hemorraghe, all women as controls

288

2832

1.00

0.00

1.2

1.3

458.29

426.69

mg/l

0.47

276

2706

Cholangitis (primary sclerosing, PSC), with reimbursement 202

156

1.03

0.00

1.3

2.0

413.69

442.93

mg/l

0.20

147

Left hemicolectomy

166

1.02

0.00

1.1

1.2

434.94

512.35

mg/l

0.74

153

Abnormal findings on diagnostic imaging of breast

113

0.97

0.00

1.5

1.2

432.55

470.08

mg/l

0.24

106

Malignant neoplasm of larynx, including Hilmo

132

0.98

0.00

1.8

1.2

950.77

509.83

mg/l

1.57

125

Allergic contact dermatitis due to drugs in contact with skin

178

1.01

0.00

1.2

1.3

624.89

479.35

mg/l

0.57

164

Malignant neoplasm of small intestine, including Hilmo

238

1.01

0.00

1.5

1.2

582.42

504.00

mg/l

0.37

223

Postpartum hemorraghe, parous women as controls

288

2449

1.00

0.00

1.2

1.3

458.29

434.10

mg/l

0.33

276

2341

Hyphaema and other vascular disorders of iris and ciliary body

129

1.01

0.00

1.2

1.3

518.54

439.77

mg/l

0.55

120

Pure hyperglyceridaemia

177

1.02

0.00

1.4

546.61

531.54

mg/l

0.06

168

Premature separation of placenta [abruptio placentae]

201

0.99

0.00

1.3

1.4

481.85

472.49

mg/l

0.03

191

Polycystic kidney disease

203

0.98

0.00

1.2

1.6

617.65

494.71

mg/l

0.51

191

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

185

0.97

0.00

1.2

441.17

491.87

mg/l

0.46

173

Benign neoplasm of urinary organs

370

1.00

0.00

1.2

1.3

463.73

525.08

mg/l

0.73

347

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

225

0.98

0.00

1.1

1.2

573.86

468.35

mg/l

0.52

209

Leiomyosarcoma, including Hilmo

0.90

0.00

1.0

1.3

540.29

483.97

mg/l

—

Periodic paralysis

0.00

0.0

4.2

—

347.17

—

Toxic effect of other inorganic substances

0.00

0.0

1.0

—

553.00

—

Vibratory urticaria

0.00

0.0

1.2

—

639.11

—

Crushing injuries involving multiple body regions

0.00

0.0

1.4

—

438.40

—

Cicatricial pemphigoid

0.00

0.0

1.3

—

355.44

—

Benign neoplasm: Scapula and long bones of upper limb

0.98

0.00

1.1

1.3

488.13

440.07

mg/l

—

Hypotension due to drugs

0.95

-0.00

1.4

1.2

507.88

517.49

mg/l

—

Disorders of tyrosine metabolism

0.00

-0.00

0.0

1.1

—

361.63

—

Lipid storage disorder, other/unspecified

0.00

-0.00

0.0

1.4

—

304.00

—

Myelofibrosis

0.00

-0.00

0.0

1.0

—

392.20

—

Benign neoplasm: Appendix

0.99

-0.00

1.7

1.2

389.29

486.38

mg/l

—

Carcinoma in situ of bronchus and lung

0.00

-0.00

0.0

1.0

—

377.60

—

Fibrothorax

0.00

-0.00

0.0

1.0

—

664.57

—

Cholangitis (primary sclerosing, PSC)

480

1.00

-0.00

1.2

1.6

465.10

510.49

mg/l

0.52

456

Macular pucker, drug-induced

0.00

-0.00

0.0

1.1

—

619.67

—

Miliaria rubra

0.00

-0.00

0.0

1.5

—

594.13

—

Acquired keratosis follicularis

0.00

-0.00

0.0

1.1

—

302.00

—

Androgen resistance syndrome

0.00

-0.00

0.0

3.4

—

491.44

—

Selective deficiency of immunoglobulin M [IgM]

0.00

-0.00

0.0

4.6

—

367.40

—

Other deformity of hallux (acquired)

1.00

-0.00

2.0

1.3

373.00

442.93

mg/l

—

Diseases caused by chlamydiae

0.92

-0.00

1.3

367.67

456.74

mg/l

—

Malignant neoplasm of pyriform sinus

0.00

-0.00

0.0

1.6

—

552.20

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

2.5

—

252.25

—

Cardiovascular devices associated with adverse incidents

0.00

-0.00

0.0

1.2

—

461.50

—

Intentional self-harm by crashing of motor vehicle

0.00

-0.00

0.0

1.3

—

616.00

—

Trichomoniasis

0.91

-0.00

1.1

541.71

480.59

mg/l

—

Ischaemic infarction of muscle

0.00

-0.00

0.0

1.2

—

681.60

—

Immunodeficiency with increased immunoglobulin M [IgM]

0.00

-0.00

0.0

1.3

—

392.83

—

Drowning and submersion in swimming-pool or bath

0.00

-0.00

0.0

1.5

—

953.83

—

Histoplasmosis

0.00

-0.00

0.0

1.0

—

383.29

—

Undescended testis, unilateral

0.99

-0.00

2.6

4.5

307.13

415.11

mg/l

—

Ascariasis

0.00

-0.00

0.0

1.3

—

376.00

—

Iliac crest spur

0.00

-0.00

0.0

1.5

—

402.83

—

Legal intervention and operations of war

0.00

-0.00

0.0

1.1

—

610.25

—

Heberden's nodes [with arthropathy]

0.96

-0.00

1.7

1.2

485.14

502.49

mg/l

—

Chondrolysis

0.00

-0.00

0.0

1.0

—

401.00

—

Disorders of fructose metabolism

0.00

-0.00

0.0

1.4

—

458.00

—

Malignant neoplasm of anus and anal canal, including Hilmo

0.93

-0.00

1.1

1.2

458.56

489.13

mg/l

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

-0.00

0.0

1.4

—

828.40

—

Fetus and newborn affected by maternal complications of pregnancy

0.93

-0.00

2.3

6.0

261.75

392.14

mg/l

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.1

—

423.25

—

Secondary sideroblastic anaemia due to drugs and toxins

0.00

-0.00

0.0

1.2

—

499.67

—

Cleft palate

0.95

-0.00

1.0

1.9

492.00

357.49

mg/l

—

Explosion and rupture of other specified pressurized devices

0.00

-0.00

0.0

1.1

—

562.44

—

Legal intervention

0.00

-0.00

0.0

1.0

—

698.17

—

Toxic effect of metals

0.00

-0.00

0.0

1.3

—

370.00

—

Trachoma

0.00

-0.00

0.0

1.2

—

531.60

—

Trichomoniasis

0.88

-0.00

1.2

1.1

512.00

484.24

mg/l

—

Nanophthalmos, microphthalmos and macrophthalmos

0.00

-0.00

0.0

5.9

—

245.71

—

Traumatic amputation of forearm

0.00

-0.00

0.0

1.3

—

331.71

—

Other birth injuries

0.00

-0.00

0.0

1.0

—

281.43

—

Intracranial laceration and haemorrhage due to birth injury

0.00

-0.00

0.0

1.2

—

401.00

—

Crushing injury of thorax and traumatic amputation of part of thorax

0.00

-0.00

0.0

1.2

—

793.20

—

Slow fetal growth and fetal malnutrition

0.96

-0.00

1.0

6.5

294.29

418.21

mg/l

—

Labyrinthine dysfunction

0.00

-0.00

0.0

1.3

—

484.44

—

Other benign neoplasm of uterus: Cervix uteri

0.92

-0.00

1.0

1.2

553.60

360.21

mg/l

—

Autoimmune hepatitis

0.99

-0.00

1.7

520.14

427.97

mg/l

—

Cardiovascular disorders originating in the perinatal period

1.00

-0.00

2.0

5.8

1223.00

457.42

mg/l

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.2

—

286.20

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.2

—

292.20

—

Cholera

0.00

-0.00

0.0

1.3

—

423.13

—

Actinic reticuloid

0.00

-0.00

0.0

1.0

—

362.00

—

Carcinoma in situ, other/unspecified

0.00

-0.00

0.0

1.1

—

719.29

—

Birth injury to scalp

0.00

-0.00

0.0

4.6

—

267.12

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS